Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,A1BG,Alpha-1B-glycoprotein,18124,81,3.36 [0.89-12.66],0.0737795034034476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AAMDC,Mth938 domain-containing protein,17604,78,1.00 [0.67-1.49],0.9846849580958243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,20792,98,0.70 [0.51-0.97],0.0331347657426857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,17476,78,2.66 [1.69-4.19],2.4889358662144856e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABHD14B,Protein ABHD14B,20634,98,0.76 [0.54-1.05],0.0996693184176522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABL1,Tyrosine-protein kinase ABL1,20792,98,1.37 [1.08-1.75],0.010985309321031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABO,Histo-blood group ABO system transferase,18123,81,1.05 [0.91-1.22],0.5138175789183071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABRAXAS2,BRISC complex subunit Abraxas 2,17476,78,1.12 [0.82-1.53],0.4638200352825612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",20402,95,1.68 [1.39-2.03],5.975532988079389e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",17790,82,1.12 [0.85-1.48],0.4272078023642984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",18107,82,1.05 [0.84-1.31],0.6879575174712914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAN,Aggrecan core protein,20664,97,0.53 [0.27-1.01],0.0536591707208156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE,Angiotensin-converting enzyme,18123,81,2.81 [1.40-5.62],0.0035469523901297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,20501,98,1.86 [1.44-2.39],1.563461119031129e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACHE,Acetylcholinesterase,17690,82,0.94 [0.52-1.73],0.8548328436168625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOT13,Acyl-coenzyme A thioesterase 13,18042,82,1.12 [0.94-1.34],0.2062213410120803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,20881,98,1.03 [0.73-1.44],0.8694645918494825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,17564,80,0.35 [0.20-0.62],0.0003028879235419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,20963,101,3.28 [2.12-5.06],8.548542378907248e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP6,Lysophosphatidic acid phosphatase type 6,21046,101,0.99 [0.78-1.27],0.952348918034596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRBP,Acrosin-binding protein,18044,80,1.05 [0.63-1.74],0.8464370036316797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRV1,Acrosomal protein SP-10,17564,80,1.32 [1.09-1.60],0.0044803879559538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,17476,78,1.35 [0.80-2.27],0.2539153954583075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",20501,98,2.27 [1.82-2.83],2.399034891427965e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,17476,78,1.57 [1.18-2.11],0.0022594661318981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN4,Alpha-actinin-4,20526,99,1.09 [0.66-1.79],0.7346394204733246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,20657,99,6.25 [4.39-8.90],3.2425090127674747e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,20881,98,1.89 [1.47-2.43],6.649277660585614e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,17476,78,2.09 [1.51-2.89],9.234515562020085e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACYP1,Acylphosphatase-1,17629,81,0.83 [0.60-1.14],0.2478024167510364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA,Adenosine deaminase,21127,101,0.92 [0.57-1.47],0.7152231117045784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,20786,98,6.64 [4.98-8.85],4.918241569259451e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17564,80,4.51 [3.22-6.30],1.6082354168752385e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,20501,98,2.25 [1.27-3.96],0.0051735185761129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,20696,99,1.86 [1.17-2.97],0.0090078361592195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,21127,101,2.19 [1.27-3.80],0.0050597809635947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,21047,102,2.49 [1.60-3.86],4.692777153342413e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,18042,82,4.63 [3.08-6.97],1.7058357747332994e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,17564,80,2.48 [1.78-3.46],8.13380066098963e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,21140,101,1.97 [0.96-4.06],0.0640710611067364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,20792,98,2.62 [1.72-3.98],6.611608330133048e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,20501,98,1.09 [0.62-1.91],0.76717237174698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17564,80,1.76 [1.09-2.86],0.0211576208733164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,20948,102,0.72 [0.49-1.05],0.0913928320040845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,18104,80,3.33 [2.47-4.48],3.191535026214775e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL4,ADAMTS-like protein 4,17604,78,1.32 [0.54-3.23],0.5420486660222157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL5,ADAMTS-like protein 5,18107,82,1.77 [1.15-2.72],0.0093793049963522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,20402,95,0.91 [0.51-1.64],0.7608139439012489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADD1,Alpha-adducin,17690,82,0.78 [0.58-1.03],0.0795397096168585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,20657,99,3.32 [2.03-5.44],1.6812992697956918e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,17690,82,2.18 [1.35-3.51],0.0013714510892707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,18042,82,1.99 [1.39-2.83],0.0001470634815317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,20956,99,8.22 [5.04-13.40],2.810998545632878e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,21037,101,4.22 [3.19-5.58],5.535558360228633e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRF5,Adhesion G protein-coupled receptor F5,18107,82,2.28 [1.02-5.08],0.0447946820224855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,20792,98,2.28 [1.97-2.63],5.920150795153346e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,20881,98,0.37 [0.28-0.50],3.938148869383379e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRV1,Adhesion G-protein coupled receptor V1,17515,78,1.04 [0.77-1.40],0.7943226632479424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH1B,All-trans-retinol dehydrogenase,17690,82,1.07 [0.82-1.39],0.6204435027607584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,20501,98,1.15 [0.92-1.44],0.2127901510321929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADIPOQ,Adiponectin,18124,81,0.68 [0.50-0.93],0.0161938119068891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,21071,101,34.29 [17.67-66.55],1.512965521653541e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADRA2A,Alpha-2A adrenergic receptor,17476,78,0.91 [0.64-1.30],0.6080037971071739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFAP1,Actin filament-associated protein 1,17690,82,1.07 [0.84-1.37],0.5859933920551698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFM,Afamin,18124,81,0.70 [0.25-1.94],0.4932532542705214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFP,Alpha-fetoprotein,20618,99,0.56 [0.41-0.76],0.000168327067947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGBL2,Cytosolic carboxypeptidase 2,17515,78,0.84 [0.68-1.05],0.127017808229089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGER,Advanced glycosylation end product-specific receptor,20816,98,1.22 [0.80-1.87],0.3497067695982657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,20285,98,1.97 [1.69-2.30],3.418557935394893e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,20371,95,1.55 [1.20-1.99],0.000643047263523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,20956,99,3.86 [3.10-4.81],8.518676422951995e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,21127,101,2.69 [1.93-3.76],5.6029224198376935e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGT,Angiotensinogen,18123,81,1.94 [0.80-4.72],0.1442655577837615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGXT,Serine--pyruvate aminotransferase,20881,98,1.70 [1.38-2.11],1.0420167167432964e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHCY,Adenosylhomocysteinase,20881,98,1.05 [0.81-1.37],0.6938989193676894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,17604,78,0.84 [0.41-1.71],0.6318336094031217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK2,Protein AHNAK2,17604,78,1.55 [0.80-3.02],0.1943843013129049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,18044,80,0.75 [0.51-1.10],0.1379145248103935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSG,Alpha-2-HS-glycoprotein,18123,81,1.35 [0.61-2.99],0.4662637215550208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSP,Alpha-hemoglobin-stabilizing protein,20851,101,0.76 [0.62-0.94],0.0119284551567837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIDA,"Axin interactor, dorsalization-associated protein",17606,79,1.11 [0.89-1.38],0.3695710504821445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1,Allograft inflammatory factor 1,20402,95,1.11 [0.78-1.57],0.5574619548396147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1L,Allograft inflammatory factor 1-like,17604,78,1.24 [0.88-1.75],0.2166832379046273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",20762,98,1.30 [1.11-1.52],0.0009294419456367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK1,Adenylate kinase isoenzyme 1,20881,98,0.54 [0.40-0.73],5.219888470541484e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK2,"Adenylate kinase 2, mitochondrial",18060,81,1.08 [0.89-1.32],0.4338289481301641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKAP12,A-kinase anchor protein 12,17690,82,0.52 [0.18-1.57],0.2480938832692684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B1,Aldo-keto reductase family 1 member B1,20402,95,1.09 [0.86-1.40],0.4676949328051905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,17606,79,1.43 [1.11-1.84],0.0050842643606088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1C4,Aldo-keto reductase family 1 member C4,20501,98,1.15 [0.84-1.57],0.3990264350515117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,17564,80,1.65 [1.30-2.09],4.5642452950274816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT1S1,Proline-rich AKT1 substrate 1,20435,99,0.96 [0.74-1.26],0.7714177347867625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT2,RAC-beta serine/threonine-protein kinase,18071,81,0.95 [0.81-1.12],0.5370475133755588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT3,RAC-gamma serine/threonine-protein kinase,20312,94,1.08 [0.79-1.48],0.6369952134579605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,21140,101,13.71 [6.79-27.68],2.8693936793239894e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH1A1,Retinal dehydrogenase 1,20889,101,0.89 [0.65-1.22],0.4667728723127206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",18044,80,0.94 [0.60-1.48],0.7868080941667048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",20816,99,1.29 [1.05-1.57],0.0149809843521847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",18071,81,1.79 [1.24-2.58],0.0019380575736829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALMS1,Alstrom syndrome protein 1,17790,82,1.49 [1.02-2.20],0.0407055413475039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPI,Intestinal-type alkaline phosphatase,17564,80,1.16 [0.98-1.38],0.0817010864605876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPP,"Alkaline phosphatase, placental type",20792,98,1.23 [1.05-1.44],0.0100576344779948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBN,Ameloblastin,20526,99,0.88 [0.45-1.73],0.7086231960172186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,21037,101,26.90 [13.82-52.36],3.4543691994380403e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,18104,80,1.19 [0.53-2.68],0.676585352048658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMFR,E3 ubiquitin-protein ligase AMFR,20435,99,1.05 [0.82-1.36],0.6815839336915449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO1,Amphoterin-induced protein 1,17606,79,1.17 [0.80-1.72],0.4137102712089914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,20792,98,5.90 [3.14-11.06],3.234326021693829e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMN,Protein amnionless,20526,99,1.25 [0.87-1.78],0.2257552332738995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOT,Angiomotin,17690,82,1.77 [1.06-2.96],0.0294122088621645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOTL2,Angiomotin-like protein 2,17969,80,1.15 [0.75-1.75],0.5247054430404954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMPD3,AMP deaminase 3,18060,81,0.69 [0.51-0.93],0.0140067296198727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,16995,75,0.83 [0.52-1.32],0.4320640762963882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2A,Pancreatic alpha-amylase,20090,95,0.80 [0.55-1.16],0.2418385759395443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2B,Alpha-amylase 2B,19456,92,0.72 [0.49-1.05],0.0903394761147513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,20851,98,2.31 [1.52-3.51],8.258276256353297e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT1,Angiopoietin-1,20803,99,1.08 [0.87-1.35],0.466345572632038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,21071,101,6.22 [4.38-8.83],1.5192015931338663e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,20553,98,4.49 [2.46-8.20],9.759037954354731e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL2,Angiopoietin-related protein 2,20885,99,2.00 [1.30-3.07],0.0016011482035617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL3,Angiopoietin-related protein 3,20923,98,0.68 [0.40-1.15],0.1500396424109834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,20922,99,5.25 [3.60-7.67],7.69920403885724e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,21071,101,3.51 [2.53-4.86],5.579470080254661e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANK2,Ankyrin-2,17476,78,0.82 [0.56-1.19],0.2900166713727331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,17564,80,1.10 [0.85-1.43],0.4565747052642626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRA2,Ankyrin repeat family A protein 2,17467,80,0.92 [0.61-1.37],0.6693396547572539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRD54,Ankyrin repeat domain-containing protein 54,20402,95,0.57 [0.39-0.84],0.0040434160973291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,17604,78,0.64 [0.30-1.36],0.2464666000180186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANPEP,Aminopeptidase N,20963,98,1.85 [0.98-3.48],0.0558731037982911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA1,Annexin A1,17601,82,1.18 [0.74-1.89],0.4773504894568835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,20435,99,1.46 [1.22-1.74],2.7703778077143973e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA11,Annexin A11,20816,99,0.90 [0.69-1.18],0.4439310318970995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA2,Annexin A2,17346,78,1.14 [0.85-1.54],0.3758228028953109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA3,Annexin A3,21047,102,0.97 [0.75-1.24],0.78110097709169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA4,Annexin A4,20795,98,0.88 [0.69-1.13],0.3138950838932102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA5,Annexin A5,20360,99,2.10 [1.30-3.41],0.0026493472797634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],20526,99,0.62 [0.41-0.95],0.0268605225972742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,20989,98,13.78 [8.76-21.67],6.709802938464635e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP1G2,AP-1 complex subunit gamma-like 2,18044,80,1.25 [0.97-1.60],0.085866774049844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP2B1,AP-2 complex subunit beta,17606,79,1.05 [0.70-1.58],0.7998769644424654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3B1,AP-3 complex subunit beta-1,18042,82,1.21 [0.94-1.56],0.1469067913617766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3S2,AP-3 complex subunit sigma-2,18060,81,1.20 [0.83-1.75],0.3356491972557357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,20792,98,1.16 [0.80-1.69],0.4263343902604081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APCS,Serum amyloid P-component,17967,81,0.42 [0.22-0.80],0.0082284108991142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,21012,101,0.86 [0.62-1.17],0.3330919874439174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,20881,98,0.50 [0.35-0.72],0.000213947936682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA1,Apolipoprotein A-I,18124,81,0.37 [0.21-0.66],0.0006067740744316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA2,Apolipoprotein A-II,18123,81,1.04 [0.68-1.59],0.8613279197626935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,18124,81,3.50 [2.65-4.63],1.309180762796955e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOB,Apolipoprotein B-100,18123,81,1.02 [0.42-2.43],0.9725031103099732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOBR,Apolipoprotein B receptor,17604,78,0.54 [0.34-0.85],0.0072893529512274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOC1,Apolipoprotein C-I,18096,81,0.46 [0.31-0.67],6.106572673826234e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOD,Apolipoprotein D,17330,80,0.44 [0.29-0.65],4.778126360196999e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOE,Apolipoprotein E,18124,81,0.82 [0.57-1.17],0.2698904088662842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,18123,81,0.37 [0.19-0.72],0.003483704476687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOH,Beta-2-glycoprotein 1,20889,101,1.11 [0.70-1.75],0.6621335627927112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOL1,Apolipoprotein L1,18123,81,0.57 [0.36-0.91],0.0183638294321351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,20956,98,0.39 [0.28-0.55],7.255460919976204e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APP,Amyloid-beta precursor protein,20853,100,1.10 [0.85-1.44],0.4606580108536333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APPL2,DCC-interacting protein 13-beta,17690,82,1.03 [0.86-1.25],0.7318434317033073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APRT,Adenine phosphoribosyltransferase,20654,99,1.09 [0.74-1.59],0.6643009628796346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARAF,Serine/threonine-protein kinase A-Raf,17790,82,1.12 [0.82-1.52],0.478842616340002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,20792,98,5.19 [4.16-6.47],2.7501534610186753e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARF6,ADP-ribosylation factor 6,18042,82,1.02 [0.84-1.24],0.8029221127057515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARFIP1,Arfaptin-1,18071,81,1.09 [0.81-1.45],0.5759681338579015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG1,Arginase-1,20762,100,0.53 [0.37-0.75],0.0003441315493145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG2,"Arginase-2, mitochondrial",18044,80,1.14 [0.71-1.83],0.5953441582183393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP1,Rho GTPase-activating protein 1,20402,95,0.54 [0.37-0.80],0.0021867951656847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP25,Rho GTPase-activating protein 25,20402,95,1.01 [0.76-1.34],0.9667754944197288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP30,Rho GTPase-activating protein 30,17790,82,1.21 [0.76-1.93],0.4148847556367809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP45,Rho GTPase-activating protein 45,17690,82,1.12 [0.87-1.44],0.363358565511539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP5,Rho GTPase-activating protein 5,17467,80,1.17 [0.92-1.49],0.1897558077500568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,18060,81,1.11 [0.88-1.41],0.3695226553615637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,18071,81,1.09 [0.87-1.35],0.4562381244336779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,20854,99,1.12 [0.94-1.33],0.211251561470039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,17515,78,1.36 [1.06-1.75],0.0159118477985315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID3A,AT-rich interactive domain-containing protein 3A,17515,78,0.78 [0.46-1.31],0.3461225039939216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID4B,AT-rich interactive domain-containing protein 4B,20435,99,0.41 [0.22-0.74],0.0032557554715933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL13B,ADP-ribosylation factor-like protein 13B,17476,78,0.98 [0.73-1.32],0.905786462822228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,17476,78,0.74 [0.42-1.28],0.2792439696360547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,17515,78,0.98 [0.67-1.43],0.9054042313980588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,20526,99,1.23 [0.75-2.01],0.4056672607703896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,17476,78,0.81 [0.51-1.30],0.38676641897272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSA,Arylsulfatase A,20889,101,1.19 [0.84-1.70],0.3251624790206031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSB,Arylsulfatase B,20792,98,1.17 [0.86-1.59],0.3177231750081131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART3,Ecto-ADP-ribosyltransferase 3,20989,98,1.70 [1.05-2.73],0.0294047119571639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART5,Ecto-ADP-ribosyltransferase 5,17515,78,1.12 [0.80-1.56],0.5073861873819853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARTN,Artemin,20526,99,0.88 [0.57-1.36],0.5709186144060396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH1,Acid ceramidase,17935,80,1.68 [1.27-2.22],0.0002665872930335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH2,Neutral ceramidase,20696,99,1.43 [0.98-2.07],0.061203808541126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,20696,99,6.36 [4.60-8.79],3.7107945985526245e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,18123,81,5.29 [2.65-10.58],2.4774874861124785e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPN,Asporin,18107,82,1.91 [1.16-3.13],0.0104655825409484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPSCR1,Tether containing UBX domain for GLUT4,18071,81,0.86 [0.63-1.18],0.3456460866725096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,17604,78,0.97 [0.78-1.21],0.793593368829953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASS1,Argininosuccinate synthase,17476,78,1.13 [0.85-1.50],0.3913916789065073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,20435,99,1.11 [0.87-1.41],0.3915349826645707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,17467,80,0.77 [0.38-1.53],0.453662394854131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG16L1,Autophagy-related protein 16-1,18042,82,1.21 [0.96-1.53],0.1129045467264045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG4A,Cysteine protease ATG4A,20402,95,0.72 [0.52-0.98],0.0357918692916124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATOX1,Copper transport protein ATOX1,20948,102,1.27 [0.99-1.64],0.0611313461975396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,17476,78,1.40 [1.07-1.83],0.0129573366109856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,17476,78,1.15 [0.60-2.19],0.6733790992743713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,17476,78,0.94 [0.52-1.69],0.829601766498121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B4,Protein ATP1B4,17467,80,0.96 [0.57-1.61],0.8741478333655285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,17476,78,0.71 [0.44-1.15],0.1611310275921181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",17476,78,0.90 [0.57-1.43],0.6649135809168888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5IF1,"ATPase inhibitor, mitochondrial",20956,99,1.09 [0.93-1.28],0.2930059713139162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5PO,"ATP synthase subunit O, mitochondrial",20435,99,0.85 [0.53-1.35],0.489060218750144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6AP2,Renin receptor,20402,95,1.90 [1.44-2.52],7.292772647067775e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1D,V-type proton ATPase subunit D,20792,98,0.79 [0.39-1.58],0.5011076918949379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1F,V-type proton ATPase subunit F,20407,98,0.87 [0.66-1.14],0.3115342801728116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G1,V-type proton ATPase subunit G 1,17604,78,0.89 [0.66-1.21],0.4649644985202157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G2,V-type proton ATPase subunit G 2,17476,78,1.03 [0.82-1.30],0.7934057575012148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,18042,82,1.98 [1.55-2.53],3.2797509293009124e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRN,"Attractin, Isoform 2",18124,81,5.18 [1.65-16.32],0.0049481586849225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN10,Ataxin-10,20435,99,0.96 [0.75-1.23],0.754737831773828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2,Ataxin-2,17515,78,0.92 [0.74-1.16],0.485351611235394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2L,Ataxin-2-like protein,18071,81,1.02 [0.67-1.56],0.9164185086300648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN3,Ataxin-3,18060,81,0.74 [0.54-1.02],0.0674296556811592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXIN1,Axin-1,20854,99,1.09 [0.90-1.31],0.3764324140908628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,20989,98,3.78 [2.06-6.91],1.6346725517427087e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZI2,5-azacytidine-induced protein 2,18071,81,1.26 [0.88-1.80],0.2133676546391436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZU1,Azurocidin,20282,95,0.95 [0.74-1.22],0.6604553906486497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,18124,81,1.87 [1.54-2.26],1.92018210975738e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,17476,78,1.37 [0.49-3.80],0.5491556679988151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",17604,78,9.61 [5.64-16.37],8.817178669146098e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",20956,99,8.63 [5.27-14.14],1.156876130367926e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",20889,101,1.51 [0.74-3.07],0.2541598034472356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BABAM1,BRISC and BRCA1-A complex member 1,17564,80,1.86 [1.09-3.18],0.02365727421456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BACH1,Transcription regulator protein BACH1,20854,99,1.28 [1.01-1.61],0.0378933531518246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG3,BAG family molecular chaperone regulator 3,20657,99,0.95 [0.61-1.47],0.8048487550826481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG4,BAG family molecular chaperone regulator 4,17564,80,1.48 [1.01-2.18],0.0447283002381348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG6,Large proline-rich protein BAG6,20501,98,1.10 [0.67-1.80],0.7179948387106687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,20402,95,1.84 [1.50-2.26],5.189377725347734e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,20402,95,3.94 [2.88-5.37],6.78145126102231e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BANK1,B-cell scaffold protein with ankyrin repeats,20854,99,1.12 [0.94-1.34],0.1904040453192099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAP18,Chromatin complexes subunit BAP18,18060,81,1.16 [0.87-1.54],0.3038382668499338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BATF,Basic leucine zipper transcriptional factor ATF-like,17606,79,1.06 [0.83-1.36],0.648187360108824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAX,Apoptosis regulator BAX,20399,99,1.14 [0.94-1.38],0.1883856786806768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,20889,101,3.21 [2.07-4.97],1.791520515101502e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,20696,99,0.31 [0.22-0.44],1.5734252508174764e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",18107,82,1.37 [0.73-2.54],0.3262867649062229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",17515,78,0.46 [0.25-0.83],0.0101225609093412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCHE,Cholinesterase,17789,81,0.57 [0.26-1.27],0.1688433153994203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2,Apoptosis regulator Bcl-2,18042,82,1.45 [1.10-1.91],0.0081455167091994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L1,Bcl-2-like protein 1,18060,81,0.99 [0.81-1.23],0.9515593048364598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",20854,99,2.55 [1.52-4.26],0.0003740505970297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L15,Bcl-2-like protein 15,17564,80,1.25 [0.89-1.76],0.2028263211416244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,17467,80,1.09 [0.79-1.50],0.6042917667525094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,18044,80,0.47 [0.25-0.89],0.0202710902846082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCR,Breakpoint cluster region protein,20854,99,1.18 [0.97-1.43],0.0993170198869925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BDNF,Brain-derived neurotrophic factor,18104,80,1.03 [0.80-1.33],0.8198854564943349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BECN1,Beclin-1,17604,78,1.12 [0.80-1.58],0.50358856493439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BEX3,Protein BEX3,17467,80,1.07 [0.70-1.64],0.7448980670346983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGLAP,Osteocalcin,18104,80,0.57 [0.44-0.72],3.933115448605598e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGN,Biglycan,20368,95,1.13 [0.97-1.32],0.1238798928072057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHLHE40,Class E basic helix-loop-helix protein 40,17515,78,0.82 [0.59-1.13],0.2226834718391823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,17476,78,1.19 [0.52-2.72],0.6884865224509555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BID,BH3-interacting domain death agonist,20854,99,0.95 [0.72-1.24],0.6893024399539337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIN2,Bridging integrator 2,20889,101,1.03 [0.85-1.24],0.7980704183310084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIRC2,Baculoviral IAP repeat-containing protein 2,20402,95,1.06 [0.81-1.40],0.6616112316600051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLMH,Bleomycin hydrolase,21140,101,0.47 [0.27-0.80],0.0060540655531367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLNK,B-cell linker protein,17564,80,0.87 [0.49-1.53],0.6212008485857835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,17515,78,0.82 [0.59-1.14],0.2363139275512133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,18060,81,1.16 [0.72-1.88],0.5465022710296898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLVRB,Flavin reductase,20889,101,0.64 [0.48-0.86],0.0030367832896349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP10,Bone morphogenetic protein 10,17690,82,3.36 [1.57-7.19],0.0018410168602723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP4,Bone morphogenetic protein 4,20657,99,1.43 [1.02-2.00],0.0377295226582675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP6,Bone morphogenetic protein 6,20466,98,1.56 [1.01-2.40],0.0436045794230731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,17690,82,7.82 [4.61-13.26],2.4775060656862147e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,18107,82,1.10 [0.62-1.95],0.7404977622416412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17564,80,2.10 [1.43-3.09],0.0001410959961988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,20501,98,8.07 [4.36-14.94],2.937103741214845e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA1,BolA-like protein 1,17515,78,1.00 [0.67-1.49],0.9925755449884632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA2_BOLA2B,BolA-like protein 2,17604,78,0.49 [0.33-0.74],0.0006832813660648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFA2,BPI fold-containing family A member 2,17003,76,0.76 [0.61-0.94],0.0108014850916605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB1,BPI fold-containing family B member 1,20837,99,0.91 [0.70-1.19],0.4978792904986614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB2,BPI fold-containing family B member 2,18073,82,1.12 [0.83-1.52],0.4602838539269126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRAP,BRCA1-associated protein,17864,81,1.05 [0.86-1.28],0.6442813054908589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD1,Bromodomain-containing protein 1,17790,82,1.40 [0.77-2.55],0.270670672955535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD2,Bromodomain-containing protein 2,17515,78,0.78 [0.39-1.59],0.4992072004066371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD3,Bromodomain-containing protein 3,17476,78,0.91 [0.55-1.50],0.7005049724698307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRDT,Bromodomain testis-specific protein,17476,78,0.99 [0.54-1.78],0.9627166227971876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRK1,Protein BRICK1,20435,99,0.81 [0.55-1.20],0.2921942030715847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRME1,Break repair meiotic recombinase recruitment factor 1,17515,78,0.93 [0.54-1.60],0.7861347194032734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRSK2,Serine/threonine-protein kinase BRSK2,18071,81,1.59 [1.02-2.48],0.0401833222440366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,21094,101,8.37 [4.46-15.69],3.4242341409397435e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSND,Barttin,17467,80,1.20 [0.68-2.15],0.5270100185170371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,21081,102,3.07 [1.70-5.54],0.0001958019036591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST2,Bone marrow stromal antigen 2,21081,102,1.73 [1.33-2.26],4.70292957705477e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTC,Probetacellulin,20402,95,1.02 [0.80-1.31],0.8684761590974162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTD,Biotinidase,18124,81,3.77 [1.30-10.91],0.0142407738522451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTLA,B- and T-lymphocyte attenuator,17467,80,1.11 [0.89-1.39],0.3360608348758555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN1A1,Butyrophilin subfamily 1 member A1,18008,80,1.04 [0.62-1.76],0.8721233676097468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,20956,99,6.19 [4.26-8.98],9.645943573957181e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,20854,99,2.33 [1.82-2.98],2.0843885421506954e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTNL10,Butyrophilin-like protein 10,17467,80,0.96 [0.54-1.73],0.8983613696646343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C19orf12,Protein C19orf12,20435,99,1.17 [0.92-1.48],0.2007325779647565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1GALT1C1,C1GALT1-specific chaperone 1,17476,78,1.62 [0.98-2.68],0.0588875193218024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,21029,100,5.79 [3.24-10.34],2.8217806439849675e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",18071,81,0.81 [0.55-1.20],0.2909926828097241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QL2,Complement C1q-like protein 2,17564,80,0.66 [0.40-1.09],0.1027394157259533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,20989,98,3.28 [2.48-4.34],9.325184229579491e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,17690,82,1.59 [0.88-2.87],0.1220608819133188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,18071,81,1.54 [0.91-2.62],0.110489974673259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,17663,82,0.87 [0.57-1.35],0.5447679809555515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1R,Complement C1r subcomponent,18124,81,0.83 [0.24-2.84],0.7646826133006528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1RL,Complement C1r subcomponent-like protein,18090,81,6.49 [2.15-19.62],0.0009169287641028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1S,Complement C1s subcomponent,18124,81,1.18 [0.43-3.25],0.7498230094895877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,20956,98,5.95 [2.46-14.41],7.752546334666126e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2CD2L,Phospholipid transfer protein C2CD2L,20407,98,1.49 [1.10-2.01],0.0108522402331063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2orf69,UPF0565 protein C2orf69,17606,79,1.12 [0.81-1.55],0.4966237977994013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C3,Complement C3,17199,78,1.08 [0.65-1.80],0.7759490822841797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C4BPB,C4b-binding protein beta chain,20948,102,0.63 [0.40-1.01],0.0544352999370997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C5,Complement C5,18124,81,1.92 [0.46-7.95],0.3687931028265417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,17682,80,3.85 [2.69-5.49],1.3393682554426297e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7orf50,Uncharacterized protein C7orf50,18060,81,0.62 [0.20-1.93],0.4042740691362898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C8B,Complement component C8 beta chain,18124,81,1.64 [0.82-3.31],0.1636234546179854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9,Complement component C9,18123,81,0.83 [0.59-1.18],0.3081776004471831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9orf40,Uncharacterized protein C9orf40,18042,82,0.68 [0.52-0.90],0.0060468662226105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA1,Carbonic anhydrase 1,20439,97,0.53 [0.38-0.73],9.469650496727088e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA11,Carbonic anhydrase-related protein 11,20402,95,1.74 [1.21-2.52],0.0030734862674438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,20792,98,4.81 [3.66-6.33],3.43072516018601e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA13,Carbonic anhydrase 13,20634,96,0.99 [0.83-1.17],0.8655860629039999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA14,Carbonic anhydrase 14,21071,101,1.21 [0.75-1.97],0.432265188753933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA2,Carbonic anhydrase 2,20821,101,0.61 [0.46-0.80],0.0003823492198966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA3,Carbonic anhydrase 3,21110,100,1.09 [0.82-1.47],0.5473625404734348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA4,Carbonic anhydrase 4,21140,101,0.87 [0.42-1.80],0.7039178105145691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",20501,98,1.37 [1.15-1.62],0.0003478767752855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,20830,101,0.54 [0.41-0.71],1.5475818936572537e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA7,Carbonic anhydrase 7,17790,82,1.11 [0.70-1.76],0.655118498078725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA8,Carbonic anhydrase-related protein,17564,80,1.72 [0.98-3.00],0.057462907742467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,21071,101,2.63 [1.97-3.51],6.621921922505332e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CABP2,Calcium-binding protein 2,17606,79,1.23 [0.89-1.69],0.2085037005001455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,17515,78,0.61 [0.29-1.29],0.1954798217323652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,17476,78,0.93 [0.60-1.43],0.742313943047719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,17515,78,0.88 [0.59-1.30],0.5094100044934076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,18071,81,1.21 [0.95-1.53],0.1273183406381013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACYBP,Calcyclin-binding protein,17660,81,1.11 [0.90-1.37],0.3177201700723759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CADPS,Calcium-dependent secretion activator 1,17606,79,0.94 [0.53-1.69],0.848744038806615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB1,Calbindin,20792,98,1.44 [0.99-2.09],0.0540229260385664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB2,Calretinin,20435,99,1.97 [1.57-2.48],5.839896048253029e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,20668,98,1.76 [1.45-2.15],1.9913891668966995e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCB,Calcitonin gene-related peptide 2,18060,81,1.68 [1.16-2.45],0.0064985685051783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,21008,101,1.11 [0.94-1.32],0.2292337582306648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,17604,78,1.16 [0.87-1.54],0.302455076330136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALY,Neuron-specific vesicular protein calcyon,17476,78,0.69 [0.37-1.30],0.2503467952348303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,20402,95,1.50 [1.04-2.16],0.0319541824735833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,17606,79,1.36 [0.97-1.92],0.0749130882679351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,18071,81,1.15 [0.95-1.40],0.1480471743758018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,20812,98,5.34 [2.36-12.07],5.741626665564813e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPG,Macrophage-capping protein,20744,100,1.29 [0.96-1.72],0.0899764505632662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPN3,Calpain-3,18044,80,1.07 [0.62-1.84],0.816133878157316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPS,Calcyphosin,18060,81,1.05 [0.86-1.29],0.6082103316021428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CARHSP1,Calcium-regulated heat-stable protein 1,20435,99,0.43 [0.29-0.64],2.564196825203369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASC3,Protein CASC3,17606,79,1.23 [0.77-1.96],0.3811879117468312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP1,Caspase-1,20435,99,1.05 [0.82-1.34],0.7049971198381205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP10,Caspase-10,20435,99,1.01 [0.79-1.30],0.9280226898314188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP2,Caspase-2,20854,99,1.16 [0.91-1.50],0.2340885677766531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP3,Caspase-3,21140,101,1.02 [0.84-1.25],0.8358917331082296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP4,Caspase-4,17790,82,0.95 [0.82-1.08],0.4216993876952485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP7,Caspase-7,18060,81,1.05 [0.82-1.34],0.7142008773941403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP8,Caspase-8,21012,101,0.66 [0.49-0.89],0.007257252889956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP9,Caspase-9,17564,80,0.89 [0.62-1.29],0.5385280217152457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASQ2,Calsequestrin-2,17476,78,1.37 [0.99-1.90],0.0581430756156386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAT,Catalase,17860,78,0.45 [0.29-0.71],0.0006068462698405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLIF,Cobalamin binding intrinsic factor,20852,98,1.69 [1.35-2.11],4.8681574324572606e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN1,Cerebellin-1,17515,78,0.92 [0.71-1.21],0.566447163797611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN4,Cerebellin-4,21071,101,1.04 [0.60-1.80],0.9000185895523455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBS,Cystathionine beta-synthase,17604,78,1.42 [0.98-2.07],0.0673110951789285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBX2,Chromobox protein homolog 2,17476,78,1.43 [0.99-2.08],0.0596904208006243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,20696,99,1.02 [0.80-1.30],0.8815112672941718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCAR2,Cell cycle and apoptosis regulator protein 2,18060,81,0.93 [0.59-1.46],0.763262727600565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC134,Coiled-coil domain-containing protein 134,18044,80,1.31 [0.92-1.88],0.1338605350952724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC28A,Coiled-coil domain-containing protein 28A,17606,79,1.10 [0.53-2.27],0.7943833847867725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC50,Coiled-coil domain-containing protein 50,18071,81,1.14 [0.90-1.46],0.2843722231456567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,20881,98,2.20 [1.46-3.32],0.0001650360613057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,17604,78,0.95 [0.67-1.35],0.7878435618583592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,21127,101,3.50 [2.18-5.63],2.094699430927037e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL13,C-C motif chemokine 13,21101,101,1.00 [0.78-1.30],0.9758267625112016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,20851,98,1.81 [1.34-2.44],9.674773181221566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,21140,101,3.70 [2.69-5.10],1.1322735355975737e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,21140,101,2.25 [1.58-3.20],5.929627369927879e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL17,C-C motif chemokine 17,20807,98,1.10 [0.90-1.34],0.3385467919242989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL18,C-C motif chemokine 18,20620,97,1.07 [0.87-1.33],0.5142318262251533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL19,C-C motif chemokine 19,21081,102,1.10 [0.96-1.25],0.1555991410450746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL2,C-C motif chemokine 2,20657,99,1.00 [0.72-1.40],0.9803690094722244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,21127,101,1.56 [1.36-1.80],3.3033228188224045e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,20956,99,2.30 [1.84-2.87],2.0620612798575494e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL22,C-C motif chemokine 22,20635,98,1.45 [1.06-2.00],0.0217383998282927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL23,C-C motif chemokine 23,20956,99,1.88 [1.24-2.85],0.0029036603160688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL24,C-C motif chemokine 24,20922,99,1.23 [1.00-1.52],0.0455917186281742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,21127,101,2.62 [1.87-3.66],2.00457607184496e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL26,C-C motif chemokine 26,20854,99,0.97 [0.79-1.18],0.7396383022655116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL27,C-C motif chemokine 27,20881,98,0.92 [0.69-1.23],0.5811322178893414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL28,C-C motif chemokine 28,20780,99,1.55 [1.19-2.02],0.0010555385562956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,20854,99,1.43 [1.22-1.68],1.0269686792249529e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL4,C-C motif chemokine 4,20885,99,1.19 [0.95-1.50],0.1268013919084764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL5,C-C motif chemokine 5,20989,98,1.04 [0.88-1.24],0.6540953086026067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,20854,99,1.66 [1.35-2.05],1.600607090055945e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL8,C-C motif chemokine 8,21037,101,1.20 [0.90-1.59],0.2091608302822783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN1,CCN family member 1,20758,98,1.40 [1.08-1.81],0.0117233561410165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN2,CCN family member 2,20855,99,1.10 [0.80-1.52],0.5528056585147497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,21101,101,2.99 [2.09-4.27],2.305861228494445e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,21071,101,3.87 [2.75-5.43],6.018829680986515e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,20889,101,3.04 [2.02-4.60],1.1738649662446385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCND2,G1/S-specific cyclin-D2,17790,82,0.93 [0.53-1.62],0.7938231447963738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCNE1,G1/S-specific cyclin-E1,17564,80,1.13 [0.93-1.37],0.2339656973210262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,20696,99,0.36 [0.24-0.54],9.707469039603036e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCT5,T-complex protein 1 subunit epsilon,20402,95,0.86 [0.56-1.31],0.4744719724701677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD101,Immunoglobulin superfamily member 2,18042,82,1.58 [0.96-2.60],0.0742347902380277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,20889,101,3.90 [2.30-6.61],4.489695827968086e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,20494,98,3.14 [2.21-4.45],1.3875260623145548e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,21127,101,2.78 [2.10-3.68],1.2318620489204697e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,20989,98,2.57 [1.79-3.67],2.524276353795582e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,20889,101,1.11 [0.55-2.25],0.7644220516812377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164L2,CD164 sialomucin-like 2 protein,17606,79,0.90 [0.49-1.66],0.739318740381282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD177,CD177 antigen,20854,101,1.09 [0.95-1.26],0.2278613490020068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD1C,T-cell surface glycoprotein CD1c,20948,102,0.42 [0.26-0.68],0.0003815656854752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2,T-cell surface antigen CD2,17476,78,1.66 [1.23-2.26],0.001020912095811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200,OX-2 membrane glycoprotein,20854,99,2.54 [1.54-4.17],0.0002424554028825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,20784,98,1.50 [0.92-2.47],0.1064691072959482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,20422,95,3.31 [2.14-5.11],7.745208798230835e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD209,CD209 antigen,20934,100,1.15 [0.73-1.82],0.5347224980340648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,21127,101,1.65 [1.16-2.35],0.0052075232253382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD226,CD226 antigen,17564,80,1.71 [1.06-2.76],0.0266474929021557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,21127,101,4.43 [2.66-7.39],1.084812235038742e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD248,Endosialin,18104,80,0.53 [0.31-0.91],0.0210038527893416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,20948,102,3.90 [3.12-4.86],1.3170899605991417e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,20696,99,3.85 [2.86-5.18],5.768040704676048e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,20847,98,12.46 [8.17-19.00],9.885698807101804e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,20402,95,2.84 [2.22-3.63],8.126206649485356e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2AP,CD2-associated protein,20881,98,0.97 [0.74-1.26],0.8232068306791236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,17690,82,5.26 [2.96-9.33],1.4461117632811956e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,21081,102,4.41 [2.92-6.67],1.7417976165865046e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,21014,100,3.95 [2.88-5.42],1.5663025066578652e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LF,CMRF35-like molecule 1,21071,101,2.15 [1.53-3.02],1.0654016045582563e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LG,CMRF35-like molecule 9,20889,101,1.46 [0.90-2.36],0.1260895340694653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,20792,98,5.40 [4.07-7.16],9.75940766852066e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD33,Myeloid cell surface antigen CD33,20948,102,1.15 [0.92-1.45],0.2210872961924943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD34,Hematopoietic progenitor cell antigen CD34,21017,101,0.38 [0.18-0.79],0.0093701892908689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD36,Platelet glycoprotein 4,17564,80,1.85 [1.21-2.81],0.0041281565491718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,20792,98,3.78 [2.36-6.07],3.369473653453436e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3D,T-cell surface glycoprotein CD3 delta chain,17515,78,0.95 [0.48-1.87],0.8845291123681882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,17790,82,0.92 [0.49-1.74],0.7955747281704298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,17564,80,1.08 [0.87-1.34],0.4707399077374709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD4,T-cell surface glycoprotein CD4,20818,99,3.24 [2.43-4.31],8.901255688800427e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,20851,99,2.14 [1.59-2.86],3.841587066446426e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40LG,CD40 ligand,21127,101,1.00 [0.80-1.24],0.976766413812613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,20792,98,3.96 [2.56-6.13],6.036852216795085e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,20922,99,5.85 [3.87-8.84],5.981884843534101e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,21037,101,2.31 [1.87-2.85],8.783667447442815e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,20169,92,3.87 [2.60-5.75],2.654844423201964e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD58,Lymphocyte function-associated antigen 3,20808,98,0.86 [0.31-2.39],0.7664311613898112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,20165,96,5.38 [3.61-8.01],1.171350153901632e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5L,CD5 antigen-like,18035,81,1.55 [1.00-2.40],0.0498599136116498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD6,T-cell differentiation antigen CD6,21094,101,1.01 [0.73-1.41],0.9443700554075738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD63,CD63 antigen,20657,99,1.66 [1.15-2.39],0.0065589162712973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD69,Early activation antigen CD69,20775,98,1.10 [0.90-1.34],0.3548507557084293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,17536,79,2.24 [1.54-3.25],2.238489762481845e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,20854,99,2.53 [1.86-3.44],2.9486010613340683e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,17690,82,2.34 [1.67-3.29],8.17332957782288e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,21081,102,6.81 [4.71-9.86],2.570256595092056e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,21127,101,2.81 [2.23-3.54],1.903346794510336e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,18107,82,4.49 [3.19-6.31],5.760085072712224e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD82,CD82 antigen,17790,82,1.65 [1.13-2.39],0.0086313750643597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,20854,99,4.13 [3.03-5.63],2.3544431688863626e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD84,SLAM family member 5,20854,99,1.20 [0.69-2.07],0.5238514244570739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD86,T-lymphocyte activation antigen CD86,18042,82,1.05 [0.51-2.16],0.8887514527565454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,21081,102,1.98 [1.51-2.60],7.293097850418109e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD93,Complement component C1q receptor,20099,94,3.11 [1.82-5.32],3.5358613808421275e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,20889,101,6.16 [3.33-11.38],6.738745680314225e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99L2,CD99 antigen-like protein 2,20889,101,4.03 [2.10-7.70],2.5733327403820573e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDA,Cytidine deaminase,18076,82,0.76 [0.47-1.23],0.2626233072436157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDAN1,Codanin-1,18060,81,1.05 [0.45-2.48],0.9035007772489972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC123,Cell division cycle protein 123 homolog,17467,80,1.09 [0.81-1.48],0.5704298998627875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC25A,M-phase inducer phosphatase 1,17467,80,0.83 [0.45-1.54],0.5591233280017625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC26,Anaphase-promoting complex subunit CDC26,18004,82,1.10 [0.82-1.49],0.5198840065809875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC27,Cell division cycle protein 27 homolog,20402,95,1.25 [0.94-1.65],0.1224491052858573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC37,Hsp90 co-chaperone Cdc37,20948,102,0.95 [0.77-1.16],0.5990124332649501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,18042,82,1.20 [0.99-1.46],0.0623435380052714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,20696,99,2.40 [1.89-3.06],1.0271793527686752e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,20206,93,2.18 [1.78-2.66],1.9910164115505332e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,21053,101,1.65 [1.36-2.00],2.766301338732129e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,20881,98,2.12 [1.70-2.63],1.5166474651706435e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,20881,98,5.28 [3.27-8.53],1.0853154140496415e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH22,Cadherin-22,17790,82,1.17 [0.58-2.37],0.6595688375380033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH23,Cadherin-23,18060,81,0.91 [0.39-2.13],0.8243632611047758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,21081,102,3.01 [2.02-4.49],6.854100643686272e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH4,Cadherin-4,17515,78,0.79 [0.48-1.30],0.3495736268756533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH5,Cadherin-5,21140,101,1.90 [1.09-3.34],0.0246322263524349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,20881,98,3.00 [2.19-4.12],7.812390265646138e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR1,Cadherin-related family member 1,20435,99,0.75 [0.48-1.16],0.1899209243277611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR2,Cadherin-related family member 2,20792,98,1.55 [1.15-2.11],0.0046763065892568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR5,Cadherin-related family member 5,20881,98,0.94 [0.59-1.49],0.7812112111680984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK1,Cyclin-dependent kinase 1,17467,80,1.68 [0.93-3.03],0.0864934403893426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,18071,81,0.96 [0.70-1.33],0.8264363101217655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKL5,Cyclin-dependent kinase-like 5,17515,78,0.84 [0.53-1.33],0.4470009615567345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,20792,98,1.21 [1.03-1.43],0.0240899162978665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,20792,98,0.95 [0.79-1.15],0.5945925491828548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,20792,98,1.83 [1.26-2.66],0.0015030978250012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,20878,98,1.68 [0.86-3.27],0.1302362261524451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDSN,Corneodesmosin,21070,101,1.82 [1.25-2.66],0.0019754881957288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,20917,102,3.84 [1.81-8.12],0.0004356835595972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,18042,82,0.67 [0.52-0.87],0.0026990912387992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,17790,82,1.30 [1.05-1.62],0.0171105519354814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,18042,82,1.95 [1.26-3.01],0.0026549097957274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,17790,82,1.28 [0.89-1.85],0.1863880407891238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,20854,99,1.32 [1.08-1.60],0.0056280508389933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,20402,95,1.07 [0.74-1.54],0.7278068662989962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,20138,94,1.77 [1.38-2.27],6.467204181668536e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,18104,80,1.94 [1.51-2.50],2.522796428851647e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,20501,98,1.64 [1.19-2.25],0.002455282598412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPA,CCAAT/enhancer-binding protein alpha,17564,80,1.52 [0.96-2.40],0.0751755445292029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPB,CCAAT/enhancer-binding protein beta,20501,98,1.11 [0.72-1.72],0.6407985273193905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA2A,Chymotrypsin-like elastase family member 2A,18104,80,0.97 [0.69-1.37],0.8768697893796207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA3A,Chymotrypsin-like elastase family member 3A,21107,101,1.02 [0.76-1.37],0.8745812310317641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,17690,82,1.77 [0.87-3.63],0.1166091753865456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEMIP2,Cell surface hyaluronidase,17564,80,1.81 [1.30-2.53],0.0005160944027773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,17515,78,0.97 [0.67-1.40],0.8575219212324591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPF,Centromere protein F,17790,82,0.71 [0.48-1.05],0.0891538748917848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPJ,Centromere protein J,17790,82,1.24 [0.97-1.59],0.0884836027614942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP112,Centrosomal protein of 112 kDa,17476,78,1.28 [0.87-1.90],0.2136196840000008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP152,Centrosomal protein of 152 kDa,17467,80,1.29 [0.85-1.95],0.2306374353938027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP164,Centrosomal protein of 164 kDa,20526,99,1.02 [0.78-1.33],0.8948234707912552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP170,Centrosomal protein of 170 kDa,17604,78,1.27 [0.96-1.66],0.0888339546017549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP20,Centrosomal protein 20,20402,95,1.20 [0.95-1.51],0.1215266579426706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP290,Centrosomal protein of 290 kDa,17790,82,0.98 [0.64-1.50],0.9358888766788868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP350,Centrosome-associated protein 350,17467,80,1.01 [0.58-1.75],0.9800624947216772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP43,Centrosomal protein 43,20339,96,0.99 [0.76-1.29],0.9598835873363724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP85,Centrosomal protein of 85 kDa,20402,95,1.24 [0.95-1.62],0.1193354700085988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CERT,Ceramide transfer protein,20435,99,0.95 [0.71-1.27],0.7473437431955938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES1,Liver carboxylesterase 1,20937,99,1.15 [0.96-1.39],0.1238695302340464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,20792,98,1.70 [1.30-2.22],0.0001193219950806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES3,Carboxylesterase 3,20792,98,0.88 [0.67-1.14],0.3216460672616341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN2,Centrin-2,20435,99,1.07 [0.84-1.37],0.589963244030187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN3,Centrin-3,18042,82,1.10 [0.85-1.42],0.4797123336156014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFB,Complement factor B,17811,81,4.02 [2.03-7.98],6.847126589691007e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,20402,95,2.31 [1.78-3.00],2.83791248946802e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,18124,81,3.06 [1.59-5.89],0.0008032519770411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFH,Complement factor H,17080,78,2.72 [1.04-7.13],0.0419380771273853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR2,Complement factor H-related protein 2,17997,79,1.22 [0.81-1.84],0.3424566560645575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR4,Complement factor H-related protein 4,18084,81,0.67 [0.51-0.88],0.0034725739358221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR5,Complement factor H-related protein 5,17905,81,0.78 [0.48-1.28],0.321867417447817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFI,Complement factor I,18124,81,4.85 [1.62-14.53],0.0048312175777615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFP,Properdin,18124,81,0.51 [0.18-1.40],0.1900641605160811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,20889,101,2.11 [1.71-2.60],1.7860138892403708e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,18123,81,1.28 [0.72-2.25],0.3979251372664835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGN,Cingulin,17606,79,0.76 [0.42-1.36],0.3536808609460996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,20881,98,3.41 [2.35-4.96],1.2475271272776658e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,20402,95,0.79 [0.57-1.09],0.1528368326867621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,17690,82,0.42 [0.33-0.55],4.193368185981336e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18060,81,2.73 [2.22-3.37],5.609751500290783e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,18044,80,2.97 [2.10-4.22],9.778601547941627e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHEK2,Serine/threonine-protein kinase Chk2,20501,98,0.70 [0.39-1.24],0.2221913913298559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,18104,80,1.83 [1.58-2.12],1.2095007984024292e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,21028,101,2.35 [1.62-3.42],7.2639627898184e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,20455,94,1.89 [1.60-2.24],1.1672251363075778e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHIT1,Chitotriosidase-1,20967,99,0.99 [0.89-1.11],0.8631359415835703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHL1,Neural cell adhesion molecule L1-like protein,20957,97,1.41 [0.77-2.57],0.2666838254287899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHM,Rab proteins geranylgeranyltransferase component A 1,17606,79,1.00 [0.70-1.43],0.9952152919330624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP1A,Charged multivesicular body protein 1a,20696,99,0.91 [0.73-1.13],0.391386085613026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP6,Charged multivesicular body protein 6,18107,82,1.07 [0.75-1.52],0.7232316092522909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHP1,Calcineurin B homologous protein 1,17515,78,0.95 [0.68-1.32],0.7464721963873153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,20922,99,5.21 [3.23-8.40],1.420831817542232e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL2,Chordin-like protein 2,20881,98,1.27 [0.88-1.85],0.2055267584595224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRM1,Muscarinic acetylcholine receptor M1,17606,79,0.98 [0.54-1.79],0.95886362342338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIAPIN1,Anamorsin,20948,102,0.99 [0.75-1.30],0.9155891082771322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,18104,80,3.08 [2.36-4.02],1.6134571709952626e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CINP,Cyclin-dependent kinase 2-interacting protein,17790,82,1.10 [0.71-1.70],0.6797450729210344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIRBP,Cold-inducible RNA-binding protein,18042,82,1.04 [0.84-1.29],0.7294146548864994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIT,Citron Rho-interacting kinase,17606,79,1.01 [0.64-1.60],0.9530207844254444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,21023,101,4.60 [3.52-5.99],1.935794559128977e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKB,Creatine kinase B-type,18104,80,1.57 [1.08-2.27],0.0174690229178479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",20781,99,1.52 [1.15-2.00],0.0033063428585568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLASP1,CLIP-associating protein 1,17467,80,1.20 [0.91-1.58],0.2044835835352292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLC,Galectin-10,20849,98,0.98 [0.75-1.28],0.8813792736977295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,20696,99,2.45 [1.49-4.03],0.0004036934221692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC11A,C-type lectin domain family 11 member A,20861,100,0.96 [0.66-1.39],0.833142793032175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC12A,C-type lectin domain family 12 member A,17564,80,3.08 [1.72-5.51],0.0001600503588744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,20889,101,4.37 [2.81-6.81],6.200457272673678e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,20501,98,3.23 [2.09-5.00],1.492138797351376e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1B,C-type lectin domain family 1 member B,21081,102,1.14 [0.96-1.36],0.1432413321800672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC2L,C-type lectin domain family 2 member L,17606,79,1.16 [0.79-1.71],0.4579615871238286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC3B,Tetranectin,17718,81,0.36 [0.21-0.63],0.0003249328053957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,20854,99,0.38 [0.25-0.58],6.371166559367673e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4C,C-type lectin domain family 4 member C,20854,99,0.69 [0.48-0.99],0.043009953887847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,20854,99,2.12 [1.66-2.70],1.94767034914788e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4G,C-type lectin domain family 4 member G,20854,99,1.08 [0.64-1.85],0.7662393597750446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4M,C-type lectin domain family 4 member M,18076,80,0.84 [0.54-1.30],0.4248069096743275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,20809,98,3.10 [1.86-5.16],1.3148663181289434e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,20402,95,2.88 [2.10-3.94],4.0649363185568416e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,21127,101,2.21 [1.54-3.17],1.800743197738886e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,17606,79,1.87 [1.42-2.47],8.263737728536495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIC5,Chloride intracellular channel protein 5,17606,79,1.10 [0.61-1.98],0.7551722307591485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLINT1,Clathrin interactor 1,17467,80,0.85 [0.52-1.38],0.5051319154794001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIP2,CAP-Gly domain-containing linker protein 2,20854,99,1.11 [0.95-1.30],0.1945880301437815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,21071,101,7.53 [4.44-12.75],6.076539861665725e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLNS1A,Methylosome subunit pICln,17606,79,0.38 [0.19-0.79],0.0094175526704558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",20668,98,1.13 [0.95-1.36],0.1728385038368973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPS,Colipase,20851,101,0.90 [0.70-1.16],0.4200039315407283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSPN,Claspin,20407,98,1.08 [0.67-1.74],0.7443835968724666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN1,Calsyntenin-1,20435,99,0.93 [0.64-1.34],0.689516094727735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,21127,101,3.33 [2.56-4.35],6.096115194515075e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,18060,81,3.03 [1.72-5.32],0.0001158348059247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLTA,Clathrin light chain A,20501,98,0.80 [0.52-1.21],0.2908152408604318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLU,Clusterin,18124,81,1.04 [0.53-2.03],0.9147045169695922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,20842,98,0.47 [0.31-0.70],0.0001966646383887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMC1,COX assembly mitochondrial protein homolog,18107,82,1.09 [0.88-1.35],0.4470714114661105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMIP,C-Maf-inducing protein,18044,80,1.08 [0.84-1.37],0.5521059296373938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNDP1,Beta-Ala-His dipeptidase,20989,98,1.09 [0.75-1.60],0.6429197555366859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,17515,78,0.95 [0.60-1.50],0.831967507886759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",17573,78,0.90 [0.69-1.19],0.464239786849336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY2,Protein canopy homolog 2,20501,98,0.99 [0.74-1.33],0.9420037681337692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY4,Protein canopy homolog 4,20792,98,1.09 [0.86-1.39],0.4571431126301419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNST,Consortin,20881,98,1.13 [0.97-1.33],0.1205073059059469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTF,Ciliary neurotrophic factor,17515,78,0.60 [0.32-1.14],0.1211974474684434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN1,Contactin-1,21140,101,1.26 [0.65-2.45],0.5008930105821988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN2,Contactin-2,21071,101,2.45 [1.68-3.59],3.841644426904485e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN3,Contactin-3,20889,101,2.55 [1.33-4.90],0.004918773050953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN4,Contactin-4,20889,101,3.75 [1.86-7.55],0.0002115412620977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,20945,100,0.51 [0.31-0.83],0.0070038230699402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP2,Contactin-associated protein-like 2,20854,99,2.46 [1.83-3.30],2.310430185005438e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP4,Contactin-associated protein-like 4,17606,79,1.11 [0.92-1.33],0.2930368529530539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COCH,Cochlin,18107,82,1.19 [0.76-1.86],0.4553038521763334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL15A1,Collagen alpha-1(XV) chain,18104,80,0.49 [0.23-1.02],0.0577220818828759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,20971,101,13.68 [7.58-24.71],4.07528202565211e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL1A1,Collagen alpha-1(I) chain,21140,101,0.35 [0.16-0.79],0.0113047513863688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL24A1,Collagen alpha-1(XXIV) chain,18042,82,1.27 [0.86-1.88],0.2212285330583721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL28A1,Collagen alpha-1(XXVIII) chain,17606,79,0.96 [0.73-1.26],0.7554278668123515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL2A1,Collagen alpha-1(II) chain,17604,78,0.93 [0.72-1.22],0.6073392305672856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,18104,80,3.34 [1.51-7.39],0.0029730913905523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,20881,98,4.50 [3.08-6.56],5.5413364046150415e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A4,Collagen alpha-4(IV) chain,17764,82,1.01 [0.68-1.51],0.9516444280133814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,17690,82,2.72 [1.89-3.92],7.481127981094508e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,21140,101,4.19 [3.08-5.69],5.892072106057202e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A1,Collagen alpha-1(IX) chain,20854,99,0.90 [0.61-1.35],0.62291538901317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A2,Collagen alpha-2(IX) chain,17790,82,0.88 [0.54-1.44],0.6093849414746193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,20847,98,7.92 [5.14-12.18],5.10448166323305e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD1,COMM domain-containing protein 1,17604,78,0.95 [0.66-1.37],0.784647107681588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD9,COMM domain-containing protein 9,18044,80,0.85 [0.48-1.51],0.584360725204465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMP,Cartilage oligomeric matrix protein,20679,95,0.94 [0.54-1.64],0.8331408356136083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMT,Catechol O-methyltransferase,20268,95,0.92 [0.73-1.14],0.4414345498732043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPB2,Coatomer subunit beta',17476,78,1.18 [0.74-1.88],0.4963390615983563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPE,Coatomer subunit epsilon,20435,99,0.82 [0.53-1.27],0.3741442497212793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",17604,78,1.37 [0.86-2.16],0.1833027105081184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO1A,Coronin-1A,20482,97,1.10 [0.91-1.32],0.3373032359453302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO6,Coronin-6,17515,78,1.48 [0.98-2.23],0.061843993787293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",20792,98,1.19 [0.95-1.51],0.1340840320467398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX6B1,Cytochrome c oxidase subunit 6B1,18107,82,1.87 [1.10-3.18],0.0201439519379411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA1,Carboxypeptidase A1,21140,101,1.04 [0.79-1.36],0.8006233278140218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,21020,101,2.31 [1.84-2.90],7.461433878625222e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA4,Carboxypeptidase A4,17351,79,0.61 [0.37-1.00],0.0498660325420812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB1,Carboxypeptidase B,21140,101,1.08 [0.81-1.43],0.601172588074902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB2,Carboxypeptidase B2,18096,81,1.15 [0.45-2.93],0.7661243871238981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPE,Carboxypeptidase E,20899,99,0.59 [0.40-0.88],0.0101486192048627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPLX2,Complexin-2,17467,80,1.04 [0.52-2.06],0.9149685322408048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,20978,101,6.03 [3.93-9.24],1.6400493369866779e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",17564,80,1.27 [0.57-2.83],0.5613700957064953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,21081,102,0.78 [0.59-1.02],0.0742131912702128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPQ,Carboxypeptidase Q,18072,80,2.76 [1.57-4.85],0.0004442864952279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPTP,Ceramide-1-phosphate transfer protein,17476,78,0.70 [0.39-1.26],0.2308028562959816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPVL,Probable serine carboxypeptidase CPVL,21028,101,1.90 [1.22-2.94],0.0043870557757221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM1,Probable carboxypeptidase X1,20948,102,1.14 [0.90-1.46],0.2792647273564985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,18107,82,5.58 [3.10-10.04],1.0266443420624192e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,18058,81,3.15 [1.82-5.45],4.060246814787472e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,20989,98,2.31 [1.63-3.27],2.374979246646018e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,20402,95,1.29 [1.06-1.57],0.0097025924034297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRADD,Death domain-containing protein CRADD,20668,98,0.87 [0.69-1.10],0.2420108841590296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREB3,Cyclic AMP-responsive element-binding protein 3,17467,80,1.10 [0.77-1.57],0.6148951942686819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREBZF,CREB/ATF bZIP transcription factor,17467,80,1.69 [0.83-3.46],0.1483755942526658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREG1,Protein CREG1,20614,102,0.89 [0.57-1.38],0.5934036034197498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,17690,82,4.62 [2.74-7.82],1.0573150291723532e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,20922,99,2.05 [1.52-2.77],3.034788568812419e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,20369,95,0.63 [0.50-0.79],6.510727874293722e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,20847,98,8.06 [4.42-14.69],9.912511795886276e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHR1,Corticotropin-releasing factor receptor 1,20501,98,0.70 [0.49-0.98],0.0399390785990679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,20956,99,16.55 [8.23-33.28],3.389089380622516e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,20696,99,2.05 [1.63-2.58],5.899805516407042e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP2,Cysteine-rich secretory protein 2,21071,101,0.68 [0.51-0.91],0.0089718614526269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP3,Cysteine-rich secretory protein 3,17952,79,0.46 [0.21-0.98],0.0451392995058703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRKL,Crk-like protein,20883,99,1.02 [0.86-1.21],0.8294700261412057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRLF1,Cytokine receptor-like factor 1,20956,99,5.93 [2.99-11.74],3.391898579681165e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRNN,Cornulin,20312,99,0.78 [0.60-1.02],0.0701018292180763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAC1,Cartilage acidic protein 1,21140,101,0.51 [0.30-0.89],0.0180968862426189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAM,Cytotoxic and regulatory T-cell molecule,20696,99,2.10 [1.48-2.96],2.7485431886750865e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAP,Cartilage-associated protein,17606,79,0.98 [0.65-1.50],0.940493102558616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRX,Cone-rod homeobox protein,20501,98,1.00 [0.84-1.19],0.9833207685271184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB1,Beta-crystallin B1,18107,82,1.26 [0.93-1.70],0.143374515877968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB2,Beta-crystallin B2,18060,81,1.05 [0.83-1.32],0.7028937815989191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYGD,Gamma-crystallin D,18060,81,0.86 [0.69-1.07],0.1715636378593236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYM,Ketimine reductase mu-crystallin,17515,78,0.99 [0.73-1.34],0.9542695603727024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYZL1,Quinone oxidoreductase-like protein 1,17604,78,0.87 [0.69-1.11],0.2700938218000169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSDE1,Cold shock domain-containing protein E1,17476,78,1.17 [0.99-1.38],0.0615487648311264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,20956,99,10.38 [6.20-17.39],5.968882144120902e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,18123,81,2.73 [1.80-4.12],1.988543336650759e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2,Granulocyte-macrophage colony-stimulating factor,17476,78,1.34 [0.82-2.21],0.2420211611061186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,20696,99,1.58 [1.25-2.00],0.0001274389041703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RB,Cytokine receptor common subunit beta,17564,80,0.69 [0.42-1.13],0.1391796870595517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3,Granulocyte colony-stimulating factor,20526,99,0.98 [0.66-1.44],0.900253634782057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3R,Granulocyte colony-stimulating factor receptor,17564,80,1.62 [0.89-2.97],0.11647384015749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSH1,Chorionic somatomammotropin hormone 1,18123,81,0.51 [0.24-1.08],0.0774712168229624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK1D,Casein kinase I isoform delta,17564,80,1.14 [0.84-1.54],0.3958607912904717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK2A1,Casein kinase II subunit alpha,18071,81,0.79 [0.50-1.25],0.3190205207330766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG4,Chondroitin sulfate proteoglycan 4,18104,80,2.30 [1.20-4.39],0.0119069003886205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG5,Chondroitin sulfate proteoglycan 5,17515,78,0.84 [0.52-1.35],0.4693374410251626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,17476,78,1.39 [1.18-1.62],4.74155640727352e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST1,Cystatin-SN,15734,68,1.02 [0.80-1.30],0.867088079600392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,20954,98,5.54 [3.71-8.27],6.078660804850707e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST5,Cystatin-D,20426,98,1.43 [1.04-1.97],0.027667911275832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST6,Cystatin-M,20346,97,1.66 [1.18-2.34],0.0038693376723355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,20885,99,1.35 [1.19-1.53],2.2354015178094536e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,20594,95,1.75 [1.21-2.54],0.002846610604148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,17757,82,0.89 [0.56-1.39],0.5959235604096074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTBS,Di-N-acetylchitobiase,17869,78,3.82 [1.70-8.56],0.0011416628006206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTF1,Cardiotrophin-1,20501,98,0.92 [0.75-1.14],0.4581228838683548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,18104,80,3.65 [2.06-6.45],8.516335004726563e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTLA4,Cytotoxic T-lymphocyte protein 4,18104,80,1.55 [0.83-2.90],0.169153641926007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTNNA1,Catenin alpha-1,17515,78,0.64 [0.29-1.40],0.2598725191600586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRB1,Chymotrypsinogen B,20889,101,0.85 [0.62-1.16],0.3006408563366646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,20843,98,0.73 [0.55-0.96],0.0262989375843169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,18060,81,0.66 [0.49-0.89],0.0065447857852696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSB,Cathepsin B,20904,101,1.65 [1.21-2.24],0.0014170033432937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSC,Dipeptidyl peptidase 1,20808,99,1.20 [0.81-1.77],0.3651294032738433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,19538,88,2.86 [2.24-3.66],6.54445728947383e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,17690,82,2.00 [1.36-2.95],0.0004719223345445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSF,Cathepsin F,20948,102,1.17 [0.76-1.81],0.4798611390349576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSH,Pro-cathepsin H,20417,98,1.35 [1.07-1.71],0.0125583367762834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,20881,98,6.52 [3.46-12.31],7.134916600020078e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,21127,101,4.27 [2.93-6.24],5.762124096800988e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,16428,79,12.32 [5.65-26.88],2.808626757934684e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSV,Cathepsin L2,20994,100,1.15 [0.76-1.75],0.5110335977970959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,20926,98,5.71 [3.47-9.39],7.540125561736317e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,17606,79,1.14 [0.68-1.92],0.6112784305038287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CWC15,Spliceosome-associated protein CWC15 homolog,17940,81,1.23 [0.90-1.67],0.1929903035023552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CX3CL1,Fractalkine,20696,99,2.90 [1.86-4.50],2.363972842989824e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,20854,99,2.33 [1.75-3.12],1.015707676985616e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL1,Growth-regulated alpha protein,20819,99,1.24 [1.04-1.47],0.0162652603294333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL10,C-X-C motif chemokine 10,20956,99,1.19 [0.94-1.52],0.1496569149920729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL11,C-X-C motif chemokine 11,21081,102,1.16 [0.95-1.41],0.1404648698481602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL12,Stromal cell-derived factor 1,20526,99,1.20 [0.76-1.89],0.4390849493903725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,21081,102,1.49 [1.28-1.75],5.169798087479115e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL14,C-X-C motif chemokine 14,20526,99,1.30 [1.08-1.56],0.0062685445332173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,21104,101,5.34 [2.80-10.17],3.5794398413854175e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,21127,101,1.85 [1.37-2.48],5.132307710741247e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL3,C-X-C motif chemokine 3,20851,99,0.97 [0.80-1.17],0.7506346666054551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL5,C-X-C motif chemokine 5,20810,97,0.99 [0.85-1.16],0.8882724183018753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL6,C-X-C motif chemokine 6,21127,101,1.18 [0.93-1.48],0.1691073892652269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,20750,100,1.39 [1.17-1.65],0.0001994357119185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,20956,99,1.64 [1.31-2.05],1.3506198321220492e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5A,Cytochrome b5,17467,80,0.94 [0.67-1.31],0.707272287497871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5R2,NADH-cytochrome b5 reductase 2,17858,82,1.18 [0.82-1.69],0.3767251675618699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",17476,78,0.85 [0.63-1.15],0.2890758544469069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTH3,Cytohesin-3,17467,80,1.03 [0.80-1.34],0.8124691668725111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTL1,Cytokine-like protein 1,18104,80,1.16 [0.49-2.76],0.7401561754914214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAAM1,Disheveled-associated activator of morphogenesis 1,17690,82,1.16 [0.92-1.48],0.2150849049480192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAB2,Disabled homolog 2,21071,101,1.02 [0.87-1.19],0.8207461295699892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,20956,99,2.27 [1.59-3.24],5.555776846412035e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAND5,DAN domain family member 5,17564,80,1.10 [0.78-1.54],0.5876965220048712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPK2,Death-associated protein kinase 2,17564,80,1.15 [0.80-1.66],0.4558745069489281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,20854,99,0.93 [0.81-1.07],0.2924153901327515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",20668,98,0.84 [0.66-1.08],0.1719982975652093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBH,Dopamine beta-hydroxylase,18092,81,0.91 [0.77-1.08],0.2744497804631618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBI,Acyl-CoA-binding protein,20793,101,1.21 [0.96-1.52],0.0981115923188444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBN1,Drebrin,17564,80,1.37 [0.92-2.05],0.1241465785876655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBNL,Drebrin-like protein,20956,99,1.06 [0.88-1.28],0.5454718911137619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",20948,102,4.49 [3.25-6.21],8.294606562661333e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCC,Netrin receptor DCC,17606,79,0.44 [0.22-0.90],0.0251434969126496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCDC2C,Doublecortin domain-containing protein 2C,17467,80,1.04 [0.71-1.50],0.8522106758147663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCLRE1C,Protein artemis,17467,80,1.65 [0.93-2.92],0.0846932732400729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,20501,98,5.57 [3.03-10.26],3.4212719129672674e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTD,Deoxycytidylate deaminase,17690,82,1.02 [0.82-1.27],0.8676018643445301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN1,Dynactin subunit 1,21071,101,1.02 [0.78-1.34],0.897731328732196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN2,Dynactin subunit 2,20792,98,0.92 [0.76-1.12],0.4241804567055126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN6,Dynactin subunit 6,20435,99,0.85 [0.65-1.12],0.2496252312468014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTPP1,dCTP pyrophosphatase 1,20881,98,0.94 [0.53-1.69],0.8430783980542285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D1,DCN1-like protein 1,17515,78,0.79 [0.55-1.14],0.2127083803924292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D2,DCN1-like protein 2,17467,80,1.03 [0.78-1.36],0.8095253942978959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCXR,L-xylulose reductase,20948,102,0.98 [0.71-1.35],0.8933033729236932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDA1,DET1- and DDB1-associated protein 1,17476,78,0.94 [0.53-1.67],0.8379343035786737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",20792,98,2.18 [1.57-3.02],3.4232401942271022e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDC,Aromatic-L-amino-acid decarboxylase,20852,98,1.21 [0.84-1.75],0.306378718447467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDHD2,Phospholipase DDHD2,18071,81,1.12 [0.82-1.53],0.4841584908467449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDI2,Protein DDI1 homolog 2,17690,82,0.64 [0.48-0.85],0.0020194225193434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,21081,102,7.87 [4.48-13.85],7.668148145193036e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDT,D-dopachrome decarboxylase,18104,80,0.68 [0.40-1.16],0.1567457924879082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX1,ATP-dependent RNA helicase DDX1,18042,82,1.01 [0.69-1.47],0.9734093894290052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX25,ATP-dependent RNA helicase DDX25,17606,79,0.74 [0.37-1.49],0.3996426343662854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX39A,ATP-dependent RNA helicase DDX39A,17564,80,1.00 [0.38-2.61],0.9966242644995472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX4,Probable ATP-dependent RNA helicase DDX4,17564,80,0.88 [0.57-1.38],0.5845632317703784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX53,Probable ATP-dependent RNA helicase DDX53,17606,79,0.54 [0.28-1.04],0.0672861282461863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX58,Antiviral innate immune response receptor RIG-I,20402,95,0.91 [0.65-1.28],0.6008006492039795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",20854,99,1.20 [1.00-1.44],0.0513765044521988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,20466,97,1.84 [1.49-2.28],2.5106589725148412e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,17435,80,1.77 [1.37-2.28],1.1787327621389212e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB104A_DEFB104B,Beta-defensin 104,17515,78,0.61 [0.38-1.00],0.0480762148788707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB116,Beta-defensin 116,17515,78,0.81 [0.57-1.15],0.2381737203493792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB118,Beta-defensin 118,17515,78,0.85 [0.52-1.41],0.5300854531769892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,20576,98,1.26 [1.11-1.42],0.0002364661441296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENND2B,DENN domain-containing protein 2B,17476,78,1.15 [0.77-1.70],0.49839219152556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENR,Density-regulated protein,17564,80,0.87 [0.59-1.29],0.4996981614837111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DFFA,DNA fragmentation factor subunit alpha,21127,101,0.92 [0.71-1.20],0.5297224615599649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGCR6,Protein DGCR6,17515,78,0.98 [0.56-1.73],0.9440505267654692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKA,Diacylglycerol kinase alpha,17564,80,1.14 [0.78-1.67],0.4848429064506117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKZ,Diacylglycerol kinase zeta,20526,99,1.11 [0.67-1.82],0.6899430187410859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHODH,Dihydroorotate dehydrogenase,17476,78,0.85 [0.50-1.42],0.5243842473324947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHPS,Deoxyhypusine synthase,18044,80,1.83 [1.30-2.59],0.0006003826708089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,18060,81,1.22 [0.83-1.78],0.3070904647230865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIABLO,"Diablo homolog, mitochondrial",20809,98,0.98 [0.84-1.14],0.7823573816573614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK1C,Divergent protein kinase domain 1C,17606,79,0.75 [0.43-1.33],0.3239086920661449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK2B,Divergent protein kinase domain 2B,17690,82,0.63 [0.29-1.39],0.2531563626276421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK1,Dickkopf-related protein 1,21081,102,1.29 [0.96-1.72],0.0897675631377293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,21140,101,3.19 [1.79-5.69],8.349364076683551e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,20658,99,3.22 [2.55-4.07],8.602657892134141e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKKL1,Dickkopf-like protein 1,20792,98,1.30 [1.02-1.64],0.032005698805014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLG4,Disks large homolog 4,18060,81,1.16 [0.88-1.55],0.2974624183334433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLGAP5,Disks large-associated protein 5,18071,81,1.34 [0.99-1.82],0.0550256634839993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLK1,Protein delta homolog 1,21140,101,1.03 [0.77-1.39],0.8252382807822108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,20948,102,8.31 [5.79-11.94],1.6088719922635506e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL4,Delta-like protein 4,17604,78,0.83 [0.57-1.21],0.3348787448987036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,17604,78,1.82 [1.39-2.37],1.0198117829288813e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,17604,78,0.33 [0.27-0.41],9.586561439096683e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA1,DnaJ homolog subfamily A member 1,17467,80,0.95 [0.61-1.49],0.8323559838449653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA2,DnaJ homolog subfamily A member 2,21056,101,1.03 [0.83-1.27],0.7874697934109122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA4,DnaJ homolog subfamily A member 4,18060,81,0.73 [0.54-0.99],0.0422257887275052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB1,DnaJ homolog subfamily B member 1,20792,98,0.97 [0.79-1.19],0.7819531873671175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB14,DnaJ homolog subfamily B member 14,18042,82,1.17 [0.85-1.60],0.3387167672542048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB2,DnaJ homolog subfamily B member 2,17690,82,0.61 [0.41-0.92],0.0177451436455276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB6,DnaJ homolog subfamily B member 6,17532,81,1.11 [0.87-1.43],0.3869768995008522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB8,DnaJ homolog subfamily B member 8,20501,98,0.93 [0.65-1.33],0.6995297817766075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC21,DnaJ homolog subfamily C member 21,18060,81,1.22 [0.71-2.09],0.4718639390352011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,17604,78,0.96 [0.75-1.24],0.7804159195640062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC9,DnaJ homolog subfamily C member 9,18042,82,0.76 [0.58-1.00],0.0527905388433946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,20814,98,0.33 [0.17-0.66],0.0017391207252208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNLZ,DNL-type zinc finger protein,17515,78,0.81 [0.59-1.11],0.1960118261812744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM1,Dynamin-1,18042,82,1.05 [0.87-1.25],0.6148132953759309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,18071,81,1.59 [1.20-2.10],0.0012269398000556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNMBP,Dynamin-binding protein,20696,99,1.47 [1.12-1.92],0.0048624735385852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPEP,Aspartyl aminopeptidase,18060,81,1.00 [0.68-1.47],0.9977222472468104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,20917,99,0.59 [0.42-0.84],0.002968911594324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOC2B,Double C2-like domain-containing protein beta,17606,79,0.97 [0.52-1.81],0.9116469486443664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOCK9,Dedicator of cytokinesis protein 9,17515,78,0.90 [0.72-1.12],0.3313031366372433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK1,Docking protein 1,18060,81,1.00 [0.86-1.17],0.993996643770616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK2,Docking protein 2,20881,98,1.07 [0.93-1.23],0.3535643886426698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP1,Dipeptidase 1,20668,98,0.86 [0.59-1.25],0.4280940332135962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP2,Dipeptidase 2,20792,98,1.89 [1.08-3.32],0.0266503774908468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,20854,99,2.42 [1.69-3.47],1.6756465057445495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP4,Dipeptidyl peptidase 4,20512,98,0.44 [0.24-0.80],0.0074760365813868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,20792,98,4.04 [2.52-6.46],5.957209516145522e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP7,Dipeptidyl peptidase 2,20723,98,1.53 [1.17-2.01],0.0019957663480651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,21140,101,6.16 [2.86-13.29],3.473082252495686e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,21012,101,1.92 [1.56-2.36],6.707282002077308e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,20696,99,2.34 [1.67-3.28],9.09243421184434e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRG2,Developmentally-regulated GTP-binding protein 2,20792,98,0.96 [0.71-1.32],0.8218990619927802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,20639,100,6.28 [4.38-9.00],1.5215699583560848e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,18071,81,4.09 [2.38-7.03],3.3406875379063697e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG2,Desmoglein-2,20889,101,2.39 [1.33-4.30],0.0035845051726576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG3,Desmoglein-3,20999,101,1.43 [0.88-2.33],0.1517736152785068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,20725,97,0.54 [0.38-0.77],0.0005925486188619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTD1,D-aminoacyl-tRNA deacylase 1,17690,82,1.02 [0.81-1.29],0.8372798161655446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,18006,80,3.01 [2.24-4.06],4.3448371492921787e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,17606,79,0.70 [0.46-1.09],0.1131334981549779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,20792,98,2.35 [1.41-3.90],0.0009922404129559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTYMK,Thymidylate kinase,18107,82,0.88 [0.65-1.19],0.3941597860924465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUOX2,Dual oxidase 2,20501,98,0.76 [0.55-1.05],0.0985482146689139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,18044,80,1.04 [0.66-1.63],0.8800643470096402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP29,Dual specificity phosphatase 29,17606,79,0.97 [0.69-1.35],0.8539131175638772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP3,Dual specificity protein phosphatase 3,20435,99,0.78 [0.61-1.00],0.0467882130871316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",18042,82,1.23 [1.02-1.47],0.0282749409918479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DXO,Decapping and exoribonuclease protein,18060,81,0.89 [0.56-1.39],0.5999645153651453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,18044,80,1.07 [0.71-1.61],0.7488568895055893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT1,Dynein light chain Tctex-type 1,17606,79,1.29 [1.01-1.65],0.0432374575345228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT3,Dynein light chain Tctex-type 3,18044,80,0.95 [0.59-1.54],0.8412862538892776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,20696,99,1.09 [0.91-1.31],0.3529383173573821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,21046,101,5.81 [3.49-9.67],1.328687467836464e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECE1,Endothelin-converting enzyme 1,20435,99,0.94 [0.58-1.53],0.8147897770143071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",18107,82,1.55 [1.24-1.95],0.000158829095133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",17604,78,1.44 [1.18-1.77],0.0004558826149772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECI2,Enoyl-CoA delta isomerase 2,17476,78,1.26 [0.93-1.72],0.1414667987536403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECM1,Extracellular matrix protein 1,17654,80,0.87 [0.48-1.55],0.627744790114499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECSCR,Endothelial cell-specific chemotaxis regulator,17515,78,1.19 [0.82-1.73],0.3484557663301255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,21071,101,5.00 [3.97-6.30],1.8101312019415478e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,20854,99,0.95 [0.78-1.16],0.5943591122696721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDDM3B,Epididymal secretory protein E3-beta,18044,80,0.81 [0.56-1.18],0.2710925270679329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,17476,78,0.68 [0.33-1.37],0.2803348440338506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDF1,Endothelial differentiation-related factor 1,18071,81,1.16 [0.88-1.54],0.2984687622605389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,20501,98,2.86 [1.93-4.23],1.5631230731427498e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,17604,78,5.84 [3.50-9.73],1.2898152417861852e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDNRB,Endothelin receptor type B,17564,80,1.17 [0.74-1.87],0.4998961629685642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EEF1D,Elongation factor 1-delta,18107,82,1.24 [1.00-1.55],0.0539734392488847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,18042,82,2.25 [1.73-2.92],1.6956326900309283e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB2,Dynein regulatory complex protein 8,17790,82,1.51 [0.87-2.60],0.1411587389209973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,20954,98,7.75 [5.09-11.79],1.3400484198952073e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFHD1,EF-hand domain-containing protein D1,18071,81,1.68 [1.09-2.61],0.0199390637884558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,20850,101,5.76 [4.17-7.95],2.2000202570066703e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA4,Ephrin-A4,20657,99,5.63 [4.38-7.23],1.8018361252354567e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNB2,Ephrin-B2,17606,79,1.25 [0.91-1.72],0.1732010796339793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGF,Pro-epidermal growth factor,20815,99,1.05 [0.89-1.25],0.5453143309550614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,20402,95,2.32 [1.58-3.39],1.5101008108354428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFLAM,Pikachurin,18042,82,2.45 [1.41-4.27],0.0014789014552372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFR,Epidermal growth factor receptor,21140,101,0.86 [0.29-2.60],0.7935823819357842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGLN1,Egl nine homolog 1,20854,99,1.20 [0.94-1.55],0.1468648187708044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHBP1,EH domain-binding protein 1,18107,82,1.24 [0.95-1.62],0.1089216580856441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHD3,EH domain-containing protein 3,17604,78,0.99 [0.83-1.19],0.9503740916875112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",18060,81,0.96 [0.64-1.42],0.8240576554018464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",17977,82,1.14 [0.94-1.36],0.1750297831582135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,17476,78,1.28 [0.96-1.71],0.0919526854831969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,17604,78,0.88 [0.51-1.53],0.6605000907572763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4B,Eukaryotic translation initiation factor 4B,20696,99,0.74 [0.55-1.01],0.0547035405434081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4E,Eukaryotic translation initiation factor 4E,17564,80,0.95 [0.75-1.20],0.6523752623264936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,20881,98,0.91 [0.69-1.19],0.4810298554176632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,21127,101,1.16 [0.97-1.40],0.113063606196818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,18071,81,1.29 [0.97-1.71],0.0749165120564583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5,Eukaryotic translation initiation factor 5,17476,78,0.98 [0.59-1.63],0.9494598053777696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5A,Eukaryotic translation initiation factor 5A-1,20526,99,0.94 [0.52-1.70],0.8390836073618861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,18071,81,1.02 [0.80-1.30],0.8840409615544063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAVL4,ELAV-like protein 4,17515,78,1.08 [0.83-1.40],0.5747851594717557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,18107,82,3.19 [1.76-5.76],0.000124192082346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOA,Elongin-A,20792,98,1.03 [0.75-1.41],0.8758928180000793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOB,Elongin-B,17476,78,1.50 [0.98-2.30],0.0635728316938642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,20526,99,1.94 [1.43-2.64],1.933732934972646e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENDOU,Poly(U)-specific endoribonuclease,16703,79,1.68 [1.17-2.42],0.0053798900961754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENG,Endoglin,21140,101,5.67 [2.75-11.67],2.480490338489186e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO1,Alpha-enolase,20873,99,0.94 [0.76-1.18],0.5984139718258151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO2,Gamma-enolase,21081,102,0.88 [0.68-1.15],0.3559075563182241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO3,Beta-enolase,17604,78,0.63 [0.43-0.94],0.0240698902801473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOPH1,Enolase-phosphatase E1,18044,80,0.88 [0.53-1.44],0.598391267229104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,17476,78,1.40 [0.68-2.88],0.3618051238985756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPEP,Glutamyl aminopeptidase,17476,78,1.16 [0.81-1.66],0.4143070795255391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,21140,101,4.82 [2.71-8.57],8.022012691793493e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,20956,99,0.78 [0.56-1.08],0.1374727718879215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,17604,78,1.00 [0.54-1.88],0.99298214222087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,20254,97,1.51 [1.22-1.86],0.0001169391186267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENSA,Alpha-endosulfine,18044,80,0.84 [0.55-1.28],0.4181893045190137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,20402,95,1.43 [0.97-2.09],0.0687125343250666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,20501,98,0.55 [0.31-0.96],0.0352296387381114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,20501,98,2.20 [1.04-4.68],0.0398779869386784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTR1,Endosome-associated-trafficking regulator 1,17604,78,1.02 [0.72-1.45],0.9125505290024596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,17564,80,2.03 [1.34-3.09],0.0008340170699022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPB41L5,Band 4.1-like protein 5,17606,79,1.10 [0.82-1.49],0.5151296288815294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPCAM,Epithelial cell adhesion molecule,20843,97,0.85 [0.70-1.03],0.0987126822870268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPGN,Epigen,18044,80,0.70 [0.39-1.25],0.2269527774660278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,20917,99,3.57 [2.05-6.24],7.420870881068949e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA10,Ephrin type-A receptor 10,20435,99,0.94 [0.70-1.24],0.6472368671562685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,20116,96,5.97 [4.45-8.00],1.0421871302611822e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA4,Ephrin type-A receptor 4,17690,82,2.84 [1.38-5.82],0.0044738632527129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,21140,101,7.20 [4.61-11.25],4.2225192533516095e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,20668,98,4.40 [2.89-6.69],4.849582047569681e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHX2,Bifunctional epoxide hydrolase 2,20501,98,1.06 [0.80-1.41],0.6771909682361534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPN1,Epsin-1,17790,82,0.92 [0.53-1.57],0.7481638240488321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,20854,99,1.39 [1.20-1.60],7.410554746484367e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPPK1,Epiplakin,17604,78,1.00 [0.74-1.36],0.9758358555786902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,21037,101,3.09 [2.11-4.52],6.567630600336493e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,20948,102,1.75 [0.88-3.49],0.1125835323483218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,20768,98,4.53 [2.04-10.08],0.0002084186178433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,20948,102,5.51 [2.81-10.80],6.597879124341416e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBIN,Erbin,20792,98,1.03 [0.87-1.23],0.7094751953901397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERC2,ERC protein 2,17606,79,0.85 [0.61-1.20],0.369336332883489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERCC1,DNA excision repair protein ERCC-1,17467,80,0.92 [0.46-1.84],0.8042493784100322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EREG,Proepiregulin,20668,98,0.98 [0.79-1.22],0.8453682728758941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERI1,3'-5' exoribonuclease 1,17790,82,0.97 [0.52-1.78],0.9142723252964228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,17564,80,2.89 [1.87-4.46],1.7600746425087134e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,18044,80,1.15 [0.65-2.06],0.6291143265664526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP29,Endoplasmic reticulum resident protein 29,17690,82,1.09 [0.92-1.29],0.3377554085692115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP44,Endoplasmic reticulum resident protein 44,20758,98,0.98 [0.49-1.97],0.9631571011047184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,17476,78,0.95 [0.56-1.60],0.8339855232974056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,21140,101,3.92 [2.56-6.02],4.050533363109926e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESM1,Endothelial cell-specific molecule 1,20847,98,0.89 [0.52-1.50],0.6513662847688579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESPL1,Separin,17467,80,1.33 [0.99-1.79],0.0627444510002378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESR1,Estrogen receptor,17564,80,1.42 [1.07-1.88],0.0145044737942046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESYT2,Extended synaptotagmin-2,18060,81,1.35 [1.06-1.72],0.0151665284871395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI2B,Protein EVI2B,17467,80,1.09 [0.72-1.67],0.6807107184639066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI5,Ecotropic viral integration site 5 protein homolog,17564,80,1.22 [0.96-1.54],0.1010890509718796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVPL,Envoplakin,17790,82,1.23 [0.67-2.26],0.5133549240094182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXOSC10,Exosome component 10,17476,78,0.80 [0.51-1.26],0.3430515403140025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXTL1,Exostosin-like 1,17476,78,0.85 [0.50-1.45],0.5592150691376326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EZR,Ezrin,21081,102,1.06 [0.53-2.11],0.8635990874780922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F10,Coagulation factor X,18123,81,0.74 [0.37-1.46],0.3858376385765565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11,Coagulation factor XI,17860,81,1.71 [1.18-2.49],0.0046838759280823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,20889,101,1.66 [1.25-2.21],0.0005387687895681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F12,Coagulation factor XII,18124,81,1.30 [0.76-2.25],0.3402758625349278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F13B,Coagulation factor XIII B chain,18035,81,0.46 [0.20-1.05],0.066520701242383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2,Prothrombin,18124,81,0.39 [0.10-1.50],0.1719947663323037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,20922,99,1.97 [1.46-2.67],1.0806538582913806e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F3,Tissue factor,20935,101,3.15 [1.72-5.78],0.00021065746083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F7,Coagulation factor VII,20952,98,1.53 [0.86-2.71],0.1440944008750493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,20956,98,6.63 [2.73-16.10],2.9414589741996963e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",20847,98,1.83 [1.57-2.12],2.873484653268804e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP2,"Fatty acid-binding protein, intestinal",20881,98,1.23 [1.01-1.51],0.0433964779343684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",18107,82,2.97 [2.31-3.82],2.611886389868143e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",21140,101,2.96 [2.34-3.74],1.6922295310164612e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP5,Fatty acid-binding protein 5,21011,102,1.26 [0.98-1.62],0.0683070673169239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP6,Gastrotropin,20469,97,1.03 [0.77-1.39],0.8248965845892631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP9,Fatty acid-binding protein 9,20854,99,1.18 [0.88-1.58],0.270585228019238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FADD,FAS-associated death domain protein,20881,98,0.89 [0.70-1.13],0.3306630558943439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM13A,Protein FAM13A,18042,82,1.06 [0.78-1.44],0.7016830719368368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171A2,Protein FAM171A2,18071,81,0.93 [0.80-1.08],0.3481337947703424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171B,Protein FAM171B,18044,80,1.10 [0.50-2.43],0.8108589531703485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM172A,Cotranscriptional regulator FAM172A,17604,78,0.84 [0.59-1.20],0.3443986288468242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,18107,82,3.27 [2.09-5.14],2.405551082290864e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,20792,98,8.47 [4.86-14.77],4.697867125601408e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,20852,98,10.54 [7.17-15.50],4.146640680340958e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,18042,82,2.45 [1.90-3.15],3.7481555180129385e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAP,Prolyl endopeptidase FAP,21140,101,1.16 [0.62-2.16],0.6409260259281038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,17606,79,1.12 [0.85-1.49],0.4255331399341854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,21067,101,1.93 [1.49-2.51],6.408615616970599e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FASLG,Tumor necrosis factor ligand superfamily member 6,21127,101,0.77 [0.47-1.25],0.2855297406199883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,18104,80,3.97 [2.32-6.77],4.343539205643066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBN2,Fibrillin-2,17606,79,1.19 [0.83-1.70],0.3488424457534953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBP1,"Fructose-1,6-bisphosphatase 1",20881,98,1.01 [0.79-1.28],0.9554367984369064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,18107,82,1.92 [1.47-2.52],1.868586759328625e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,20854,99,2.45 [1.70-3.51],1.2253987289483408e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,18071,81,1.62 [0.66-4.01],0.2943996419615793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,20889,101,1.47 [1.14-1.89],0.0027650058581191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,20810,98,2.12 [1.44-3.12],0.0001437427234003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,20402,95,1.09 [0.80-1.48],0.5855222735897457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,20919,98,1.27 [0.89-1.83],0.1915206332644787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,18092,81,3.00 [1.92-4.68],1.2842208726123771e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN2,Ficolin-2,20815,98,0.60 [0.42-0.86],0.0051378796385522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL1,Fc receptor-like protein 1,20881,98,1.27 [0.89-1.83],0.1908062696138166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,21022,99,1.69 [1.28-2.22],0.0001914868644666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL3,Fc receptor-like protein 3,20526,99,1.08 [0.77-1.51],0.654823438175991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL5,Fc receptor-like protein 5,20889,101,1.36 [1.02-1.81],0.0334430486442299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL6,Fc receptor-like protein 6,20854,99,1.77 [1.37-2.27],9.840359663678349e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,20402,95,1.50 [1.29-1.76],2.783111116938423e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",17476,78,1.43 [1.12-1.83],0.0046616187664907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX2,"Ferredoxin-2, mitochondrial",17476,78,1.26 [0.89-1.78],0.1986737720738975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FEN1,Flap endonuclease 1,20402,95,0.80 [0.57-1.12],0.1936176480556804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FES,Tyrosine-protein kinase Fes/Fps,20402,95,0.89 [0.58-1.36],0.5882224505095744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FETUB,Fetuin-B,20956,98,1.46 [0.80-2.64],0.2149407754166023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGA,Fibrinogen alpha chain,17706,81,2.39 [1.23-4.63],0.0098435468118698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",18071,81,1.03 [0.80-1.33],0.8277435251577501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF12,Fibroblast growth factor 12,17564,80,0.86 [0.48-1.53],0.5992933319164717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF16,Fibroblast growth factor 16,17564,80,0.94 [0.57-1.54],0.803376329681053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF19,Fibroblast growth factor 19,20956,99,1.10 [0.88-1.38],0.4101093666544899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF2,Fibroblast growth factor 2,20854,99,1.26 [1.00-1.60],0.0540224554994049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF20,Fibroblast growth factor 20,17564,80,1.07 [0.66-1.73],0.7759102524598609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,21046,101,1.46 [1.29-1.65],2.230168004702705e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,21040,101,1.77 [1.51-2.08],3.692468108252908e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF3,Fibroblast growth factor 3,17564,80,1.08 [0.57-2.02],0.8171560536973792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,20526,99,3.59 [2.73-4.73],8.786710993608872e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF6,Fibroblast growth factor 6,17564,80,1.24 [0.79-1.95],0.3568525812526578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF7,Fibroblast growth factor 7,17467,80,1.12 [0.88-1.44],0.361252584081598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF9,Fibroblast growth factor 9,17435,80,0.59 [0.35-0.98],0.0406981117315285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,20948,102,0.36 [0.27-0.49],1.789663982752236e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP2,Fibroblast growth factor-binding protein 2,18104,80,0.35 [0.23-0.53],5.441238887413674e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP3,Fibroblast growth factor-binding protein 3,18060,81,0.48 [0.27-0.84],0.0111046558620332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,20948,102,10.79 [6.67-17.48],3.8356237096088973e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR4,Fibroblast growth factor receptor 4,17690,82,0.81 [0.54-1.21],0.3070500257223306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,18123,81,2.37 [1.80-3.12],6.809182045877447e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGR,Tyrosine-protein kinase Fgr,20435,99,1.03 [0.77-1.37],0.861963171918892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FH,"Fumarate hydratase, mitochondrial",17515,78,1.01 [0.77-1.32],0.95696677422263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,17476,78,0.84 [0.52-1.36],0.4827039956585548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIT,Bis(5'-adenosyl)-triphosphatase,20435,99,0.79 [0.62-1.01],0.0562172066413464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FIS1,Mitochondrial fission 1 protein,20846,99,1.08 [0.87-1.34],0.4755100063269081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,18071,81,1.09 [0.89-1.35],0.3960530929131608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,20962,99,0.95 [0.81-1.11],0.5253632854156933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,20696,99,1.31 [0.86-1.98],0.2079844257631527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,20696,99,1.12 [0.92-1.36],0.2681604689655993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,20407,98,1.08 [0.75-1.55],0.6889624159720387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBPL,FK506-binding protein-like,18042,82,0.98 [0.69-1.37],0.8914324167374235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLI1,Friend leukemia integration 1 transcription factor,20402,95,1.07 [0.92-1.25],0.3878720641380896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,20696,99,4.84 [2.99-7.82],1.3265514195724074e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT1,Vascular endothelial growth factor receptor 1,20753,98,1.86 [1.15-3.01],0.0112217076225615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,20402,95,0.86 [0.47-1.58],0.6304095351775822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,21127,101,1.82 [1.11-3.00],0.0178764663069039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT4,Vascular endothelial growth factor receptor 3,20948,102,0.94 [0.56-1.57],0.8020380196976135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMNL1,Formin-like protein 1,20435,99,0.87 [0.63-1.20],0.3961980457771458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMR1,Synaptic functional regulator FMR1,20402,95,0.97 [0.58-1.63],0.9159777074580978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FN1,Fibronectin,18124,81,0.70 [0.32-1.53],0.3668616893434268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNDC1,Fibronectin type III domain-containing protein 1,18060,81,1.24 [0.80-1.94],0.3334770140818232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,18044,80,1.19 [0.70-2.05],0.5213899186993978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLH1,Glutamate carboxypeptidase 2,17564,80,1.17 [0.99-1.37],0.0625555830501449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,20860,102,3.23 [2.31-4.50],5.654385823088262e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR2,Folate receptor beta,21081,102,2.01 [1.12-3.58],0.0188331310662703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR3,Folate receptor gamma,20880,102,1.08 [1.00-1.17],0.0597407128360076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOS,Proto-oncogene c-Fos,17435,80,1.28 [0.73-2.23],0.3885739744904193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOSB,Protein fosB,20435,99,1.32 [0.89-1.96],0.1691366297901527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXJ3,Forkhead box protein J3,17564,80,1.23 [0.78-1.96],0.3729854320994515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO1,Forkhead box protein O1,20854,99,1.10 [0.89-1.35],0.3722841444104865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO3,Forkhead box protein O3,20402,95,1.09 [0.91-1.32],0.3555079315712734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD4B,FERM domain-containing protein 4B,17476,78,1.20 [0.90-1.60],0.2251398748083424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD7,FERM domain-containing protein 7,17606,79,0.89 [0.47-1.67],0.7176293709819244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRZB,Secreted frizzled-related protein 3,20629,99,1.08 [0.52-2.22],0.8447620584682908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSHB,Follitropin subunit beta,17604,78,1.43 [0.90-2.27],0.1348657931511705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FST,Follistatin,20922,99,0.99 [0.68-1.44],0.9651659864400932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,17604,78,5.88 [3.03-11.41],1.7060756741824208e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,20816,98,8.43 [6.06-11.74],1.3606137405049074e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FTCD,Formimidoyltransferase-cyclodeaminase,18022,81,1.40 [1.13-1.75],0.0024553228341714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUCA1,Tissue alpha-L-fucosidase,20993,101,1.03 [0.84-1.27],0.7441304451426392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUOM,Fucose mutarotase,17690,82,1.41 [1.03-1.93],0.0332891076263844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FURIN,Furin,20948,102,1.89 [1.10-3.24],0.0205515253977825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUS,RNA-binding protein FUS,20371,95,0.74 [0.44-1.22],0.2373667084599105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",17760,82,0.99 [0.68-1.42],0.9408219913657262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,21081,102,1.91 [1.31-2.77],0.0006790392586057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT8,"Alpha-(1,6)-fucosyltransferase",20696,99,1.10 [0.81-1.48],0.5515517664958196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXN,"Frataxin, mitochondrial",21071,101,1.04 [0.83-1.32],0.7097765354693366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXYD5,FXYD domain-containing ion transport regulator 5,20526,99,1.07 [0.82-1.40],0.6041315988310676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FYB1,FYN-binding protein 1,20851,101,0.99 [0.82-1.20],0.9427597640038674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD10,Frizzled-10,17606,79,0.72 [0.45-1.17],0.1900293974515134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD8,Frizzled-8,17515,78,1.46 [1.05-2.02],0.023350368158425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,18044,80,1.25 [0.86-1.83],0.2467873545882918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,17790,82,1.01 [0.73-1.41],0.9352751593780254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,17515,78,1.00 [0.74-1.36],0.9814614909666418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD1,Glutamate decarboxylase 1,17467,80,1.75 [0.80-3.86],0.163208860960423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD2,Glutamate decarboxylase 2,17564,80,1.16 [0.80-1.68],0.4226762156252616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,17790,82,0.74 [0.41-1.33],0.3126718913912516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,17604,78,1.25 [0.89-1.76],0.1969700445773784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAGE2A,G antigen 2A,17467,80,1.25 [0.98-1.59],0.0763134094417194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAL,Galanin peptides,20956,99,0.94 [0.72-1.24],0.6766877424710596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,20792,98,4.96 [2.86-8.59],1.1064803726215424e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,21071,101,0.54 [0.28-1.04],0.0639999629645828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,20526,99,2.12 [1.56-2.88],1.6692387166276051e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,18107,82,1.09 [0.54-2.22],0.8052294262104738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,20792,98,4.14 [1.66-10.38],0.0023967073376653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAMT,Guanidinoacetate N-methyltransferase,17476,78,0.93 [0.48-1.79],0.8266870932997866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,17307,79,1.17 [0.54-2.53],0.6888590931092876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GART,Trifunctional purine biosynthetic protein adenosine-3,18071,81,1.03 [0.46-2.30],0.9418672773695216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS2,Growth arrest-specific protein 2,17790,82,1.01 [0.66-1.55],0.9662654769649898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS6,Growth arrest-specific protein 6,21009,100,3.55 [1.76-7.18],0.0004148488356383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GASK1A,Golgi-associated kinase 1A,17476,78,0.49 [0.29-0.81],0.005662861575633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,18060,81,1.47 [1.31-1.65],3.6008618249022075e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,17467,80,1.37 [0.62-3.05],0.439144937061238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",17604,78,1.17 [0.90-1.52],0.2392717016195319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBA,Lysosomal acid glucosylceramidase,17606,79,1.47 [1.02-2.12],0.0403217779330688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP1,Guanylate-binding protein 1,18023,80,1.29 [0.93-1.79],0.131414402829556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP2,Guanylate-binding protein 2,20526,99,1.14 [0.85-1.53],0.3954735174176652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP4,Guanylate-binding protein 4,20435,99,0.81 [0.56-1.19],0.2879813861359532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP6,Guanylate-binding protein 6,17476,78,0.97 [0.58-1.62],0.8946933456479378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GC,Vitamin D-binding protein,18124,81,0.71 [0.30-1.70],0.4444193740597267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCC1,GRIP and coiled-coil domain-containing protein 1,18060,81,1.12 [0.93-1.36],0.233120787650368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,20402,95,1.94 [1.67-2.26],7.044658931343906e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,17251,79,1.50 [1.05-2.13],0.0242409970399406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCLM,Glutamate--cysteine ligase regulatory subunit,17476,78,0.76 [0.44-1.30],0.3201365035891549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",20792,98,4.75 [2.97-7.58],7.34111679903144e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,21140,101,2.85 [2.41-3.37],7.464098512467426e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF2,Growth/differentiation factor 2,20881,98,1.88 [1.16-3.04],0.009863438749956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,20435,99,2.31 [1.57-3.41],2.3811082407883048e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GET3,ATPase GET3,18107,82,1.12 [0.76-1.65],0.5766881391427272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFAP,Glial fibrillary acidic protein,20367,95,1.00 [0.67-1.50],0.9998195853985448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFER,FAD-linked sulfhydryl oxidase ALR,20402,95,1.56 [1.20-2.03],0.0008220472143815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,20402,95,0.83 [0.67-1.01],0.0642364549087076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,21046,101,11.08 [7.48-16.42],4.0241846380249046e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA2,GDNF family receptor alpha-2,20792,98,2.91 [1.40-6.06],0.0043633980378766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA3,GDNF family receptor alpha-3,20628,99,2.28 [1.24-4.19],0.008224688495838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRAL,GDNF family receptor alpha-like,17541,79,0.68 [0.47-0.97],0.0358441184865084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGA1,ADP-ribosylation factor-binding protein GGA1,20435,99,0.91 [0.70-1.18],0.474732049783848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGACT,Gamma-glutamylaminecyclotransferase,18107,82,0.93 [0.70-1.24],0.6287606384596807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGCT,Gamma-glutamylcyclotransferase,18075,82,0.74 [0.48-1.16],0.187639737511199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGH,Gamma-glutamyl hydrolase,20542,96,1.86 [1.15-3.03],0.0122184593929193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,20850,101,1.96 [1.50-2.57],1.0405169374465265e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT5,Glutathione hydrolase 5 proenzyme,20696,99,1.89 [0.86-4.14],0.1135276132362712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH1,Somatotropin,20852,98,1.13 [1.02-1.25],0.0160244060487059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH2,Growth hormone variant,20402,95,0.97 [0.86-1.10],0.6731461076289675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHR,Growth hormone receptor,17690,82,0.58 [0.27-1.28],0.1768023032265056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRHR,Growth hormone-releasing hormone receptor,20435,99,0.99 [0.71-1.38],0.9754790891938838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRL,Appetite-regulating hormone,20881,98,1.03 [0.83-1.27],0.7910947818483065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GID8,Glucose-induced degradation protein 8 homolog,18071,81,0.62 [0.27-1.42],0.2592642959985385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIGYF2,GRB10-interacting GYF protein 2,18071,81,1.40 [1.08-1.81],0.011917071919005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP7,GTPase IMAP family member 7,17690,82,0.59 [0.36-0.96],0.034448321891729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP8,GTPase IMAP family member 8,17467,80,1.38 [0.96-1.99],0.0841263763439177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,17604,78,2.12 [1.55-2.91],3.005770694649894e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,18060,81,3.92 [2.56-6.02],3.9213278940223265e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC3,PDZ domain-containing protein GIPC3,18042,82,1.03 [0.83-1.27],0.8190252402334839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPR,Gastric inhibitory polypeptide receptor,17564,80,0.92 [0.55-1.54],0.7522919001467846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIT1,ARF GTPase-activating protein GIT1,17564,80,1.02 [0.82-1.28],0.8350820057180682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GJA8,Gap junction alpha-8 protein,17467,80,0.72 [0.47-1.10],0.1300362408687173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GKN1,Gastrokine-1,20051,98,1.68 [0.96-2.95],0.0686184726978395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,17660,81,2.62 [1.64-4.17],5.258627925865067e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLB1,Beta-galactosidase,20696,99,1.51 [1.01-2.26],0.0465016543192523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLI2,Zinc finger protein GLI2,17564,80,1.78 [1.10-2.87],0.0178218716030982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLO1,Lactoylglutathione lyase,20501,98,0.86 [0.63-1.18],0.3518449561218763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLOD4,Glyoxalase domain-containing protein 4,20812,99,0.74 [0.45-1.24],0.2531450520783038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLP1R,Glucagon-like peptide 1 receptor,17515,78,0.85 [0.45-1.62],0.6306157167431156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX,Glutaredoxin-1,20746,97,0.79 [0.57-1.09],0.149655500368667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",17690,82,1.14 [0.92-1.42],0.23587750129943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,20435,99,0.94 [0.62-1.43],0.7713877524171303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLYR1,Putative oxidoreductase GLYR1,18044,80,0.88 [0.61-1.27],0.4920794854636133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,17658,79,1.95 [1.54-2.47],3.689357540705152e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMFG,Glia maturation factor gamma,18107,82,0.96 [0.72-1.27],0.7592467019020737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR,GMP reductase 1,21127,101,0.54 [0.40-0.74],9.075737186507724e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR2,GMP reductase 2,17690,82,0.84 [0.62-1.15],0.2885044953156807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNAS,Neuroendocrine secretory protein 55,18071,81,1.27 [1.04-1.55],0.0213121628961099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,20402,95,0.85 [0.64-1.12],0.2511741607209506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,17606,79,0.71 [0.43-1.19],0.1992896567691688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNLY,Granulysin,20889,101,1.06 [0.78-1.46],0.6936078276186782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,17604,78,0.54 [0.23-1.24],0.1434172385487045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,17690,82,0.36 [0.20-0.66],0.0009612736098405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLGA3,Golgin subfamily A member 3,18071,81,1.37 [1.06-1.76],0.0155860940125369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,21081,102,5.57 [3.56-8.74],6.746040747989118e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,20854,99,1.02 [0.85-1.21],0.8544337968640913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GORASP2,Golgi reassembly-stacking protein 2,18042,82,1.21 [0.80-1.81],0.3690764248883168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOT1,"Aspartate aminotransferase, cytoplasmic",18104,80,0.89 [0.55-1.42],0.6172457280281498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BA,Platelet glycoprotein Ib alpha chain,20817,98,1.19 [0.71-1.99],0.5066662344210376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BB,Platelet glycoprotein Ib beta chain,17476,78,1.13 [0.82-1.54],0.4538268010273067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,20230,96,1.16 [0.94-1.44],0.1528523258307782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP5,Platelet glycoprotein V,17690,82,0.94 [0.53-1.69],0.8428926658928017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP6,Platelet glycoprotein VI,20851,101,1.09 [0.89-1.32],0.4097047069981281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,20792,98,0.72 [0.62-0.82],2.8519722611365176e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC1,Glypican-1,21071,101,1.83 [1.02-3.29],0.0434908201109132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC5,Glypican-5,20696,99,0.56 [0.41-0.76],0.0002527822748961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPD1,Glycerol-3-phosphate dehydrogenase,18044,80,1.93 [1.40-2.67],6.690954898231727e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPHA2,Glycoprotein hormone alpha-2,18042,82,0.92 [0.56-1.53],0.7602741174781047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPI,Glucose-6-phosphate isomerase,18123,81,1.10 [0.72-1.70],0.6549109494262686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,18042,82,1.33 [0.96-1.86],0.088595717444911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPKOW,G-patch domain and KOW motifs-containing protein,20435,99,1.27 [0.81-1.97],0.2976873170882771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,20311,94,5.44 [3.02-9.82],1.8254696065493305e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR101,Probable G-protein coupled receptor 101,17515,78,0.62 [0.36-1.06],0.0816530016659265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR158,Probable G-protein coupled receptor 158,18071,81,1.27 [0.73-2.22],0.3923603391239965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,18042,82,1.57 [1.15-2.15],0.0049130327916551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,20501,98,3.12 [2.48-3.92],2.0138351171458741e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,18044,80,1.79 [1.46-2.20],1.9456877423024212e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRAP2,GRB2-related adapter protein 2,20881,98,0.99 [0.86-1.13],0.8419558699907856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,18107,82,1.01 [0.72-1.41],0.9440975617284002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",18071,81,0.84 [0.47-1.49],0.5456305789538329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",17515,78,1.10 [0.76-1.58],0.6120904790623252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRK5,G protein-coupled receptor kinase 5,20501,98,0.89 [0.61-1.29],0.5296936045535972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,20777,101,5.51 [3.65-8.31],4.881286783747264e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRP,Gastrin-releasing peptide,17604,78,1.00 [0.66-1.51],0.99152956789324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",20792,98,2.30 [1.90-2.79],1.6071944936792372e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRSF1,G-rich sequence factor 1,17371,80,1.25 [0.99-1.58],0.0660259721479826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSAP,Gamma-secretase-activating protein,20402,95,1.07 [0.87-1.31],0.5256895503491983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,18043,81,0.27 [0.15-0.49],2.524218615280516e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSR,"Glutathione reductase, mitochondrial",18027,80,0.92 [0.35-2.46],0.8716122853108681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA1,Glutathione S-transferase A1,20849,98,1.04 [0.84-1.29],0.7138586067372694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA3,Glutathione S-transferase A3,20402,95,1.17 [0.94-1.46],0.1634743113064999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTM4,Glutathione S-transferase Mu 4,17476,78,1.17 [0.91-1.50],0.2208217906075547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTP1,Glutathione S-transferase P,20306,99,0.76 [0.56-1.01],0.0615608763910244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTT2B,Glutathione S-transferase theta-2B,18060,81,0.98 [0.90-1.07],0.6665807035870523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,17790,82,0.84 [0.58-1.21],0.340242593128915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTPBP2,GTP-binding protein 2,17606,79,1.02 [0.79-1.33],0.8747499377374706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,20775,101,3.45 [2.44-4.89],2.9591418776089435e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCY2C,Heat-stable enterotoxin receptor,17790,82,0.80 [0.58-1.10],0.1759651712156922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUK1,Guanylate kinase,17476,78,1.41 [0.93-2.13],0.1092889684647674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUSB,Beta-glucuronidase,20963,101,1.28 [0.97-1.69],0.0844460943556099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GYS1,"Glycogen [starch] synthase, muscle",20501,98,0.91 [0.75-1.11],0.356676938491977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMA,Granzyme A,21127,101,2.06 [1.30-3.26],0.0020322723208071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMB,Granzyme B,20854,99,0.73 [0.54-1.00],0.0485581818551503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMH,Granzyme H,20501,98,1.08 [0.89-1.31],0.4459988261927637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,H2AP,Huntingtin-interacting protein M,17467,80,1.09 [0.73-1.64],0.677956577535442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",17476,78,0.95 [0.66-1.36],0.7779059179706951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",21012,101,0.59 [0.46-0.77],0.0001083471512047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,21071,101,1.33 [1.16-1.53],4.821709813258602e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",20889,101,1.02 [0.81-1.27],0.8957313229489752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,21037,101,3.06 [2.60-3.61],2.219060007245561e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,20889,101,4.29 [3.11-5.90],5.7205228717924185e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBEGF,Proheparin-binding EGF-like growth factor,21012,101,0.90 [0.71-1.14],0.3699417311255987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBQ1,Hemoglobin subunit theta-1,21071,101,0.50 [0.37-0.69],2.572483127974665e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBZ,Hemoglobin subunit zeta,18107,82,0.73 [0.59-0.91],0.0049795744880083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCG22,Protein PBMUCL2,17476,78,0.96 [0.61-1.51],0.8554788134168163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCLS1,Hematopoietic lineage cell-specific protein,21127,101,0.86 [0.62-1.19],0.3567943047895093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC8,Histone deacetylase 8,17564,80,1.14 [0.84-1.53],0.4023107425279174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC9,Histone deacetylase 9,17515,78,0.76 [0.49-1.17],0.2141752778132205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDDC2,5'-deoxynucleotidase HDDC2,18042,82,0.55 [0.33-0.91],0.0201364653534053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGF,Hepatoma-derived growth factor,21036,101,1.02 [0.84-1.24],0.8169978359682353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,18060,81,1.15 [0.83-1.59],0.400681102352674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEBP1,Heme-binding protein 1,20501,98,0.94 [0.65-1.36],0.746116010165637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,17690,82,4.00 [1.96-8.16],0.0001419835783324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPACAM2,HEPACAM family member 2,18060,81,1.15 [0.70-1.88],0.5917763790312254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,18107,82,8.97 [3.93-20.50],1.9133967565076962e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEXIM1,Protein HEXIM1,20854,99,1.20 [0.96-1.49],0.1077945201705276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,21127,101,3.49 [2.36-5.15],3.102627647961681e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGFAC,Hepatocyte growth factor activator,17964,81,2.74 [1.21-6.22],0.0156064996275067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,20402,95,0.90 [0.72-1.13],0.374599347928419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,18060,81,1.32 [1.01-1.73],0.0393371012070285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIF1A,Hypoxia-inducible factor 1-alpha,17564,80,1.33 [1.03-1.71],0.0288990084607752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1,Huntingtin-interacting protein 1,17476,78,0.95 [0.49-1.84],0.8694543922374626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,18022,80,2.04 [1.63-2.56],5.191833501084501e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,18071,81,2.04 [1.47-2.81],1.568216539201364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HK2,Hexokinase-2,20501,98,0.97 [0.52-1.82],0.9351193756614352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",18071,81,2.27 [1.19-4.32],0.0126771786662373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",20785,98,1.78 [1.13-2.82],0.0131068749405123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",20854,99,5.40 [3.70-7.86],1.6578588755492888e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMBS,Porphobilinogen deaminase,21071,101,0.47 [0.31-0.71],0.0003481996639302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMCN2,Hemicentin-2,17657,82,1.66 [1.15-2.40],0.0074268614717223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",17604,78,1.12 [0.73-1.71],0.6045151400260755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",17476,78,0.79 [0.47-1.33],0.3769984929195787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMMR,Hyaluronan mediated motility receptor,17429,80,0.88 [0.53-1.46],0.6224858008143115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX1,Heme oxygenase 1,20650,98,0.56 [0.37-0.83],0.0041767298703247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX2,Heme oxygenase 2,20435,99,1.31 [0.94-1.84],0.1160320256067672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNF1A,Hepatocyte nuclear factor 1-alpha,17606,79,0.80 [0.55-1.16],0.2378549108402067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,20601,98,1.93 [1.40-2.66],5.403231805910249e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,20428,98,0.95 [0.75-1.20],0.6432806727932935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,18071,81,1.06 [0.71-1.59],0.7761886648467045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPCAL1,Hippocalcin-like protein 1,21127,101,1.08 [0.85-1.38],0.5249790257823761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,20402,95,0.33 [0.20-0.54],7.963986096481885e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPSE,Heparanase,17874,79,1.26 [1.00-1.59],0.053647002377331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRAS,GTPase Hras,17761,82,1.09 [0.89-1.32],0.4117766096712795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,17604,78,1.73 [1.03-2.91],0.0390558701501231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRG,Histidine-rich glycoprotein,18035,81,1.79 [0.92-3.50],0.0871068558135739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS1BP3,HCLS1-binding protein 3,17604,78,0.98 [0.77-1.25],0.8594364886574928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,20792,98,2.09 [1.29-3.40],0.0028985597226836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,21071,101,1.36 [0.85-2.18],0.1981511883827066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17564,80,2.46 [1.51-4.01],0.0003054781938664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSBP1,Heat shock factor-binding protein 1,17604,78,1.18 [0.93-1.48],0.1692096476582631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,20854,99,0.68 [0.44-1.06],0.090477122677748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,18060,81,1.40 [1.01-1.94],0.0431679195380684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,17476,78,0.83 [0.53-1.31],0.4246515818032124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,17604,78,1.28 [0.85-1.94],0.2343721211425518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSP90B1,Endoplasmin,20338,98,0.86 [0.61-1.21],0.3730308935996563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA1A,Heat shock 70 kDa protein 1A,20917,99,1.09 [0.85-1.39],0.4847904435587833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,18044,80,1.80 [1.38-2.34],1.2222333759673566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB1,Heat shock protein beta-1,20559,97,1.14 [0.87-1.51],0.3428450914917334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,21071,101,4.71 [3.38-6.56],5.952750993476893e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,20749,96,4.39 [3.03-6.35],4.154151231755984e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1A,5-hydroxytryptamine receptor 1A,17515,78,0.92 [0.65-1.30],0.6484166231541412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1B,5-hydroxytryptamine receptor 1B,17515,78,0.83 [0.47-1.46],0.5170417423463607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTRA2,"Serine protease HTRA2, mitochondrial",20948,102,1.20 [0.92-1.58],0.1791166304119274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,20800,95,8.36 [4.58-15.26],4.522450750607178e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,21140,101,6.98 [3.56-13.66],1.4726202888611145e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICA1,Islet cell autoantigen 1,20526,99,0.96 [0.77-1.20],0.7347892617892422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,20812,98,4.17 [2.49-6.99],5.81296471390005e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,21140,101,3.38 [1.91-5.96],2.752817570653697e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,21140,101,3.06 [1.70-5.51],0.0002002867757802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM4,Intercellular adhesion molecule 4,20854,99,0.61 [0.44-0.86],0.0043069872023857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM5,Intercellular adhesion molecule 5,20881,98,1.69 [1.17-2.46],0.0054332634078685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICOSLG,ICOS ligand,20792,98,4.28 [1.75-10.46],0.0014006390380928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ID4,DNA-binding protein inhibitor ID-4,17790,82,1.16 [0.74-1.83],0.5183905955017778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,20435,99,1.23 [0.87-1.74],0.2437485180539117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDO1,"Indoleamine 2,3-dioxygenase 1",17604,78,0.93 [0.64-1.34],0.6833425882225874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDS,Iduronate 2-sulfatase,21127,101,0.43 [0.07-2.81],0.3783270247640063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,21071,101,3.26 [2.17-4.91],1.2829277560636094e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17621,79,2.78 [1.84-4.21],1.2498253445607696e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,17790,82,1.11 [0.72-1.70],0.6343784873208411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,17790,82,1.39 [0.86-2.25],0.1824431860497826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNAR1,Interferon alpha/beta receptor 1,18042,82,1.53 [0.70-3.35],0.2837390671450299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNG,Interferon gamma,20526,99,1.20 [1.02-1.41],0.0279559363988777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,20956,99,3.34 [2.36-4.73],1.2133063211012887e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,20696,99,2.03 [1.50-2.76],5.472843962404288e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL1,Interferon lambda-1,20435,99,1.50 [1.08-2.09],0.0160756980165817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL2,Interferon lambda-2,17515,78,0.87 [0.57-1.34],0.5327178708568912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNLR1,Interferon lambda receptor 1,20854,99,1.65 [1.12-2.43],0.0110452622523351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNW1,Interferon omega-1,17476,78,0.73 [0.35-1.51],0.3929842658363123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFT20,Intraflagellar transport protein 20 homolog,17606,79,0.93 [0.58-1.49],0.7628638898683034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGBP1,Immunoglobulin-binding protein 1,18071,81,0.76 [0.55-1.07],0.1210550487865315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,17515,78,0.61 [0.33-1.15],0.1265773854280509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,18104,80,0.37 [0.19-0.71],0.0027387102112985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,20792,98,5.95 [3.79-9.36],1.0458703993928586e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,17476,78,0.82 [0.49-1.39],0.4653601200239892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,20889,101,6.37 [3.64-11.15],9.121141953654491e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP1,Insulin-like growth factor-binding protein 1,21110,100,1.05 [0.91-1.21],0.5179774914518506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,21110,101,1.89 [1.42-2.52],1.2607369699391483e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,20989,98,0.38 [0.26-0.55],4.4657008876058123e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,20637,99,3.35 [2.75-4.08],3.731017847852629e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,20813,97,2.85 [1.93-4.20],1.351788914240813e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,21140,101,2.85 [2.31-3.52],3.860073206654622e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,20881,98,4.36 [3.05-6.24],8.273430435778403e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFL4,Insulin growth factor-like family member 4,17564,80,1.11 [0.85-1.43],0.4481173604293028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGHMBP2,DNA-binding protein SMUBP-2,17476,78,1.02 [0.70-1.49],0.9130199807324648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,18102,81,2.41 [1.66-3.49],3.847475113372974e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLON5,IgLON family member 5,17467,80,1.05 [0.87-1.29],0.5968134540967622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF21,Immunoglobulin superfamily member 21,17604,78,0.60 [0.33-1.09],0.0939356239195919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,20792,98,2.90 [2.32-3.63],8.44528900685277e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,20881,98,4.10 [2.87-5.86],1.0317813177092956e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,18107,82,1.68 [1.35-2.11],5.077547802594934e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKBKG,NF-kappa-B essential modulator,20854,99,1.12 [0.91-1.37],0.2767523406385682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKZF2,Zinc finger protein Helios,20402,95,0.99 [0.79-1.23],0.8995756848085684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,20526,99,1.41 [1.18-1.68],0.0001955955971764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RA,Interleukin-10 receptor subunit alpha,20526,99,1.22 [0.95-1.56],0.1169676180549757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,20956,99,3.71 [2.88-4.78],2.1187283127854e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL11,Interleukin-11,20526,99,0.99 [0.74-1.32],0.9504756843668356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,20792,98,2.06 [1.70-2.51],4.074304668960961e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,21127,101,2.29 [1.70-3.10],6.26167224267437e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,20526,99,4.28 [3.13-5.86],9.97130390357262e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,17564,80,2.05 [1.38-3.05],0.0003945311277475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13,Interleukin-13,20526,99,1.03 [0.72-1.48],0.8694422247966351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,20631,101,1.06 [0.50-2.22],0.8855880091421048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,17515,78,0.92 [0.43-1.97],0.8296566629348942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15,Interleukin-15,20854,99,2.76 [1.67-4.56],6.943289229572973e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,20526,99,4.33 [2.70-6.95],1.15086133041492e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL16,Pro-interleukin-16,21127,101,1.29 [0.87-1.92],0.2013036992429461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17A,Interleukin-17A,20483,98,1.24 [0.90-1.72],0.1826661862690585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,20526,99,1.70 [1.45-1.99],2.673492610519017e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17D,Interleukin-17D,20526,99,1.20 [0.77-1.87],0.4169797644214924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17F,Interleukin-17F,20526,99,1.10 [0.88-1.38],0.3937259647470762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RA,Interleukin-17 receptor A,20889,101,1.20 [0.80-1.80],0.3731453341906485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RB,Interleukin-17 receptor B,20591,99,1.02 [0.74-1.42],0.8900898046482296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,20774,98,2.75 [2.05-3.70],1.819515086317572e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,20989,98,7.19 [4.83-10.70],2.2340257050529203e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,21127,101,9.61 [6.14-15.04],3.6538836657357096e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18RAP,Interleukin-18 receptor accessory protein,20561,97,0.90 [0.79-1.01],0.0714863909472266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,20353,95,1.69 [1.43-2.00],6.680538065126468e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1A,Interleukin-1 alpha,20526,99,1.05 [0.80-1.39],0.7317463315322501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1B,Interleukin-1 beta,20432,98,1.23 [0.93-1.62],0.1532610928041687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,20850,101,6.35 [4.72-8.55],4.6518399369718325e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,20810,98,7.78 [3.24-18.72],4.609164118921824e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RAP,Interleukin-1 receptor accessory protein,20889,101,1.35 [0.94-1.95],0.1055205454235062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,21067,101,3.91 [2.66-5.76],4.381930777469341e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL2,Interleukin-1 receptor-like 2,20526,99,0.74 [0.47-1.16],0.1890219772075821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,20817,99,2.09 [1.69-2.59],1.3233420876835215e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2,Interleukin-2,20526,99,0.99 [0.55-1.77],0.9669367080772768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20,Interleukin-20,20526,99,1.05 [0.73-1.51],0.8074929244549064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RA,Interleukin-20 receptor subunit alpha,20526,99,1.33 [0.99-1.79],0.0623345719612022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RB,Interleukin-20 receptor subunit beta,17564,80,0.89 [0.53-1.49],0.6472810736211175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL21R,Interleukin-21 receptor,17564,80,1.12 [0.86-1.46],0.3852698905863215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,18044,80,1.45 [1.12-1.88],0.0044316018174345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,20526,99,1.12 [0.76-1.66],0.5533114859073114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL24,Interleukin-24,20526,99,0.90 [0.61-1.32],0.5792535465355402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL25,Interleukin-25,17403,80,1.04 [0.55-1.97],0.9024187973963874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,20754,100,2.56 [2.04-3.22],4.847899600915975e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RB,Interleukin-2 receptor subunit beta,20526,99,1.35 [0.88-2.06],0.1712604872574271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RG,Cytokine receptor common subunit gamma,18044,80,1.63 [1.05-2.51],0.0291896682580965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3,Interleukin-3,17467,80,1.05 [0.72-1.51],0.813216097869001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31,Interleukin-31,17564,80,0.97 [0.63-1.48],0.871479734443375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31RA,Interleukin-31 receptor subunit alpha,17502,79,1.53 [0.87-2.67],0.1368072626781477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL32,Interleukin-32,20854,99,1.58 [1.11-2.26],0.0114226897933413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL33,Interleukin-33,20526,99,1.92 [1.29-2.88],0.0014611504346169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL34,Interleukin-34,20399,99,1.07 [0.66-1.76],0.7749631541430158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36A,Interleukin-36 alpha,17564,80,0.84 [0.55-1.29],0.4291054007011456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36G,Interleukin-36 gamma,17503,80,1.10 [0.84-1.45],0.4906071562856502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3RA,Interleukin-3 receptor subunit alpha,20526,99,1.93 [1.16-3.24],0.0120009779476597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4,Interleukin-4,20526,99,1.20 [0.95-1.51],0.1357252337742882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,20854,99,3.39 [2.47-4.66],5.307685842090643e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5,Interleukin-5,20526,99,0.96 [0.84-1.11],0.6056371894442427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5RA,Interleukin-5 receptor subunit alpha,20854,99,1.59 [1.24-2.05],0.0003242380016612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,20792,98,1.58 [1.36-1.84],1.948903507843336e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6R,Interleukin-6 receptor subunit alpha,20783,98,2.29 [1.35-3.90],0.002117975141727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,20881,98,9.02 [4.91-16.59],1.448275785055016e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7,Interleukin-7,20854,99,0.94 [0.71-1.24],0.6744989857148871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7R,Interleukin-7 receptor subunit alpha,20889,101,0.82 [0.59-1.15],0.2560059658671681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL9,Interleukin-9,17790,82,1.12 [0.81-1.56],0.4800643429027896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,20398,99,1.12 [0.84-1.50],0.4296591616805675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,18044,80,2.65 [2.08-3.39],5.55368168550489e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPA1,Inositol monophosphatase 1,20696,99,0.89 [0.66-1.20],0.4477966484128157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPACT,Protein IMPACT,18060,81,0.76 [0.52-1.11],0.1597546178003231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,17515,78,0.30 [0.13-0.72],0.0067703532692485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ING1,Inhibitor of growth protein 1,20407,98,1.09 [0.77-1.53],0.6354313495348224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,17690,82,2.39 [1.71-3.36],4.420262311569218e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,20889,101,5.48 [3.33-9.01],2.1242461469464733e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP1,Inositol polyphosphate 1-phosphatase,20792,98,1.00 [0.71-1.40],0.9829424998564622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",17604,78,1.02 [0.70-1.48],0.9276879354054772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",18071,81,0.76 [0.42-1.36],0.3495009386081217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",20792,98,1.16 [0.96-1.39],0.1277226572602323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL3,Insulin-like 3,18060,81,0.82 [0.65-1.02],0.0795574218994517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL4,Early placenta insulin-like peptide,18044,80,1.73 [1.38-2.17],1.8942294087624804e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,18042,82,1.41 [1.16-1.73],0.0006329123505068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,17564,80,8.28 [4.44-15.41],2.687334058991608e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,20657,99,1.04 [0.85-1.27],0.692748939917692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,20792,98,1.56 [1.15-2.14],0.0049403744410981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",20501,98,1.26 [1.05-1.51],0.0109135296105704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK1,Interleukin-1 receptor-associated kinase 1,20526,99,1.13 [0.87-1.46],0.3538407750114466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK4,Interleukin-1 receptor-associated kinase 4,20854,99,0.99 [0.84-1.18],0.9302868458755916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,20136,97,1.05 [0.67-1.66],0.8232752121003928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM1,Isthmin-1,20854,99,1.09 [0.69-1.74],0.7092375709707919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM2,Isthmin-2,18104,80,0.89 [0.53-1.49],0.646478300534184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IST1,IST1 homolog,17904,81,1.00 [0.81-1.24],0.9799525156496768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,20854,99,0.41 [0.25-0.68],0.0004735796141174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA2,Integrin alpha-2,17690,82,0.55 [0.31-1.00],0.0501860973359083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,20889,101,9.14 [4.87-17.17],5.886437006764411e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA6,Integrin alpha-6,20854,99,0.76 [0.52-1.11],0.1489835424190531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAL,Integrin alpha-L,17564,80,2.01 [1.17-3.45],0.0111325580421249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAM,Integrin alpha-M,20889,101,2.08 [1.21-3.56],0.007742021002034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAV,Integrin alpha-V,21071,101,0.37 [0.18-0.75],0.0058776324829355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAX,Integrin alpha-X,17790,82,1.18 [0.83-1.67],0.3481646456367814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1,Integrin beta-1,20884,98,3.84 [1.89-7.81],0.0001980298851326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP1,Integrin beta-1-binding protein 1,20402,95,1.39 [0.89-2.17],0.1533325625639282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP2,Integrin beta-1-binding protein 2,20501,98,1.01 [0.86-1.18],0.8918851597331235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,20762,98,3.26 [1.94-5.46],7.630744436409626e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB5,Integrin beta-5,20948,102,1.19 [0.80-1.79],0.3902769478917057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB6,Integrin beta-6,20526,99,3.56 [2.01-6.31],1.4126539016524907e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,21071,101,2.52 [1.83-3.47],1.648942131626144e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,18104,80,3.85 [2.94-5.03],5.620648606857891e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,18124,81,1.21 [0.40-3.68],0.7327975887881261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,20989,98,5.17 [3.27-8.19],2.4467682911985248e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,18124,81,2.06 [0.96-4.40],0.0627639217887965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,18044,80,1.18 [0.78-1.77],0.4313399169341673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITM2A,Integral membrane protein 2A,20854,99,1.00 [0.75-1.33],0.9861230877746734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPA,Inosine triphosphate pyrophosphatase,17476,78,0.95 [0.70-1.28],0.724474474175136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",17604,78,1.17 [0.87-1.57],0.3036938445912822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",17515,78,0.83 [0.51-1.35],0.4442312945644597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",20435,99,0.71 [0.48-1.05],0.0876868817546012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IZUMO1,Izumo sperm-egg fusion protein 1,17467,80,1.25 [0.86-1.81],0.2462635220325366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,21081,102,4.35 [2.86-6.60],5.475381800449862e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,17690,82,1.76 [1.26-2.47],0.0010247942611447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JCHAIN,Immunoglobulin J chain,20526,99,1.38 [1.04-1.85],0.0273415098582241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,17467,80,0.99 [0.71-1.39],0.9693854690062004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JPT2,Jupiter microtubule associated homolog 2,18042,82,1.07 [0.84-1.35],0.5994579720410529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JUN,Transcription factor AP-1,20526,99,1.38 [1.03-1.85],0.029119065076504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,20792,98,2.31 [1.52-3.50],8.267785796471114e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZN,Kazrin,18042,82,1.15 [0.94-1.41],0.170465293848961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,17515,78,1.30 [0.94-1.80],0.1124063475763515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,17606,79,1.21 [0.95-1.54],0.1197563246390113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNIP4,Kv channel-interacting protein 4,20435,99,0.89 [0.60-1.31],0.5475794090523123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCTD5,BTB/POZ domain-containing protein KCTD5,17710,80,1.52 [1.02-2.26],0.0379213659985954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDM3A,Lysine-specific demethylase 3A,17564,80,1.14 [0.93-1.40],0.2208983876739488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDR,Vascular endothelial growth factor receptor 2,20948,102,0.78 [0.39-1.59],0.5004568776224245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KEL,Kell blood group glycoprotein,20435,99,1.34 [0.82-2.18],0.2433685726353249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHDC3L,KH domain-containing protein 3,17467,80,0.93 [0.66-1.31],0.67053589624478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHK,Ketohexokinase,17604,78,1.31 [0.92-1.88],0.1372969835214345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA0319,Dyslexia-associated protein KIAA0319,18060,81,1.23 [0.67-2.26],0.5122068525800021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549,UPF0606 protein KIAA1549,17790,82,1.16 [0.85-1.59],0.3541235191911924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549L,UPF0606 protein KIAA1549L,17790,82,1.11 [0.56-2.23],0.7595199219391238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA2013,Uncharacterized protein KIAA2013,18044,80,0.96 [0.62-1.48],0.8587337338790222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,17476,78,1.93 [1.39-2.68],7.799462425516306e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF20B,Kinesin-like protein KIF20B,17515,78,0.87 [0.63-1.19],0.3818513484015285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF22,Kinesin-like protein KIF22,17476,78,1.15 [0.96-1.38],0.1293722495962663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIFBP,KIF-binding protein,20792,98,1.12 [0.90-1.40],0.3001220736645807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,18044,80,1.43 [1.13-1.81],0.0028926723495685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,20402,95,1.49 [1.20-1.86],0.0003525993647524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,18042,82,1.08 [0.96-1.22],0.188426375693286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,20402,95,1.01 [0.87-1.17],0.9020263980335887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,17467,80,1.04 [0.82-1.32],0.7495766163854845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL1,Kin of IRRE-like protein 1,17515,78,0.91 [0.59-1.38],0.6467031522440398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL2,Kin of IRRE-like protein 2,20435,99,1.06 [0.70-1.62],0.7723675435717621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIT,Mast/stem cell growth factor receptor Kit,20956,98,0.56 [0.31-1.03],0.0635301913251539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KITLG,Kit ligand,20881,98,0.73 [0.47-1.14],0.1718214958029177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLB,Beta-klotho,20435,99,1.00 [0.79-1.27],0.99130841122763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLF4,Krueppel-like factor 4,17515,78,1.01 [0.59-1.72],0.9830110238979024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLHL41,Kelch-like protein 41,18071,81,1.02 [0.69-1.49],0.9384397371366852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK1,Kallikrein-1,20693,101,0.94 [0.82-1.08],0.3651250040411904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK10,Kallikrein-10,20889,102,1.13 [0.75-1.69],0.5568177272882462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,20748,102,2.55 [2.05-3.17],5.2514558592936026e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK12,Kallikrein-12,20402,95,1.08 [0.94-1.24],0.276655789914417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK13,Kallikrein-13,20416,97,0.85 [0.58-1.26],0.422369188104152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK14,Kallikrein-14,21071,101,1.21 [0.83-1.77],0.311655043682646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK15,Kallikrein-15,18009,80,0.91 [0.60-1.40],0.6741402265738855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK3,Prostate-specific antigen,18104,80,0.76 [0.63-0.93],0.0061795685504677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,21071,101,2.25 [1.96-2.57],4.488517414026771e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK6,Kallikrein-6,20907,102,2.15 [1.23-3.75],0.0072460826350323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK7,Kallikrein-7,17256,79,0.38 [0.21-0.70],0.0016524782420937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK8,Kallikrein-8,20184,101,1.77 [1.14-2.74],0.011323458378501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLKB1,Plasma kallikrein,17753,81,1.16 [0.49-2.74],0.7363023371568337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,21127,101,7.90 [5.53-11.29],6.609419866188837e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,17515,78,0.91 [0.60-1.37],0.6499638253268457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,21127,101,3.01 [2.09-4.34],3.6445754358905276e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,17564,80,1.79 [1.37-2.33],1.562769836469669e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,18060,81,2.45 [1.88-3.19],2.5757588310565863e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT14,"Keratin, type I cytoskeletal 14",19809,94,0.70 [0.36-1.37],0.3011059221954923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT17,"Keratin, type I cytoskeletal 17",17476,78,0.73 [0.40-1.31],0.2878532064897112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",20792,98,1.70 [1.45-1.99],8.080301286183735e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",20816,99,2.46 [2.03-2.99],9.24076840716714e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT5,"Keratin, type II cytoskeletal 5",20435,99,0.90 [0.63-1.27],0.5406197744423209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT6C,"Keratin, type II cytoskeletal 6C",17476,78,0.76 [0.38-1.52],0.4357484475098963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",17515,78,1.49 [1.32-1.67],1.0809796496808479e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,20845,98,0.82 [0.60-1.13],0.221766901854633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYNU,Kynureninase,21127,101,1.21 [0.83-1.75],0.3203618917401947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L1CAM,Neural cell adhesion molecule L1,20948,102,1.48 [0.82-2.67],0.1970534618512824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,18107,82,1.18 [0.94-1.47],0.1455577156268737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACRT,Extracellular glycoprotein lacritin,18016,80,0.69 [0.37-1.29],0.2430800225135189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACTB2,Endoribonuclease LACTB2,20881,98,0.96 [0.74-1.26],0.7898738212767484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,20792,98,3.02 [2.45-3.72],4.668221683589631e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,20847,98,3.41 [2.68-4.35],1.8486004334732402e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,20696,99,1.31 [1.10-1.57],0.003107834161933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA1,Laminin subunit alpha-1,17476,78,1.21 [0.84-1.73],0.3038316829628528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA4,Laminin subunit alpha-4,20956,99,1.73 [1.07-2.82],0.0262354342239978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,17604,78,4.31 [2.10-8.83],6.669805489222525e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP1,Lysosome-associated membrane glycoprotein 1,17596,78,1.62 [1.19-2.20],0.0023740365659766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP2,Lysosome-associated membrane glycoprotein 2,20244,97,1.34 [0.57-3.14],0.4996646250892352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,21094,101,1.81 [1.32-2.48],0.0002235838161133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMTOR5,Ragulator complex protein LAMTOR5,18044,80,0.85 [0.49-1.49],0.5740440270059244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAP3,Cytosol aminopeptidase,20526,99,1.07 [0.74-1.55],0.7111944785277015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LARP1,La-related protein 1,18044,80,1.11 [0.80-1.53],0.5335123123476565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT,Linker for activation of T-cells family member 1,21127,101,1.12 [0.88-1.42],0.3551573451918748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT2,Linker for activation of T-cells family member 2,20792,98,1.11 [0.97-1.28],0.1412776120163534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LATS1,Serine/threonine-protein kinase LATS1,17564,80,1.09 [0.85-1.39],0.5063624528515074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,20668,98,5.35 [4.07-7.02],1.4749393214452956e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBP,Lipopolysaccharide-binding protein,20989,98,1.67 [1.26-2.22],0.0003439415027473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBR,Delta(14)-sterol reductase LBR,21081,102,1.27 [1.03-1.57],0.0266077493777574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCAT,Phosphatidylcholine-sterol acyltransferase,18123,81,0.98 [0.35-2.73],0.9734023766256824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,18071,81,1.70 [1.39-2.08],3.139110785685028e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,20269,94,2.72 [1.97-3.76],1.045766787372813e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCP1,Plastin-2,18104,80,0.66 [0.40-1.07],0.0891879255674679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLR,Low-density lipoprotein receptor,20935,100,1.04 [0.73-1.47],0.8337796057544468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,18071,81,1.09 [0.88-1.34],0.4328634362199683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LECT2,Leukocyte cell-derived chemotaxin-2,18107,82,1.48 [1.10-2.00],0.0088301700705828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEFTY2,Left-right determination factor 2,21046,101,2.06 [1.46-2.89],3.697590195254693e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEG1,Protein LEG1 homolog,17117,79,1.11 [0.82-1.48],0.5011179408411445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LELP1,Late cornified envelope-like proline-rich protein 1,17515,78,1.07 [0.81-1.42],0.635900699373461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEO1,RNA polymerase-associated protein LEO1,18071,81,1.58 [0.98-2.55],0.0586926189097081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEP,Leptin,20881,98,1.41 [1.05-1.89],0.0216933470924335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEPR,Leptin receptor,20881,98,1.86 [1.18-2.93],0.0077992537260997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,18071,81,1.82 [1.35-2.47],0.0001031473106847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,20881,98,1.91 [1.23-2.96],0.003694350695622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,20947,99,2.61 [1.50-4.57],0.0007397589331275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,18124,81,2.87 [1.93-4.27],1.8409541941947445e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,20847,98,3.99 [3.21-4.97],1.2413017372258873e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS7_LGALS7B,Galectin-7,20836,100,1.50 [1.08-2.09],0.0160994300799956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS8,Galectin-8,21081,102,1.18 [0.90-1.56],0.2263953585770111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,20851,99,6.77 [4.42-10.35],1.2240165691497356e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGMN,Legumain,20956,99,1.92 [1.21-3.04],0.0054590106004737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHB,Lutropin subunit beta,20402,95,1.11 [0.92-1.33],0.2906766189412215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,20888,99,0.57 [0.44-0.73],1.6034623891515526e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIF,Leukemia inhibitory factor,20435,99,1.01 [0.72-1.42],0.9575899633562278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,20854,99,8.98 [6.29-12.83],1.364829321284199e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,20889,101,1.84 [1.10-3.08],0.0210247715485966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,18104,80,1.14 [0.93-1.41],0.2082946836286351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,17476,78,0.68 [0.40-1.15],0.1489493121678521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,20852,98,3.36 [2.01-5.62],3.595607311062426e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,18107,82,1.57 [1.17-2.12],0.0030124209656343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,21140,101,4.10 [2.27-7.40],2.934375171017481e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,21037,101,3.36 [1.94-5.83],1.650267229825281e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,20526,99,2.90 [2.07-4.05],4.5607514886551775e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,21140,101,1.02 [0.79-1.32],0.8554660158065265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIPF,Gastric triacylglycerol lipase,17604,78,1.06 [0.75-1.51],0.7258833071903428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB1,Lamin-B1,18009,82,0.99 [0.69-1.41],0.9345920502536638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,18060,81,2.86 [1.60-5.12],0.0003994142349877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,18071,81,2.13 [1.56-2.92],2.3142466268829405e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD2,Leiomodin-2,17515,78,0.88 [0.59-1.32],0.550639741204505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LONP1,"Lon protease homolog, mitochondrial",17604,78,1.33 [1.07-1.64],0.0091763630866784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPA,Apolipoprotein(a),17713,80,0.98 [0.88-1.10],0.7590138611177569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,20792,98,1.13 [0.79-1.62],0.4880592796249786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPL,Lipoprotein lipase,20881,98,0.57 [0.43-0.77],0.0002599452747317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,20131,97,2.22 [1.68-2.92],1.5888951396489312e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPP,Lipoma-preferred partner,17476,78,0.95 [0.69-1.31],0.7457490363673758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,17476,78,1.26 [0.94-1.68],0.1189557297450928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,17606,79,0.53 [0.28-1.01],0.052073788141199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRG1,Leucine-rich alpha-2-glycoprotein,18124,81,3.36 [1.66-6.79],0.0007300909800679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,21012,101,3.54 [2.27-5.50],2.0768929695906503e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,17510,80,2.87 [1.72-4.78],5.126355309449544e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,20792,98,1.61 [0.86-3.01],0.1391949604945316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,20881,98,4.08 [2.75-6.06],3.044400059612776e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2,Low-density lipoprotein receptor-related protein 2,17606,79,0.98 [0.55-1.75],0.9357280165646183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2BP,LRP2-binding protein,17606,79,1.31 [1.07-1.60],0.0084794196568024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,21081,102,1.18 [0.90-1.55],0.238031725737254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,20792,98,2.57 [1.75-3.79],1.5324351468859869e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,18042,82,2.10 [1.32-3.35],0.0017943263126206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC38,Leucine-rich repeat-containing protein 38,17606,79,1.08 [0.68-1.72],0.7310200756978971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC59,Leucine-rich repeat-containing protein 59,18107,82,1.26 [0.87-1.83],0.2189913039747149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,18044,80,1.47 [1.00-2.18],0.0527107948725783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRN1,Leucine-rich repeat neuronal protein 1,20526,99,0.44 [0.29-0.67],0.000131844521501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,17606,79,0.90 [0.52-1.55],0.7018260241573124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,18071,81,0.44 [0.25-0.78],0.0046844774221427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,20402,95,0.99 [0.70-1.38],0.9353901833060632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,17790,82,0.99 [0.76-1.29],0.9301161697158468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSP1,Lymphocyte-specific protein 1,20854,99,1.29 [0.84-1.99],0.2456381541370534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA,Lymphotoxin-alpha,20854,99,1.75 [1.20-2.55],0.0033548780433691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA4H,Leukotriene A-4 hydrolase,21071,101,0.51 [0.36-0.73],0.000164471283597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTB,Lymphotoxin-beta,18044,80,1.14 [0.64-2.01],0.6622244629399079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,21140,101,6.71 [4.71-9.56],5.900316249095126e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,20402,95,1.78 [1.43-2.22],2.3097243650532281e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,20737,98,5.55 [3.79-8.14],1.610212664626706e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTO1,Protein LTO1 homolog,20526,99,1.27 [0.92-1.76],0.146823559855846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LUZP2,Leucine zipper protein 2,18044,80,1.52 [1.03-2.25],0.035049543962648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LXN,Latexin,20596,99,0.57 [0.42-0.77],0.0002429598140897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,20750,99,2.18 [1.57-3.03],2.8225225149495377e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY75,Lymphocyte antigen 75,20854,99,1.74 [1.09-2.80],0.0215483875352931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,20621,97,4.99 [3.12-7.98],1.905886899098736e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,20696,99,2.94 [2.13-4.06],6.930349017152949e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYAR,Cell growth-regulating nucleolar protein,20402,95,0.70 [0.45-1.09],0.1166682425385477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYN,Tyrosine-protein kinase Lyn,20792,98,1.06 [0.86-1.32],0.5796253689159424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD1,Ly6/PLAUR domain-containing protein 1,20435,99,0.99 [0.73-1.33],0.9303880487236954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD3,Ly6/PLAUR domain-containing protein 3,20788,102,1.70 [1.01-2.86],0.0457326548489878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD8,Ly6/PLAUR domain-containing protein 8,20402,95,1.66 [1.25-2.22],0.000544662177855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPLA2,Acyl-protein thioesterase 2,17515,78,0.99 [0.80-1.21],0.90450248663569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,17606,79,0.94 [0.75-1.18],0.5941637198557874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,18124,81,3.22 [1.15-9.08],0.0266725125398436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYZL2,Lysozyme-like protein 2,17467,80,0.98 [0.58-1.67],0.940825302542087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LZTFL1,Leucine zipper transcription factor-like protein 1,17690,82,0.99 [0.74-1.32],0.9537374651084616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,M6PR,Cation-dependent mannose-6-phosphate receptor,17604,78,0.78 [0.42-1.47],0.4473814207958361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,20635,98,1.48 [1.18-1.85],0.0007338753678184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAEA,E3 ubiquitin-protein transferase MAEA,20402,95,1.00 [0.61-1.62],0.9895701008133676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAG,Myelin-associated glycoprotein,17606,79,0.64 [0.42-0.97],0.0334775950769002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGEA3,Melanoma-associated antigen 3,17790,82,1.00 [0.78-1.28],0.9931809005832344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGED1,Melanoma-associated antigen D1,20402,95,1.29 [0.91-1.84],0.1590171629518353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,18107,82,3.66 [2.29-5.83],5.03515814892982e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC4,Apical endosomal glycoprotein,18044,80,1.64 [1.18-2.29],0.0033944471806497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",17604,78,1.62 [0.70-3.76],0.2589230891212833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN2B2,Epididymis-specific alpha-mannosidase,18107,82,1.30 [0.91-1.87],0.1491158172521822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",17467,80,0.93 [0.61-1.41],0.7295611211439921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,20956,99,1.06 [0.91-1.23],0.4777730112512717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,20948,102,5.53 [3.46-8.82],7.813488240986284e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC4,MANSC domain-containing protein 4,17476,78,1.07 [0.78-1.45],0.6805550156070249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,17515,78,0.82 [0.41-1.62],0.5657113051334426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,17476,78,0.85 [0.56-1.30],0.450817417662479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,18060,81,1.76 [1.32-2.35],0.000126243035125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,18042,82,1.11 [0.81-1.53],0.5148178124466967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,20854,99,1.02 [0.85-1.22],0.8505514157400464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,20402,95,1.21 [1.02-1.45],0.0333365335680857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,20668,98,1.02 [0.87-1.20],0.7863333200234016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK13,Mitogen-activated protein kinase 13,17467,80,1.20 [0.75-1.94],0.4482992467202555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK9,Mitogen-activated protein kinase 9,20854,99,1.14 [0.74-1.75],0.5633599959199928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPKAPK2,MAP kinase-activated protein kinase 2,17790,82,0.98 [0.73-1.30],0.866530281633617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,17467,80,1.11 [0.97-1.26],0.1157857468195564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPT,Microtubule-associated protein tau,20435,99,1.09 [0.76-1.55],0.6481151371245579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARCO,Macrophage receptor MARCO,20881,98,2.23 [1.11-4.51],0.0247985363584686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",17660,81,1.12 [0.87-1.43],0.3778984513749244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MASP1,Mannan-binding lectin serine protease 1,20668,98,2.76 [1.31-5.81],0.0073045133601822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN2,Matrilin-2,20878,98,3.29 [1.86-5.83],4.3230859155239375e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN3,Matrilin-3,20657,99,0.64 [0.37-1.11],0.108388716895007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAVS,Mitochondrial antiviral-signaling protein,20402,95,1.23 [1.01-1.49],0.0416724965285468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAX,Protein max,20435,99,1.04 [0.88-1.23],0.6197334886450261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,21140,101,1.71 [1.30-2.26],0.0001284493464093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MBL2,Mannose-binding protein C,17876,81,1.16 [0.96-1.42],0.1313521572692435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCAM,Cell surface glycoprotein MUC18,20989,98,2.31 [1.36-3.93],0.0019533604139162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",18071,81,1.03 [0.62-1.71],0.9009064325844992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEMP1,Mast cell-expressed membrane protein 1,17564,80,1.30 [1.04-1.61],0.019822689584964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,20773,98,1.88 [1.29-2.73],0.0009416523256826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCTS1,Malignant T-cell-amplified sequence 1,18042,82,1.33 [0.74-2.38],0.3406925810979476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,20696,99,1.63 [1.25-2.14],0.0003707169842336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDH1,"Malate dehydrogenase, cytoplasmic",18033,81,0.59 [0.34-1.02],0.0582519322921155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,20879,102,2.03 [1.66-2.47],3.075137485036304e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDM1,Nuclear protein MDM1,17606,79,0.96 [0.49-1.89],0.9029205505254146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",17604,78,1.21 [0.98-1.49],0.0706288833698454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED18,Mediator of RNA polymerase II transcription subunit 18,20402,95,1.07 [0.85-1.36],0.5601250890436094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED21,Mediator of RNA polymerase II transcription subunit 21,17476,78,0.95 [0.58-1.56],0.8307877440523959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,20847,98,2.15 [1.37-3.36],0.0008287490341595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,17476,78,0.79 [0.37-1.70],0.5486423099700177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,21067,101,2.21 [1.30-3.76],0.0032966828559272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MELTF,Melanotransferrin,18107,82,1.31 [0.67-2.60],0.4316946675999619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,17690,82,0.34 [0.21-0.56],2.060775053967173e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1A,Meprin A subunit alpha,18042,82,1.10 [0.84-1.45],0.4762433513401984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1B,Meprin A subunit beta,20881,98,0.93 [0.80-1.08],0.3456814158349895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEPE,Matrix extracellular phosphoglycoprotein,20847,98,0.37 [0.19-0.70],0.0022207660440907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MERTK,Tyrosine-protein kinase Mer,21127,101,1.95 [0.98-3.88],0.0577300714149832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MESD,LRP chaperone MESD,20889,101,1.05 [0.91-1.20],0.5035016871782888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MET,Hepatocyte growth factor receptor,20927,98,0.48 [0.19-1.23],0.1262421144336731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1,Methionine aminopeptidase 1,20435,99,1.02 [0.56-1.89],0.937512405206374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",20854,99,1.18 [0.96-1.45],0.108829905227969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP2,Methionine aminopeptidase 2,21046,101,1.03 [0.76-1.40],0.8467224226682861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3,Microfibril-associated glycoprotein 3,20501,98,1.07 [0.74-1.54],0.7351451069072322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3L,Microfibrillar-associated protein 3-like,17606,79,0.78 [0.51-1.20],0.2596614018115756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,17690,82,8.24 [4.46-15.20],1.512280855663913e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP5,Microfibrillar-associated protein 5,21140,101,1.45 [0.95-2.21],0.0875488719326194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,20889,101,3.56 [2.56-4.94],4.070015452578473e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGLL,Monoglyceride lipase,20922,99,1.03 [0.84-1.27],0.7638745296912215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,20854,99,1.01 [0.87-1.18],0.8621981460390331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIA,Melanoma-derived growth regulatory protein,20948,102,0.88 [0.55-1.43],0.6157894810448392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICALL2,MICAL-like protein 2,17606,79,1.17 [0.87-1.58],0.2862733169809672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,20854,99,1.20 [1.01-1.42],0.0359263385796559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIF,Macrophage migration inhibitory factor,20850,101,0.86 [0.67-1.11],0.2505747572584735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,20526,99,2.41 [1.79-3.23],5.691863663023647e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,18044,80,1.10 [0.90-1.34],0.340503144151972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINK1,Misshapen-like kinase 1,18060,81,1.05 [0.84-1.31],0.6776232202798458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MITD1,MIT domain-containing protein 1,20696,99,1.01 [0.84-1.21],0.9255807124429252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MKI67,Proliferation marker protein Ki-67,17564,80,1.42 [0.92-2.20],0.1172516722549947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLLT1,Protein ENL,17467,80,1.31 [1.04-1.66],0.0236573103785911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,20854,99,1.88 [1.52-2.33],6.183787846985702e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,20792,98,1.61 [1.30-1.98],8.249358744500374e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP1,Interstitial collagenase,20170,94,1.20 [0.97-1.47],0.0890377667042402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,20811,98,2.01 [1.56-2.60],6.53378615019767e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,20913,101,2.39 [1.83-3.12],1.2618503061658748e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP13,Collagenase 3,20435,99,1.19 [0.68-2.06],0.5475752825024338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP15,Matrix metalloproteinase-15,18107,82,0.93 [0.58-1.48],0.7510472557936809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP3,Stromelysin-1,20889,101,1.46 [1.04-2.05],0.0270996630650707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,20472,98,3.79 [2.69-5.36],3.8851896291770485e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP8,Neutrophil collagenase,21047,102,1.21 [0.95-1.53],0.1155348208862954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP9,Matrix metalloproteinase-9,20859,101,1.22 [0.91-1.64],0.186025333250434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",17476,78,1.29 [0.89-1.86],0.1751461898220211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MN1,Transcriptional activator MN1,17606,79,1.11 [0.80-1.55],0.5216530909204435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNAT1,CDK-activating kinase assembly factor MAT1,17790,82,0.73 [0.43-1.23],0.2363178621998904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNDA,Myeloid cell nuclear differentiation antigen,20849,98,0.93 [0.77-1.13],0.4658727954347629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOCS2,Molybdopterin synthase catalytic subunit,17690,82,1.38 [1.02-1.87],0.0340557140780657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOG,Myelin-oligodendrocyte glycoprotein,21071,101,1.42 [0.86-2.35],0.1731646920460565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORC3,MORC family CW-type zinc finger protein 3,18060,81,1.39 [0.70-2.80],0.3481531792112755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L1,Mortality factor 4-like protein 1,17790,82,1.12 [0.67-1.86],0.677219819707598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L2,Mortality factor 4-like protein 2,17467,80,1.27 [0.75-2.13],0.3730894291545452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORN4,MORN repeat-containing protein 4,17467,80,0.94 [0.71-1.26],0.6865713111799429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPHOSPH8,M-phase phosphoprotein 8,20501,98,1.03 [0.81-1.30],0.8103227694753643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPI,Mannose-6-phosphate isomerase,20792,98,1.09 [0.89-1.33],0.4168046735643431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,20922,99,1.13 [0.88-1.46],0.3398406579543782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPO,Myeloperoxidase,20889,101,1.41 [1.00-2.00],0.0527391135289245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPRIP,Myosin phosphatase Rho-interacting protein,18014,80,0.89 [0.54-1.46],0.634539530783522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,18123,81,9.95 [5.43-18.20],9.325050957703838e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRI1,Methylthioribose-1-phosphate isomerase,17606,79,0.67 [0.49-0.90],0.0085917455361817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL24,"39S ribosomal protein L24, mitochondrial",17476,78,1.02 [0.58-1.78],0.9495459507015708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL28,"39S ribosomal protein L28, mitochondrial",18071,81,0.93 [0.48-1.82],0.8329263234723056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL46,"39S ribosomal protein L46, mitochondrial",20435,99,0.96 [0.51-1.82],0.9112409648679862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL52,"39S ribosomal protein L52, mitochondrial",17429,80,0.93 [0.41-2.13],0.867282391204673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",18071,81,1.16 [0.90-1.49],0.2516878803631509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPS16,"28S ribosomal protein S16, mitochondrial",17564,80,0.84 [0.36-1.99],0.6987575283580264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,20759,98,1.78 [1.37-2.31],1.4566916025931915e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLNL,Mesothelin-like protein,17606,79,0.77 [0.43-1.37],0.3754041928611983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSMB,Beta-microseminoprotein,20856,99,1.19 [0.95-1.51],0.1362569782323256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,21081,102,3.75 [2.75-5.12],8.069717723333181e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,20948,102,0.99 [0.78-1.26],0.9331423372290112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MST1,Hepatocyte growth factor-like protein,17859,81,1.27 [0.83-1.95],0.2712414124358929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSTN,Growth/differentiation factor 8,20501,98,0.66 [0.48-0.91],0.0120305713039311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTDH,Protein LYRIC,17564,80,1.19 [0.96-1.47],0.1184153204332582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",18060,81,1.62 [0.82-3.18],0.16366299798647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,17790,82,1.08 [0.90-1.30],0.383550670327516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",18042,82,1.16 [0.93-1.44],0.178355469529049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTPN,Myotrophin,20501,98,0.74 [0.40-1.37],0.3390002643563387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTR,Methionine synthase,17476,78,1.17 [0.84-1.61],0.3498001747316852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS1,Protein MTSS 1,18042,82,1.20 [1.00-1.45],0.0532304037049718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS2,Protein MTSS 2,18044,80,1.15 [0.94-1.42],0.1810386025746037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTUS1,Microtubule-associated tumor suppressor 1,17790,82,1.37 [0.98-1.92],0.064676385550044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,20435,99,4.45 [3.66-5.40],7.039309824190135e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC16,Mucin-16,20792,98,1.08 [0.97-1.19],0.1732640618481296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC2,Mucin-2,18104,80,1.03 [0.82-1.29],0.8289766276522834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUCL3,Mucin-like protein 3,17467,80,1.62 [1.20-2.18],0.0015702875178276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,20526,99,1.54 [1.28-1.86],5.448265367772845e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MXRA8,Matrix remodeling-associated protein 8,17690,82,0.45 [0.28-0.71],0.0007618425570124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",18107,82,1.83 [1.46-2.29],1.0900238162475513e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC2,"Myosin-binding protein C, fast-type",17604,78,1.33 [1.09-1.62],0.0046987128452954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,18071,81,1.21 [0.88-1.66],0.2382129506224368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYDGF,Myeloid-derived growth factor,18107,82,1.19 [0.97-1.47],0.0920664147919894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH4,Myosin-4,17476,78,0.74 [0.44-1.23],0.2455467277679566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH7B,Myosin-7B,17467,80,1.12 [0.71-1.77],0.6352084457607531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH9,Myosin-9,18104,80,1.14 [0.95-1.37],0.1582767563225796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17476,78,2.04 [1.38-3.02],0.0003601994437953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,17604,78,1.71 [1.32-2.22],4.353480797543135e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL4,Myosin light chain 4,17604,78,0.96 [0.66-1.40],0.8486368615289603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL6B,Myosin light chain 6B,17606,79,0.98 [0.77-1.26],0.8862793858717839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",17606,79,1.57 [1.21-2.04],0.0006050704102334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO6,Unconventional myosin-VI,18071,81,1.34 [0.86-2.09],0.1902148319937096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO9B,Unconventional myosin-IXb,20526,99,1.13 [0.87-1.48],0.3557362864449136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOC,Myocilin,20889,101,0.89 [0.60-1.32],0.5622491676410901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM1,Myomesin-1,17515,78,1.07 [0.66-1.73],0.7977080595701159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM2,Myomesin-2,17476,78,1.55 [1.12-2.15],0.0083844520186193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,17690,82,1.44 [1.17-1.77],0.000597686051097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,20912,98,1.94 [1.45-2.61],1.0930799035140837e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZT1,Mitotic-spindle organizing protein 1,20402,95,1.23 [0.88-1.71],0.2319833674584103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA10,N-alpha-acetyltransferase 10,17476,78,0.76 [0.52-1.11],0.1617476132987566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA80,N-alpha-acetyltransferase 80,17606,79,1.11 [0.93-1.31],0.2504005852496204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,20599,98,0.84 [0.61-1.15],0.2753683798054049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NACC1,Nucleus accumbens-associated protein 1,18044,80,1.33 [0.96-1.83],0.0824361721597998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NADK,NAD kinase,20881,98,1.00 [0.72-1.39],0.9830842064245912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGA,Alpha-N-acetylgalactosaminidase,17536,79,1.44 [1.11-1.87],0.0062137030487621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGK,N-acetyl-D-glucosamine kinase,17573,78,0.57 [0.38-0.86],0.0068066314620299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,17690,82,3.97 [1.57-10.01],0.0035335402768011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAMPT,Nicotinamide phosphoribosyltransferase,20402,95,0.93 [0.65-1.35],0.7108634916122707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAP1L4,Nucleosome assembly protein 1-like 4,18004,82,0.72 [0.45-1.15],0.1708398762017464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAPRT,Nicotinate phosphoribosyltransferase,18060,81,0.51 [0.26-0.99],0.0466856346437149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",18071,81,0.93 [0.59-1.47],0.7579032783902704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,20948,102,8.99 [5.64-14.33],2.7316627260921643e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBN,Nibrin,20526,99,0.87 [0.60-1.27],0.4752293581135309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM1,Neural cell adhesion molecule 1,20989,98,1.20 [0.69-2.08],0.5256603337590564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM2,Neural cell adhesion molecule 2,20889,101,0.98 [0.50-1.92],0.9617071458886632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,21081,102,0.41 [0.30-0.56],8.315013981999721e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCF2,Neutrophil cytosol factor 2,20810,98,0.93 [0.74-1.17],0.5484837672811895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCK2,Cytoplasmic protein NCK2,20956,99,1.03 [0.87-1.21],0.7619095105679088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCLN,Nicalin,20526,99,1.23 [0.91-1.66],0.1825893045043133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,20825,99,4.66 [3.18-6.83],2.7534007570977405e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,18042,82,4.20 [2.76-6.40],2.451423636968642e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,21071,101,5.01 [2.87-8.74],1.3614791091092209e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDRG1,Protein NDRG1,20435,99,0.78 [0.55-1.11],0.1728175557839723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,18044,80,0.96 [0.66-1.41],0.8416389276935863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,17537,80,1.93 [1.14-3.28],0.0145704848360567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,18042,82,1.18 [0.95-1.46],0.1399695426836162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",20402,95,1.21 [1.02-1.45],0.0314927435353782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEB,Nebulin,17476,78,1.35 [0.83-2.18],0.2238565914304321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECAP2,Adaptin ear-binding coat-associated protein 2,17476,78,0.96 [0.70-1.32],0.8105599183177102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN1,Nectin-1,17564,80,1.25 [0.65-2.38],0.5022734125245383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,20852,98,7.29 [5.12-10.39],3.668172011127306e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,20948,102,3.13 [2.37-4.14],7.9638252562674385e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,17564,80,0.79 [0.52-1.21],0.2782898493512293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD9,Enhancer of filamentation 1,17564,80,1.26 [0.69-2.28],0.4511046481672505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,20374,98,1.65 [1.38-1.98],4.396948923080894e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEK7,Serine/threonine-protein kinase Nek7,17790,82,1.03 [0.77-1.37],0.8507260227791199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,20948,102,0.49 [0.36-0.65],1.4578982769470075e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL2,Protein kinase C-binding protein NELL2,20956,99,1.62 [0.88-2.99],0.1183094204064656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NENF,Neudesin,18044,80,1.05 [0.88-1.26],0.5794887374564367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEO1,Neogenin,18071,81,1.87 [0.91-3.85],0.0899692186943086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEXN,Nexilin,18123,81,1.15 [0.86-1.54],0.3453161837733078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,21127,101,23.92 [14.88-38.45],2.988744300302462e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFAT5,Nuclear factor of activated T-cells 5,17564,80,1.24 [0.98-1.55],0.0677062536593401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",20854,99,1.15 [0.97-1.38],0.1166677691037454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",20526,99,1.88 [1.51-2.34],2.0993683622283337e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFE2,Transcription factor NF-E2 45 kDa subunit,17604,78,1.12 [0.84-1.49],0.4373051543389821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFIC,Nuclear factor 1 C-type,18071,81,0.91 [0.56-1.47],0.7056919537550728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,17476,78,1.07 [0.81-1.43],0.6169374122846435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,17790,82,1.14 [0.81-1.61],0.4533334034512221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKBIE,NF-kappa-B inhibitor epsilon,20402,95,1.32 [0.94-1.83],0.1052393735102097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",18042,82,1.15 [0.95-1.39],0.159974479422936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFX1,Transcriptional repressor NF-X1,17476,78,1.08 [0.78-1.49],0.6308029583585656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFYA,Nuclear transcription factor Y subunit alpha,17476,78,1.09 [0.66-1.82],0.7323316917619185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGF,Beta-nerve growth factor,20696,99,3.10 [0.98-9.78],0.0534995152344621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,18107,82,2.41 [1.75-3.30],5.328108211811649e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,18060,81,2.44 [1.40-4.24],0.0015495335975439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,17273,80,6.52 [3.46-12.25],6.0450226235034275e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID1,Nidogen-1,20923,98,1.46 [0.89-2.39],0.1370132047330087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID2,Nidogen-2,20889,101,1.06 [0.84-1.34],0.6213056032529938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NINJ1,Ninjurin-1,20402,95,1.34 [1.03-1.75],0.0311935198572171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT1,Deaminated glutathione amidase,17604,78,0.53 [0.34-0.84],0.0062018904846001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT2,Omega-amidase NIT2,18033,82,1.11 [0.83-1.48],0.4928348036477161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN1,Neuroligin-1,17606,79,1.08 [0.78-1.50],0.6552302448560974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN2,Neuroligin-2,17515,78,0.72 [0.41-1.26],0.248847395433482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME1,Nucleoside diphosphate kinase A,17564,80,2.70 [1.12-6.53],0.0276504938523761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME3,Nucleoside diphosphate kinase 3,20878,98,1.24 [0.59-2.61],0.5659857483157797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMI,N-myc-interactor,17967,79,1.00 [0.76-1.32],0.9750174758958569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,20696,99,0.88 [0.68-1.15],0.3637838537980715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMRK2,Nicotinamide riboside kinase 2,17467,80,1.22 [0.76-1.94],0.4102281852304138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,18071,81,0.92 [0.65-1.30],0.6202246376202469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,20889,101,3.92 [1.95-7.88],0.0001302025557742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOP56,Nucleolar protein 56,17476,78,1.15 [0.98-1.36],0.0854326491670027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",20435,99,1.92 [1.54-2.40],8.298639149737966e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS2,"Nitric oxide synthase, inducible",17476,78,0.95 [0.53-1.68],0.8526751392012439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",20435,99,1.72 [1.43-2.08],1.4793352471299452e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,21140,101,14.27 [5.45-37.39],6.289710599635434e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH2,Neurogenic locus notch homolog protein 2,18104,80,3.97 [1.84-8.59],0.0004587518280698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH3,Neurogenic locus notch homolog protein 3,21140,101,1.70 [1.02-2.81],0.0400074528572562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPC2,NPC intracellular cholesterol transporter 2,17797,80,3.28 [2.49-4.31],2.3112769593341277e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,20881,98,3.25 [2.43-4.34],1.632875001177222e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS1,Nephrin,17564,80,1.15 [0.60-2.20],0.6766645827213411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS2,Podocin,17564,80,1.07 [0.88-1.31],0.4982183233086662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPL,N-acetylneuraminate lyase,18107,82,1.25 [0.81-1.93],0.3159030574200783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,20501,98,1.54 [1.37-1.73],9.71078189087854e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPC,C-type natriuretic peptide,20854,99,1.33 [1.02-1.76],0.0387477019458204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPR1,Atrial natriuretic peptide receptor 1,17476,78,0.38 [0.18-0.82],0.0135801112160924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTN,Neuroplastin,20402,95,1.14 [0.94-1.39],0.1811671730549381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX1,Neuronal pentraxin-1,20889,101,1.42 [0.97-2.10],0.0743408950431644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX2,Neuronal pentraxin-2,18104,80,1.76 [0.92-3.36],0.0881689985383878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTXR,Neuronal pentraxin receptor,20881,98,0.59 [0.34-1.04],0.0661244633360245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,21071,101,3.73 [2.73-5.09],1.2426165214072163e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,20881,98,5.59 [3.81-8.19],1.0926506307404493e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRGN,Neurogranin,18123,81,1.07 [0.86-1.34],0.5418554262466453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRN1,Neuritin,18071,81,1.22 [0.72-2.08],0.4512287711430993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,21022,98,6.87 [3.88-12.17],3.970170019732231e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP2,Neuropilin-2,20889,101,1.61 [0.89-2.90],0.1164518653744791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRTN,Neurturin,20526,99,1.18 [0.85-1.64],0.3336838228582388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRXN3,Neurexin-3,17606,79,0.85 [0.45-1.61],0.6121544663181302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NSFL1C,NSFL1 cofactor p47,21081,102,0.72 [0.55-0.94],0.0167896241587751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",18107,82,0.93 [0.70-1.22],0.5815145066004708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,18060,81,2.26 [1.69-3.01],3.0101159110977946e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,20816,99,0.83 [0.68-1.02],0.0711635005835531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5E,5'-nucleotidase,20948,102,1.49 [1.10-2.01],0.0090304384653558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,20854,99,3.04 [2.10-4.41],4.682476638310991e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF4,Neurotrophin-4,20402,95,0.97 [0.57-1.65],0.9187915829711286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK2,BDNF/NT-3 growth factors receptor,20881,98,1.15 [0.56-2.35],0.7047306373189635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK3,NT-3 growth factor receptor,21081,102,0.37 [0.17-0.81],0.0135066523104976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,20881,98,1.64 [1.46-1.84],4.8810771220224514e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUB1,NEDD8 ultimate buster 1,20854,99,1.04 [0.85-1.29],0.6886217769726006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,18044,80,1.22 [1.01-1.47],0.0368976138056034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,21041,101,2.56 [1.69-3.87],8.421177335189857e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDC,Nuclear migration protein nudC,21127,101,1.28 [0.96-1.70],0.090797603992723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,17604,78,0.59 [0.21-1.69],0.3284853653210151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,17476,78,0.84 [0.52-1.38],0.4978304531125761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT16,U8 snoRNA-decapping enzyme,18012,82,1.22 [0.97-1.53],0.0877854709275011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],20792,98,0.62 [0.44-0.87],0.0057640437653204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT5,ADP-sugar pyrophosphatase,20889,101,1.12 [0.80-1.56],0.5167337154030925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUMB,Protein numb homolog,17564,80,1.12 [0.86-1.45],0.4059477051518534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUP50,Nuclear pore complex protein Nup50,17476,78,1.48 [0.88-2.48],0.1435602460168249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPE4,NXPE family member 4,17476,78,0.69 [0.31-1.55],0.367734563901152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH1,Neurexophilin-1,20435,99,1.03 [0.67-1.57],0.90956208521889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH3,Neurexophilin-3,17564,80,1.07 [0.52-2.20],0.8575120208113101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OBP2B,Odorant-binding protein 2b,20621,99,0.72 [0.53-0.98],0.0339112296260657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,18071,81,2.76 [2.01-3.77],2.2912392174649115e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ODAM,Odontogenic ameloblast-associated protein,20399,99,0.72 [0.50-1.04],0.0775980324751518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OFD1,Oral-facial-digital syndrome 1 protein,17790,82,1.04 [0.75-1.44],0.8174157903755022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGA,Protein O-GlcNAcase,18042,82,1.16 [0.86-1.55],0.3307184695772878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGFR,Opioid growth factor receptor,20792,98,1.07 [0.61-1.87],0.8117534695383464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,20889,101,2.79 [2.02-3.85],3.9349859992078205e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,17790,82,0.90 [0.62-1.31],0.5767782440644333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,17039,79,1.33 [1.09-1.61],0.0039853614710804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLR1,Oxidized low-density lipoprotein receptor 1,20675,97,1.20 [0.91-1.59],0.1932433584229931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,20956,99,0.53 [0.39-0.70],1.3241471313619887e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,20792,98,0.65 [0.50-0.83],0.0006532090942965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMP,Olfactory marker protein,17515,78,0.61 [0.35-1.05],0.0739992723149843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPHN1,Oligophrenin-1,18060,81,1.07 [0.88-1.30],0.4885284103332141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPLAH,5-oxoprolinase,17604,78,1.28 [0.93-1.75],0.1295383058904556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPTC,Opticin,20792,98,0.98 [0.66-1.46],0.9302455041280412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ORM1,Alpha-1-acid glycoprotein 1,18057,81,2.79 [1.04-7.43],0.0408992391239193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSBPL2,Oxysterol-binding protein-related protein 2,18060,81,0.78 [0.41-1.48],0.443383493900041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,20878,98,4.35 [2.62-7.25],1.4881029164873493e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSM,Oncostatin-M,20751,98,1.22 [0.94-1.58],0.1296107895783559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSMR,Oncostatin-M-specific receptor subunit beta,21022,98,8.95 [3.83-20.89],4.033180458334101e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSTN,Osteocrin,17606,79,0.98 [0.57-1.69],0.9553309040247064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTOA,Otoancorin,17515,78,0.80 [0.49-1.32],0.382772451149066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD6B,Deubiquitinase OTUD6B,18042,82,0.96 [0.67-1.36],0.8086914214749386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD7B,OTU domain-containing protein 7B,18071,81,1.35 [0.98-1.85],0.0637682460283297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",17604,78,1.19 [0.90-1.56],0.2193736653399826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,21081,102,1.23 [1.09-1.40],0.0012024464223289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,P4HB,Protein disulfide-isomerase,20779,102,1.99 [1.30-3.05],0.0015301701945112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PACS2,Phosphofurin acidic cluster sorting protein 2,17476,78,1.11 [0.80-1.56],0.5288190275075196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI2,Protein-arginine deiminase type-2,20526,99,1.35 [1.07-1.70],0.0100391034682989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI4,Protein-arginine deiminase type-4,20399,99,0.79 [0.60-1.05],0.102328737701651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAEP,Glycodelin,20696,99,1.10 [0.94-1.30],0.2343036719184174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,18071,81,1.16 [1.00-1.36],0.0533711311273705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",17790,82,1.12 [0.75-1.68],0.5780876372889414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,20501,98,1.37 [1.03-1.84],0.0329065062134611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,17604,78,0.79 [0.45-1.37],0.3997416358467011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,17435,80,1.33 [0.90-1.97],0.1522580458938555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAK4,Serine/threonine-protein kinase PAK 4,20435,99,1.07 [0.81-1.40],0.650627105596325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALLD,Palladin,17564,80,1.21 [0.72-2.06],0.4722403501230399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,17938,82,2.59 [1.77-3.77],7.773754758978988e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,18060,81,3.51 [2.63-4.68],1.1338869026244005e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM3,Paralemmin-3,17476,78,1.12 [0.86-1.46],0.4022450461790052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,21055,100,1.37 [0.70-2.68],0.3504752682779343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAMR1,Inactive serine protease PAMR1,20889,101,1.92 [0.99-3.75],0.0545060042210614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAPPA,Pappalysin-1,20526,99,0.72 [0.49-1.04],0.0830863458527802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARD3,Partitioning defective 3 homolog,17790,82,1.02 [0.77-1.35],0.8793802196450826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARK7,Parkinson disease protein 7,20889,101,0.82 [0.59-1.14],0.2416593190031252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARP1,Poly [ADP-ribose] polymerase 1,20854,99,1.12 [0.87-1.45],0.3797910437247352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAXX,Protein PAXX,17690,82,1.14 [0.73-1.77],0.5605103716267479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,17467,80,0.99 [0.52-1.89],0.9698747183691178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBLD,Phenazine biosynthesis-like domain-containing protein,20435,99,0.68 [0.47-0.98],0.0371298080358164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,18042,82,1.75 [1.01-3.04],0.0444205805446987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCARE,Photoreceptor cilium actin regulator,17515,78,0.91 [0.68-1.21],0.5214689540361483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,17656,82,1.44 [0.97-2.13],0.0736678136388189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBP2,Poly(rC)-binding protein 2,18071,81,1.00 [0.75-1.33],0.9929567368865956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH1,Protocadherin-1,21063,101,2.56 [1.38-4.75],0.0028162742165073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH12,Protocadherin-12,18071,81,1.92 [0.87-4.21],0.1043673124221791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,20881,98,2.99 [2.25-3.97],3.3254155720558924e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,18042,82,1.75 [1.22-2.51],0.002387911702377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH9,Protocadherin-9,18042,82,2.51 [1.36-4.63],0.0032832438711562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDHB15,Protocadherin beta-15,18044,80,1.79 [1.17-2.74],0.0070805202826698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCNA,Proliferating cell nuclear antigen,17467,80,1.04 [0.75-1.45],0.7942231508956974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,18044,80,0.85 [0.56-1.30],0.4569813343451105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,21140,101,2.35 [1.55-3.55],5.192221523247446e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,18042,82,1.03 [0.78-1.36],0.8338530053686779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,18107,82,1.03 [0.83-1.28],0.7665429981877876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,21030,101,2.49 [1.84-3.36],2.986214101101117e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,20792,98,2.86 [2.14-3.83],1.5497264414054285e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD5,Programmed cell death protein 5,21081,102,0.88 [0.65-1.18],0.3767913708455511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD6,Programmed cell death protein 6,20881,98,1.36 [0.99-1.86],0.0551967230544805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCL2,Phosducin-like protein 2,17467,80,1.20 [0.85-1.71],0.3040253905695448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",17467,80,1.12 [0.81-1.55],0.5075126670505178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",17476,78,1.03 [0.70-1.50],0.8969851043080254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",17690,82,1.08 [0.88-1.33],0.4548797058040291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFA,Platelet-derived growth factor subunit A,21140,101,1.05 [0.82-1.34],0.6994352656133075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFB,Platelet-derived growth factor subunit B,20956,99,1.06 [0.86-1.31],0.5619382575213212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFC,Platelet-derived growth factor C,20402,95,1.83 [0.99-3.38],0.0535433807960592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,20881,98,5.00 [3.02-8.27],3.792866962276883e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRB,Platelet-derived growth factor receptor beta,21140,101,1.11 [0.67-1.85],0.6856755353411877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA2,Protein disulfide-isomerase A2,17467,80,0.98 [0.58-1.64],0.9302570499842008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA3,Protein disulfide-isomerase A3,17690,82,2.76 [1.64-4.64],0.000136453321673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA4,Protein disulfide-isomerase A4,18104,80,1.28 [0.93-1.76],0.1273939556719928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA5,Protein disulfide-isomerase A5,17467,80,1.17 [0.83-1.64],0.365268584642655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM5,PDZ and LIM domain protein 5,18071,81,1.00 [0.84-1.19],0.9920070902694952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM7,PDZ and LIM domain protein 7,20956,99,1.08 [0.94-1.24],0.2932337889717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",20402,95,1.19 [0.85-1.67],0.30471031305139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDRG1,p53 and DNA damage-regulated protein 1,17606,79,0.73 [0.43-1.22],0.2253907179295879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,17467,80,0.61 [0.32-1.17],0.1397067921522026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZD2,PDZ domain-containing protein 2,17476,78,1.47 [1.09-1.98],0.0122751177072472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17564,80,2.59 [1.93-3.48],2.3652908361422785e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEAR1,Platelet endothelial aggregation receptor 1,21140,101,4.75 [2.25-10.00],4.202588318261982e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEBP1,Phosphatidylethanolamine-binding protein 1,20889,101,0.84 [0.62-1.13],0.2535771525853691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECAM1,Platelet endothelial cell adhesion molecule,20889,101,2.11 [1.25-3.55],0.005089689980214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,17604,78,0.74 [0.33-1.67],0.4735502398139242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,17690,82,2.17 [1.48-3.19],7.515035866034766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEPD,Xaa-Pro dipeptidase,18123,81,0.52 [0.30-0.92],0.0231355413802017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PER3,Period circadian protein homolog 3,17564,80,1.07 [0.89-1.27],0.4802285969439713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PF4,Platelet factor 4,17982,80,1.13 [0.90-1.41],0.3006173779709933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN2,Prefoldin subunit 2,20435,99,1.02 [0.73-1.41],0.929525688920947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN4,Prefoldin subunit 4,17467,80,1.22 [0.84-1.77],0.2872226944369607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN6,Prefoldin subunit 6,17606,79,0.85 [0.57-1.27],0.4323373092855571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",20758,98,0.90 [0.70-1.14],0.381663391948891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGA4,Pepsin A-4,18123,81,1.67 [1.28-2.17],0.0001385697788543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",18107,82,0.93 [0.61-1.41],0.7383425651389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,21127,101,5.53 [3.91-7.81],3.4461244064485597e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,21037,101,2.15 [1.56-2.97],3.3526883353680763e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,17898,81,2.17 [1.00-4.71],0.0506181898939746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP4,Peptidoglycan recognition protein 4,17476,78,1.37 [1.04-1.80],0.0256202705160512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGM2,Phosphoglucomutase-2,17606,79,1.13 [0.83-1.54],0.4324569761398319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGR,Progesterone receptor,17564,80,1.20 [1.02-1.41],0.029443034439662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHACTR2,Phosphatase and actin regulator 2,18071,81,1.06 [0.89-1.27],0.5185551780464988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,18042,82,1.85 [1.27-2.68],0.0011860032887166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB2,Pleckstrin homology-like domain family B member 2,17467,80,1.13 [0.92-1.39],0.2488955840059299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,20696,99,4.87 [2.99-7.95],2.2755404233476886e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,17690,82,1.24 [0.75-2.04],0.4046375113872879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI16,Peptidase inhibitor 16,18123,81,0.98 [0.41-2.37],0.967820763058597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,20610,100,1.93 [1.55-2.41],3.87796386794264e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",18071,81,1.05 [0.81-1.37],0.7112527084179834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,20624,100,5.69 [4.17-7.77],8.117936759917054e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,20854,99,0.82 [0.61-1.09],0.1734021231558011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,20889,101,5.53 [4.07-7.50],4.455887149576357e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,17564,80,1.10 [0.76-1.59],0.612395672684861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,20889,101,4.07 [2.78-5.95],5.250477477860596e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,20881,98,2.64 [1.84-3.80],1.596751883014745e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,17690,82,0.65 [0.49-0.87],0.0030262436576606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PITHD1,PITH domain-containing protein 1,17435,80,1.13 [0.87-1.47],0.3421429454255568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,18107,82,14.62 [7.29-29.31],4.183900256905978e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,17476,78,1.56 [1.17-2.10],0.0028898265188808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKLR,Pyruvate kinase PKLR,20883,99,0.61 [0.45-0.81],0.0008325549185037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKN3,Serine/threonine-protein kinase N3,17790,82,1.18 [0.91-1.55],0.2154244211359976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G10,Group 10 secretory phospholipase A2,20696,99,1.91 [1.41-2.60],3.350416271191634e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,20948,102,5.72 [3.37-9.70],9.883320482531192e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G1B,Phospholipase A2,21109,101,0.85 [0.57-1.27],0.4334768851809996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G2A,"Phospholipase A2, membrane associated",20863,98,1.40 [1.15-1.70],0.0007241653202389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G4A,Cytosolic phospholipase A2,20956,99,1.07 [0.88-1.30],0.505246316090832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G7,Platelet-activating factor acetylhydrolase,20889,101,0.37 [0.25-0.53],6.671032314625282e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAT,Tissue-type plasminogen activator,21067,101,0.98 [0.69-1.39],0.9147316206862144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAU,Urokinase-type plasminogen activator,20889,101,1.79 [1.25-2.56],0.0016359276756344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,20705,98,11.22 [7.34-17.15],5.783599950507453e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLB1,"Phospholipase B1, membrane-associated",18060,81,0.63 [0.45-0.90],0.0097176454857993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",17564,80,1.44 [0.96-2.15],0.0798984440456894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",18060,81,1.11 [0.90-1.37],0.3411687934386229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,18060,81,1.41 [1.07-1.86],0.0149527718608331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLG,Plasminogen,17677,80,2.23 [0.85-5.86],0.1048129783059483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN1,Perilipin-1,20435,99,1.34 [0.87-2.05],0.1814366591994782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,20881,98,1.65 [1.14-2.41],0.0083945240720513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLPBP,Pyridoxal phosphate homeostasis protein,20881,98,0.82 [0.63-1.07],0.1410907252050674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLSCR3,Phospholipid scramblase 3,18023,81,1.50 [1.05-2.13],0.0247249828177494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLTP,Phospholipid transfer protein,21082,100,0.74 [0.47-1.17],0.2020757345174669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC1,Plexin domain-containing protein 1,20402,95,1.37 [0.85-2.20],0.2010105498006595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC2,Plexin domain-containing protein 2,18060,81,2.24 [1.58-3.17],6.364733933467183e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNA4,Plexin-A4,20854,99,1.16 [0.93-1.44],0.195065112603927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,21031,100,27.17 [17.69-41.76],2.668827785938428e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB3,Plexin-B3,20813,98,1.15 [0.80-1.64],0.4565124024123582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,20790,97,1.02 [0.92-1.12],0.7431558922450496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMCH,Pro-MCH,17476,78,0.98 [0.74-1.31],0.9047030735633772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMM2,Phosphomannomutase 2,17476,78,1.21 [0.86-1.69],0.2723163742168611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMS1,PMS1 protein homolog 1,17606,79,1.12 [0.74-1.69],0.5967225840993944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMVK,Phosphomevalonate kinase,20399,99,0.95 [0.81-1.12],0.5660882677562853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIP,Pancreatic triacylglycerol lipase,18123,81,1.23 [0.90-1.68],0.1926310574970454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,18060,81,1.40 [1.10-1.77],0.0062242932271633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP2,Pancreatic lipase-related protein 2,20847,98,1.03 [0.97-1.10],0.3698450669035191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA1,Paraneoplastic antigen Ma1,17604,78,0.85 [0.58-1.25],0.420456132536065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA2,Paraneoplastic antigen Ma2,17515,78,0.93 [0.55-1.56],0.7783187405953429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",20526,99,0.96 [0.82-1.12],0.5733189850452851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL,Podocalyxin,20792,98,1.01 [0.30-3.32],0.9923747834596456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL2,Podocalyxin-like protein 2,20948,102,1.44 [0.80-2.57],0.2211359827461969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,17564,80,2.06 [1.60-2.65],1.9178751683468363e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,17564,80,1.98 [1.09-3.60],0.0257845421224123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",20792,98,1.57 [1.11-2.21],0.0100467811302385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POMC,Pro-opiomelanocortin,17604,78,1.12 [0.84-1.48],0.4382325201622326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,18123,81,0.33 [0.21-0.52],2.036201602235466e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON2,Serum paraoxonase/arylesterase 2,20501,98,1.66 [1.01-2.74],0.0474403872154222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,20956,99,0.50 [0.37-0.66],1.8583648894291584e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POSTN,Periostin,18104,80,0.82 [0.47-1.44],0.5006498926595668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPBP,Platelet basic protein,17984,80,1.16 [0.90-1.50],0.2611638327178301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,21081,102,0.75 [0.52-1.09],0.1370047985888338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,20903,99,1.08 [0.90-1.30],0.4154299769002729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,17790,82,0.97 [0.70-1.35],0.8532604526210397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",18104,80,1.11 [0.82-1.52],0.4987142299356328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPL,Periplakin,17564,80,1.61 [0.91-2.86],0.1026849516241856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1A,Protein phosphatase 1A,20402,95,0.40 [0.20-0.78],0.0077297742629649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1B,Protein phosphatase 1B,17564,80,1.23 [0.94-1.61],0.1346582207830028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1F,Protein phosphatase 1F,18107,82,1.05 [0.72-1.53],0.7971436929653397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPME1,Protein phosphatase methylesterase 1,20792,98,0.63 [0.47-0.84],0.0019151922325518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,18044,80,1.00 [0.78-1.28],0.9881905959655528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,20948,102,1.05 [0.88-1.25],0.6175975422735627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,17790,82,1.42 [1.15-1.76],0.0013520203115492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,18071,81,1.13 [0.87-1.46],0.3714033340966385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,18071,81,1.91 [1.28-2.85],0.0016158336472189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R2,Protein phosphatase inhibitor 2,20881,98,1.06 [0.85-1.31],0.6270231581672976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R9B,Neurabin-2,21127,101,1.13 [0.94-1.36],0.1968405097901217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,18042,82,1.11 [0.94-1.31],0.2081001077284063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP3R1,Calcineurin subunit B type 1,20696,99,1.26 [0.81-1.97],0.3046552769839002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPT1,Palmitoyl-protein thioesterase 1,17606,79,1.15 [0.90-1.47],0.270449276941111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,20832,102,1.66 [1.41-1.94],5.528549670874112e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PQBP1,Polyglutamine-binding protein 1,20402,95,0.83 [0.57-1.20],0.3181705708898895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAME,Melanoma antigen preferentially expressed in tumors,17467,80,1.35 [0.63-2.88],0.4391970863393299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,18104,80,22.40 [12.41-40.43],5.963644250367932e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRC1,Protein regulator of cytokinesis 1,18044,80,0.88 [0.49-1.59],0.6806095123925495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,21005,101,4.98 [3.68-6.72],1.1864624055269467e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX1,Peroxiredoxin-1,20257,95,0.86 [0.70-1.07],0.1799237990056124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,17808,79,0.44 [0.30-0.65],3.223346258038745e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",20526,99,1.28 [1.01-1.62],0.0427229128131632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX5,"Peroxiredoxin-5, mitochondrial",21127,101,0.79 [0.61-1.03],0.0793538457895351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,21071,101,0.49 [0.36-0.66],5.802046945427045e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PREB,Prolactin regulatory element-binding protein,20526,99,2.60 [1.86-3.65],2.9274660476836023e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,20847,98,4.55 [2.68-7.72],2.0899459393927642e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,18104,80,2.33 [1.60-3.39],9.374941436110112e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG3,Proteoglycan 3,18104,80,1.03 [0.67-1.59],0.8923160677222526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,20526,99,1.40 [1.03-1.90],0.0317271103772381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,17606,79,1.31 [0.67-2.59],0.4298838238309568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,20881,98,1.13 [0.91-1.40],0.2798709677362839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,18023,81,1.16 [0.88-1.54],0.283012390119003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKCQ,Protein kinase C theta type,20526,99,1.10 [0.72-1.66],0.6655180029260582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKD2,Serine/threonine-protein kinase D2,17476,78,0.87 [0.50-1.50],0.6080111776815385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKG1,cGMP-dependent protein kinase 1,17690,82,1.02 [0.87-1.21],0.7722797490278877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,20402,95,1.27 [1.00-1.63],0.0533035806184857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRL,Prolactin,21081,102,1.21 [0.97-1.51],0.0984677353050627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRND,Prion-like protein doppel,18060,81,1.39 [0.97-1.99],0.075135187924294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROC,Vitamin K-dependent protein C,20956,98,0.78 [0.39-1.54],0.4691310215188932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROCR,Endothelial protein C receptor,17476,78,1.32 [0.75-2.32],0.3286439128636159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROK1,Prokineticin-1,20854,99,1.31 [0.93-1.85],0.1254787242609458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROS1,Vitamin K-dependent protein S,18124,81,0.45 [0.21-0.97],0.0410926411493839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR4,Proline-rich protein 4,17557,82,1.50 [1.15-1.95],0.0024078854701674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR5,Proline-rich protein 5,17564,80,1.18 [0.77-1.81],0.4454700776066772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,17604,78,2.28 [1.33-3.90],0.0026111977310719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS2,Trypsin-2,20989,98,1.62 [1.24-2.11],0.0003755463356257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,17564,80,2.18 [1.71-2.77],2.9948202875466447e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS27,Serine protease 27,20809,98,1.66 [1.05-2.60],0.0284297492518415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS53,Serine protease 53,18060,81,0.98 [0.57-1.69],0.9501188511716816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,20786,99,6.90 [5.00-9.51],4.53366409264714e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,20435,99,0.98 [0.84-1.15],0.7945435542643501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,21071,101,3.74 [2.50-5.58],1.1340933347194363e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTN3,Myeloblastin,20380,99,1.39 [1.03-1.88],0.0315551062748521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRUNE2,Protein prune homolog 2,17790,82,2.30 [1.40-3.78],0.0009721855117194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,17934,80,3.26 [2.31-4.62],2.529220246977167e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAPL1,Proactivator polypeptide-like 1,18042,82,1.11 [0.73-1.67],0.6359444549771275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSCA,Prostate stem cell antigen,18042,82,1.04 [0.96-1.13],0.3404911769447203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,20696,99,1.77 [1.43-2.18],1.267895799883102e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSIP1,PC4 and SFRS1-interacting protein,20854,99,1.09 [0.84-1.40],0.5208529132915685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMA1,Proteasome subunit alpha type-1,20402,95,0.99 [0.68-1.42],0.938452366560969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMC3,26S proteasome regulatory subunit 6A,17467,80,0.85 [0.41-1.73],0.6468899100082555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,18071,81,0.73 [0.47-1.13],0.1552366832360259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,17606,79,1.12 [0.77-1.64],0.5491830994448454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,20792,98,0.45 [0.31-0.66],4.417666683566018e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME1,Proteasome activator complex subunit 1,20654,99,0.73 [0.46-1.18],0.2020695405982583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME2,Proteasome activator complex subunit 2,20604,97,0.64 [0.38-1.07],0.0861094488775425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG3,Proteasome assembly chaperone 3,20854,99,0.59 [0.41-0.84],0.0040518470481741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG4,Proteasome assembly chaperone 4,17564,80,0.65 [0.43-0.99],0.0426946952612749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSPN,Persephin,20854,99,1.11 [0.91-1.36],0.287318949940125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSRC1,Proline/serine-rich coiled-coil protein 1,20402,95,1.18 [0.92-1.53],0.1972001592496073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,17067,79,0.98 [0.80-1.19],0.8093180230126104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",20435,99,0.60 [0.33-1.10],0.0997413250690204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,20753,98,4.57 [3.29-6.34],9.080351686258912e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGES2,Prostaglandin E synthase 2,17441,78,1.47 [1.05-2.05],0.0252653721919255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGR1,Prostaglandin reductase 1,18107,82,1.33 [1.05-1.68],0.0172273960555737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH,Parathyroid hormone,17606,79,0.90 [0.69-1.17],0.4228109016796441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,20854,99,1.80 [1.36-2.39],4.4913605173917104e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,20435,99,2.54 [1.67-3.86],1.3532687286180596e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTN,Pleiotrophin,20501,98,1.10 [0.78-1.55],0.5850926689633218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,17564,80,1.55 [1.13-2.11],0.0058623776236927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,20696,99,1.19 [0.97-1.45],0.0976925394127864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,20922,99,0.98 [0.81-1.20],0.8626233813529294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,17534,80,1.32 [0.84-2.09],0.2298659517583639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,18107,82,2.87 [1.48-5.57],0.0018138830086405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,18104,80,3.11 [1.57-6.17],0.0011440438474214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,21140,101,1.23 [0.67-2.24],0.5051840162595912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,18042,82,2.30 [1.56-3.39],2.628087679688089e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,18042,82,1.94 [1.18-3.20],0.0090272550150222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,20821,98,2.99 [1.44-6.19],0.00328456509742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,20630,98,2.86 [1.91-4.28],3.274608044787796e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,18060,81,0.90 [0.51-1.59],0.7256703207203302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,21140,101,0.83 [0.42-1.65],0.5958379718609634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,18107,82,0.77 [0.38-1.56],0.4619490801336176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,17690,82,0.73 [0.51-1.04],0.0791260600270883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,20329,98,1.45 [1.10-1.91],0.008380491485098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTTG1,Securin,17790,82,0.96 [0.56-1.64],0.8867045430084459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTX3,Pentraxin-related protein PTX3,20854,99,2.22 [1.39-3.57],0.000927149706009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVALB,Parvalbumin alpha,20981,101,0.98 [0.84-1.15],0.8093672524684804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,21081,102,4.21 [3.00-5.91],8.616540731462388e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXDNL,Peroxidasin-like protein,18044,80,0.81 [0.52-1.28],0.3780252424785491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXN,Paxillin,20435,99,1.24 [0.92-1.67],0.1654907422606868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYDC1,Pyrin domain-containing protein 1,17604,78,0.71 [0.39-1.28],0.2576675780091259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,17476,78,2.29 [1.92-2.72],2.116368547269054e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PZP,Pregnancy zone protein,18124,81,0.64 [0.34-1.19],0.1569584570797652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QDPR,Dihydropteridine reductase,20776,98,0.94 [0.62-1.42],0.7598422493412824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,20892,100,5.75 [3.53-9.38],2.4208847915429854e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,17769,80,1.78 [1.41-2.25],9.912949451220472e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB10,Ras-related protein Rab-10,18107,82,1.04 [0.73-1.48],0.8363081314612844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB11FIP3,Rab11 family-interacting protein 3,18107,82,1.07 [0.88-1.30],0.4948910907292477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB27B,Ras-related protein Rab-27B,18107,82,1.16 [0.89-1.51],0.278160645433154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB2B,Ras-related protein Rab-2B,18044,80,0.98 [0.70-1.38],0.9144705455730152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB33A,Ras-related protein Rab-33A,17476,78,1.03 [0.76-1.40],0.8361326507155491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB37,Ras-related protein Rab-37,20526,99,0.93 [0.75-1.15],0.50937234650255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB39B,Ras-related protein Rab-39B,17476,78,0.98 [0.78-1.25],0.8960738386621115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,17515,78,0.92 [0.64-1.32],0.6593649567268796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB44,Ras-related protein Rab-44,18044,80,1.19 [0.80-1.75],0.3915498109719091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,20854,99,0.44 [0.30-0.65],3.234048585740994e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6B,Ras-related protein Rab-6B,20435,99,0.97 [0.66-1.41],0.8573434603580199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEP1,Rab GTPase-binding effector protein 1,17690,82,1.06 [0.82-1.39],0.6516104111529433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEPK,Rab9 effector protein with kelch motifs,20402,95,0.92 [0.67-1.25],0.573123556793186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABGAP1L,Rab GTPase-activating protein 1-like,20526,99,0.68 [0.50-0.94],0.0177119202298564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAC3,Ras-related C3 botulinum toxin substrate 3,17606,79,0.95 [0.68-1.34],0.7754017047050565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD23B,UV excision repair protein RAD23 homolog B,20402,95,0.87 [0.58-1.29],0.4762745859862973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD51,DNA repair protein RAD51 homolog 1,17790,82,1.25 [0.94-1.67],0.1276319440846654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALB,Ras-related protein Ral-B,17564,80,2.00 [1.01-3.95],0.0463907214432365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALY,RNA-binding protein Raly,18044,80,1.07 [0.70-1.64],0.763093432586377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP1,Ran-specific GTPase-activating protein,17604,78,0.52 [0.34-0.80],0.0026617324967493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP2,E3 SUMO-protein ligase RanBP2,17515,78,0.77 [0.38-1.56],0.470707304487324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANGAP1,Ran GTPase-activating protein 1,20402,95,1.40 [0.99-1.97],0.0560286204361962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAP1A,Ras-related protein Rap-1A,17564,80,1.18 [0.93-1.49],0.1685426968995399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,17790,82,1.12 [0.79-1.59],0.5352866795332516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES1,Retinoic acid receptor responder protein 1,20402,95,1.49 [1.08-2.05],0.0151541924355296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,21022,98,1.90 [1.49-2.44],3.402766998249734e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASA1,Ras GTPase-activating protein 1,20435,99,1.25 [0.75-2.09],0.3835224068182457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,17467,80,1.63 [1.07-2.47],0.0217999453318786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASSF2,Ras association domain-containing protein 2,20402,95,1.18 [0.91-1.53],0.2244021013844963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,18071,81,2.78 [2.22-3.47],2.1522976613407851e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBKS,Ribokinase,20385,95,0.59 [0.45-0.77],0.0001587288010496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM17,Splicing factor 45,18071,81,1.15 [0.88-1.49],0.3047552004268328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM19,Probable RNA-binding protein 19,17476,78,0.83 [0.50-1.38],0.4657276587174687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM25,RNA-binding protein 25,17467,80,1.37 [0.90-2.09],0.1430492045031305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP1,Retinol-binding protein 1,17606,79,1.18 [0.91-1.53],0.2240714479395319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,20792,98,1.61 [1.30-1.99],9.37127746223427e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,20792,98,2.56 [1.98-3.31],5.882094995616169e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,18042,82,1.62 [1.25-2.10],0.0002664356609669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS,RNA-binding protein with multiple splicing,17564,80,1.06 [0.77-1.47],0.7159337226907133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS2,RNA-binding protein with multiple splicing 2,17604,78,1.15 [0.94-1.42],0.175604937746725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCC1,Regulator of chromosome condensation,18044,80,0.96 [0.61-1.51],0.8480638419547956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCOR1,REST corepressor 1,20501,98,1.03 [0.71-1.51],0.8720990941524452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,17604,78,1.50 [0.52-4.32],0.4537906111971302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REEP4,Receptor expression-enhancing protein 4,18071,81,1.28 [0.96-1.71],0.0980265652604113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,20780,97,3.04 [2.47-3.73],2.0612433997163287e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,21140,101,2.23 [1.81-2.75],6.704774209114705e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,21140,101,2.08 [1.68-2.59],2.8317417433492444e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3G,Regenerating islet-derived protein 3-gamma,18044,80,1.28 [0.78-2.10],0.3329279993614719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,20878,98,5.06 [3.89-6.58],8.638197399342398e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELB,Transcription factor RelB,17564,80,0.79 [0.49-1.27],0.3289133407933414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,20889,101,3.97 [2.72-5.80],9.479173904440097e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,20881,98,2.65 [2.30-3.06],3.256566337819887e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REPS1,RalBP1-associated Eps domain-containing protein 1,17564,80,1.13 [0.67-1.91],0.6403291309253525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REST,RE1-silencing transcription factor,17467,80,1.22 [0.71-2.10],0.4809001246628708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,20792,98,1.91 [1.20-3.03],0.0060555954413079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,20832,98,2.24 [1.64-3.06],4.36872998458996e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REXO2,"Oligoribonuclease, mitochondrial",17476,78,0.80 [0.46-1.38],0.4164083235186173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RFC4,Replication factor C subunit 4,18044,80,2.23 [1.02-4.88],0.0441161065451429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGCC,Regulator of cell cycle RGCC,18071,81,1.00 [0.76-1.31],0.9750573290868813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,17790,82,1.27 [0.99-1.64],0.0611718263364978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMA,Repulsive guidance molecule A,21081,102,1.26 [0.72-2.19],0.4144798755248021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,21081,102,2.04 [1.14-3.66],0.0167764879608314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS10,Regulator of G-protein signaling 10,18071,81,0.96 [0.68-1.36],0.8287367413862388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS8,Regulator of G-protein signaling 8,20526,99,0.95 [0.71-1.26],0.7249322849201094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RHOC,Rho-related GTP-binding protein RhoC,20583,98,1.09 [0.93-1.28],0.2893932313889115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RICTOR,Rapamycin-insensitive companion of mTOR,17564,80,0.88 [0.57-1.36],0.5671567140885678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,17690,82,1.39 [0.96-2.02],0.0802592440799854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILP,Rab-interacting lysosomal protein,21012,101,0.81 [0.61-1.08],0.1469395199450107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILPL2,RILP-like protein 2,18107,82,1.03 [0.84-1.27],0.7675559276432793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,17476,78,1.02 [0.72-1.44],0.9233311100980964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN1,Prorelaxin H1,18071,81,1.28 [0.92-1.78],0.1424844848099951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN2,Prorelaxin H2,17658,82,1.09 [0.78-1.51],0.611701076115637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,18123,81,4.90 [3.40-7.07],1.5660618690586905e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,17604,78,1.84 [1.36-2.48],7.385535707287594e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE3,Eosinophil cationic protein,20777,98,0.98 [0.84-1.15],0.7956481952180608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,17543,76,4.23 [2.74-6.54],7.588090029173165e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,18006,80,2.32 [1.90-2.84],1.662904463346185e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASEH2A,Ribonuclease H2 subunit A,18071,81,1.19 [0.77-1.82],0.4390758235119409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,21037,101,7.70 [5.30-11.20],1.1785859801834467e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,17604,78,5.75 [3.84-8.61],1.9507114445647058e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF168,E3 ubiquitin-protein ligase RNF168,17564,80,1.01 [0.59-1.74],0.9771229144237172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF31,E3 ubiquitin-protein ligase RNF31,17564,80,1.26 [0.74-2.13],0.4019623818398963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF4,E3 ubiquitin-protein ligase RNF4,17790,82,0.92 [0.65-1.30],0.6512814237318472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF41,E3 ubiquitin-protein ligase NRDP1,20402,95,1.07 [0.81-1.41],0.6186802879861355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF43,E3 ubiquitin-protein ligase RNF43,17790,82,1.35 [1.05-1.74],0.0189974055855187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF5,E3 ubiquitin-protein ligase RNF5,17604,78,0.81 [0.61-1.10],0.1740143128801773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,20878,98,4.79 [3.02-7.58],2.3586018406815824e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO2,Roundabout homolog 2,21081,102,1.56 [0.77-3.16],0.2196928579244222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO4,Roundabout homolog 4,17604,78,2.44 [0.70-8.46],0.1596299297545462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,20881,98,2.18 [1.28-3.69],0.0038665107757414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RP2,Protein XRP2,20792,98,0.85 [0.57-1.28],0.4357782175168737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPA2,Replication protein A 32 kDa subunit,17564,80,1.17 [0.60-2.30],0.6478283908938814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPE,Ribulose-phosphate 3-epimerase,17790,82,0.90 [0.66-1.23],0.5154455402422711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,17606,79,0.74 [0.41-1.31],0.2980722018604878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPL14,60S ribosomal protein L14,17604,78,0.72 [0.41-1.26],0.2523562866623712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPS10,40S ribosomal protein S10,17476,78,1.02 [0.61-1.71],0.9385269440540238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRAS,Ras-related protein R-Ras,17606,79,1.05 [0.90-1.24],0.5205360624568175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,20402,95,1.62 [1.24-2.13],0.0004825420315405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,20402,95,1.25 [0.95-1.62],0.1055612817626111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRP15,RRP15-like protein,17515,78,1.18 [0.93-1.50],0.1811625083524151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO1,R-spondin-1,20696,99,1.85 [1.20-2.87],0.0057349448337945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,21071,101,3.59 [2.22-5.79],1.679836786356904e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTBDN,Retbindin,20792,98,1.71 [1.07-2.72],0.0240513679872632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTKN2,Rhotekin-2,17476,78,1.11 [0.75-1.64],0.6178572089415082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",18071,81,1.05 [0.85-1.30],0.6472661974459601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,21071,101,4.31 [3.37-5.52],4.642936168191021e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RUVBL1,RuvB-like 1,20402,95,0.87 [0.70-1.07],0.1910920632888224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RWDD1,RWD domain-containing protein 1,21081,102,0.88 [0.67-1.15],0.3375466628941305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RYR1,Ryanodine receptor 1,17476,78,1.34 [0.85-2.11],0.2100136753379946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A11,Protein S100-A11,20734,98,1.10 [0.77-1.57],0.6118632555732233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A12,Protein S100-A12,20584,97,0.84 [0.65-1.09],0.1915008229527126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A13,Protein S100-A13,17564,80,1.44 [0.85-2.44],0.1788144321361052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A14,Protein S100-A14,18071,81,0.35 [0.21-0.59],0.0001037080537547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A16,Protein S100-A16,20399,99,0.85 [0.61-1.18],0.3258671812462228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A3,Protein S100-A3,18044,80,1.51 [1.18-1.95],0.0011582234234329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A4,Protein S100-A4,20948,102,0.79 [0.59-1.07],0.1315365128394668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100G,Protein S100-G,18071,81,0.73 [0.47-1.14],0.1660316417162421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100P,Protein S100-P,20501,98,1.41 [1.08-1.84],0.0120506454827267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAA4,Serum amyloid A-4 protein,18124,81,0.86 [0.45-1.67],0.6590318896654699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAFB2,Scaffold attachment factor B2,18071,81,0.98 [0.43-2.23],0.959012635356132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAG,S-arrestin,17515,78,1.01 [0.65-1.57],0.9768670397061644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,20854,99,1.16 [0.91-1.47],0.2313324941035492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAP18,Histone deacetylase complex subunit SAP18,17790,82,1.13 [0.88-1.45],0.3512928508326671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SARG,Specifically androgen-regulated gene protein,18042,82,1.10 [0.91-1.34],0.3084794482682224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,17476,78,1.22 [0.78-1.93],0.3851053192592754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT1,Diamine acetyltransferase 1,17476,78,0.86 [0.55-1.35],0.5195424911704141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT2,Thialysine N-epsilon-acetyltransferase,17790,82,1.35 [1.04-1.74],0.0243298265286193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SATB1,DNA-binding protein SATB1,18071,81,1.24 [0.66-2.35],0.5038038353073563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SBSN,Suprabasin,18071,80,0.75 [0.41-1.40],0.3723348163827028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCAMP3,Secretory carrier-associated membrane protein 3,20792,98,1.35 [1.10-1.65],0.0038088704467125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,21081,102,6.08 [3.94-9.38],3.1662513327304056e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB1,Scavenger receptor class B member 1,20435,99,1.38 [1.10-1.73],0.0058119367647061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,20282,98,4.27 [3.38-5.38],1.753494030623893e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,21140,101,2.39 [1.63-3.51],7.436079835339168e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,21081,102,7.25 [4.62-11.38],7.50350104908499e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,20982,101,10.04 [6.51-15.50],1.94859641721672e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG3,Secretogranin-3,20878,98,1.09 [0.64-1.85],0.7438853494078093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB1A1,Uteroglobin,20889,99,1.43 [1.03-1.98],0.0337372209184924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB2A2,Mammaglobin-A,17476,78,0.83 [0.38-1.81],0.6428902214992258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A1,Secretoglobin family 3A member 1,17690,82,2.21 [0.98-4.97],0.0561573766110616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A2,Secretoglobin family 3A member 2,20922,99,1.41 [1.21-1.65],1.5156975025374087e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,20526,99,3.21 [2.39-4.33],1.4947292962715613e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCIN,Adseverin,17515,78,0.97 [0.71-1.33],0.8594787992781932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCLY,Selenocysteine lyase,21012,101,1.71 [1.21-2.42],0.0026108698774737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2A,Sodium channel protein type 2 subunit alpha,17515,78,0.76 [0.45-1.29],0.3148218072244745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2B,Sodium channel subunit beta-2,17606,79,0.51 [0.22-1.19],0.11902254008376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3A,Sodium channel protein type 3 subunit alpha,17606,79,0.49 [0.23-1.07],0.0721695918464889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3B,Sodium channel subunit beta-3,17515,78,0.61 [0.34-1.09],0.0944481155680057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,17604,78,1.49 [0.91-2.42],0.1114698460181222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCP2,Non-specific lipid-transfer protein,20402,95,0.92 [0.72-1.18],0.52291994708625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,17544,78,1.71 [1.17-2.49],0.0053093161929901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,18107,82,2.26 [1.38-3.73],0.0013116606048234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRIB,Protein scribble homolog,17604,78,1.07 [0.86-1.33],0.5350825497624798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRN1,Secernin-1,20854,99,0.72 [0.51-1.02],0.0630950097303404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCT,Secretin,17606,79,1.20 [0.78-1.86],0.4076219356871193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,20881,98,2.82 [1.97-4.04],1.3423929088250724e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC4,Syndecan-4,20881,98,0.48 [0.34-0.69],5.314082116631358e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDCCAG8,Serologically defined colon cancer antigen 8,18044,80,1.16 [0.96-1.39],0.1245299441893315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDHB,Succinate dehydrogenase,18042,82,1.35 [1.04-1.76],0.025077576163278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDK2,Protein sidekick-2,17690,82,1.08 [0.62-1.88],0.7741228632338111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEC31A,Protein transport protein Sec31A,17604,78,0.87 [0.66-1.16],0.3400887562201294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,17604,78,2.05 [1.65-2.54],6.845015222398759e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,21140,101,2.78 [1.98-3.91],4.5320928075756644e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELENOP,Selenoprotein P,18124,81,1.56 [0.62-3.92],0.3420199055278958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELL,L-selectin,18124,81,0.62 [0.25-1.53],0.2965843281057339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELP,P-selectin,20989,98,1.34 [0.99-1.81],0.0599324344894668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELPLG,P-selectin glycoprotein ligand 1,20854,99,2.27 [1.16-4.46],0.0171470059173699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,20881,98,4.28 [2.27-8.06],7.061443637878256e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3G,Semaphorin-3G,17690,82,1.40 [0.89-2.21],0.1489944590262721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4C,Semaphorin-4C,20792,98,0.93 [0.47-1.84],0.8318116898040275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4D,Semaphorin-4D,21081,102,1.07 [0.59-1.93],0.8347319698301832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA6C,Semaphorin-6C,17564,80,2.06 [1.21-3.52],0.0081501371010788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,21067,101,3.70 [2.82-4.86],3.547035036844221e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN3,Neuronal-specific septin-3,18071,81,1.16 [0.90-1.49],0.2565778187104492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN7,Septin-7,17790,82,1.24 [0.89-1.73],0.2098311407456375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,18029,81,2.53 [1.67-3.85],1.3625964826631276e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN9,Septin-9,20792,98,0.86 [0.45-1.65],0.6461203667039712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA1,Alpha-1-antitrypsin,17791,80,7.93 [1.73-36.25],0.0075930008145943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA11,Serpin A11,21140,101,2.02 [1.33-3.08],0.0009910035098676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA12,Serpin A12,20274,94,1.19 [1.03-1.38],0.0177214726833481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA3,Alpha-1-antichymotrypsin,18071,81,2.96 [1.15-7.60],0.024124949356782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA4,Kallistatin,17810,81,2.47 [1.00-6.10],0.050095425047014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA5,Plasma serine protease inhibitor,17871,81,1.67 [1.02-2.74],0.0421420487027562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA6,Corticosteroid-binding globulin,18124,81,11.49 [3.63-36.36],3.295651878087698e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA7,Thyroxine-binding globulin,18124,81,0.85 [0.27-2.72],0.7856563187085498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,20702,97,1.57 [1.26-1.95],6.517413749875832e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB1,Leukocyte elastase inhibitor,20820,101,1.02 [0.84-1.24],0.814345813005365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB5,Serpin B5,20501,98,1.21 [0.83-1.77],0.3213842778076177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB6,Serpin B6,21008,101,1.17 [0.88-1.57],0.2811569927780385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB8,Serpin B8,21127,101,1.15 [0.89-1.50],0.2842354542615568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB9,Serpin B9,20696,99,1.15 [0.65-2.04],0.6286363713738303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINC1,Antithrombin-III,18096,81,2.17 [0.52-9.08],0.2879756817592263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPIND1,Heparin cofactor 2,18096,81,3.11 [1.52-6.35],0.0018744460792667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE1,Plasminogen activator inhibitor 1,21140,101,1.08 [0.82-1.42],0.5740260346053554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE2,Glia-derived nexin,18107,82,0.99 [0.71-1.36],0.9295154702800318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,17845,80,5.12 [2.89-9.08],2.1954097123876762e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF2,Alpha-2-antiplasmin,17787,80,2.42 [0.48-12.23],0.2866622559444783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPING1,Plasma protease C1 inhibitor,18096,81,2.14 [0.70-6.52],0.1823485694896985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINH1,Serpin H1,17790,82,1.14 [0.97-1.33],0.1189455073529499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI1,Neuroserpin,17660,81,0.79 [0.38-1.65],0.5266717644083238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI2,Serpin I2,18042,82,1.29 [0.92-1.80],0.1428279657835376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,20435,99,0.89 [0.67-1.18],0.4226921762292527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,20618,99,0.53 [0.32-0.89],0.0155448732384503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6,Seizure protein 6 homolog,17606,79,1.09 [0.54-2.17],0.8172228794030828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L,Seizure 6-like protein,20948,102,2.83 [1.60-5.00],0.0003363771321056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L2,Seizure 6-like protein 2,20792,98,3.28 [1.95-5.52],7.83386094573825e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SF3B4,Splicing factor 3B subunit 4,20792,98,0.67 [0.52-0.87],0.00306122926994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,20619,99,1.82 [1.39-2.37],9.610814485728372e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP4,Secreted frizzled-related protein 4,17690,82,1.55 [0.92-2.62],0.09799282336732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA1,Pulmonary surfactant-associated protein A1,20402,95,1.03 [0.76-1.40],0.8460246272440328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA2,Pulmonary surfactant-associated protein A2,20402,95,0.96 [0.69-1.34],0.7985487504808599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPD,Pulmonary surfactant-associated protein D,20881,98,1.49 [1.15-1.94],0.0029490970271481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SGSH,N-sulphoglucosamine sulphohydrolase,17813,81,1.51 [1.06-2.16],0.0232325132838921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2B3,SH2B adapter protein 3,20402,95,1.08 [0.90-1.30],0.3987268081983318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2D1A,SH2 domain-containing protein 1A,20854,99,1.07 [0.80-1.42],0.6408938248145082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,17515,78,1.36 [1.07-1.72],0.0121676691605412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BP1,SH3 domain-binding protein 1,18042,82,1.38 [0.96-1.99],0.0822847641247619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GL3,Endophilin-A3,17681,81,1.15 [0.90-1.47],0.2669385705023444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GLB2,Endophilin-B2,18060,81,0.89 [0.65-1.20],0.4385193726022666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHBG,Sex hormone-binding globulin,18123,81,0.42 [0.29-0.60],1.6128771585942957e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHC1,SHC-transforming protein 1,17467,80,0.95 [0.79-1.15],0.6146814882527393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHD,SH2 domain-containing adapter protein D,17447,77,1.06 [0.87-1.30],0.552627586691721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHH,Sonic hedgehog protein,17564,80,1.34 [0.86-2.08],0.1978379599682927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,18104,80,3.39 [2.62-4.41],4.153651318782475e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",20922,99,0.97 [0.78-1.19],0.7429043740594123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHPK,Sedoheptulokinase,17790,82,0.87 [0.49-1.54],0.6239890184158231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIAE,Sialate O-acetylesterase,20910,102,1.71 [1.20-2.44],0.0031267282641356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,20956,99,4.00 [3.02-5.29],2.429806196919268e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,20854,99,3.18 [2.59-3.92],7.379895069483192e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,20435,99,0.76 [0.55-1.04],0.0849638879231901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,20889,101,1.38 [1.13-1.69],0.0016857410109625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,21071,101,4.00 [2.83-5.65],3.942745968594026e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,20881,98,4.06 [2.34-7.01],5.487498023063499e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,17604,78,3.24 [2.08-5.05],2.082247492215613e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,21037,101,3.01 [1.70-5.32],0.0001507752298771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIL1,Nucleotide exchange factor SIL1,17604,78,1.15 [0.60-2.21],0.6642189804867422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,20937,99,1.86 [1.30-2.66],0.0007068786819188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,20808,98,3.39 [2.49-4.61],7.194225083719686e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,17564,80,1.14 [0.92-1.40],0.2321123159752831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,20792,98,0.91 [0.74-1.12],0.3819222092776007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",20435,99,0.69 [0.47-1.03],0.0669003278448811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,20526,99,1.66 [1.21-2.26],0.0014395594782507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP1,Src kinase-associated phosphoprotein 1,20668,98,0.90 [0.70-1.16],0.4183210585849259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP2,Src kinase-associated phosphoprotein 2,20956,99,1.05 [0.88-1.24],0.5885221137974337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKIV2L,Helicase SKI2W,17476,78,1.00 [0.59-1.68],0.99814065420328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLA2,Src-like-adapter 2,18071,81,1.11 [0.91-1.35],0.3045749365546914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,20526,99,2.51 [1.94-3.24],2.984921117669595e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,20402,95,2.60 [1.91-3.55],1.305465250212786e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,20854,99,2.15 [1.70-2.73],2.0548779538528784e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,20402,95,3.74 [2.72-5.14],4.807334418901453e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC12A2,Solute carrier family 12 member 2,17476,78,1.23 [0.62-2.43],0.5613929018321496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC13A1,Solute carrier family 13 member 1,18044,80,0.93 [0.61-1.41],0.7371788663371135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC16A1,Monocarboxylate transporter 1,20435,99,1.32 [1.05-1.67],0.0193039144721064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC1A4,Neutral amino acid transporter A,17606,79,0.99 [0.66-1.48],0.9654390216098824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC27A4,Long-chain fatty acid transport protein 4,20435,99,1.10 [0.86-1.41],0.461453421621838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC28A1,Sodium/nucleoside cotransporter 1,17467,80,1.26 [0.94-1.68],0.1212935529444935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,17467,80,1.29 [0.89-1.85],0.1776402172884288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A14,Zinc transporter ZIP14,20435,99,1.78 [1.24-2.54],0.0016062220954332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A5,Zinc transporter ZIP5,20854,99,1.68 [1.30-2.18],8.201135511472496e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC44A4,Choline transporter-like protein 4,17606,79,1.12 [0.84-1.49],0.4427990917310793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC4A1,Band 3 anion transport protein,18104,80,0.63 [0.39-1.00],0.0497853130132434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC51B,Organic solute transporter subunit beta,17476,78,0.96 [0.71-1.30],0.7847875231794633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,17690,82,1.06 [0.84-1.35],0.6232856236659023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,18042,82,1.52 [1.14-2.02],0.0044443142064319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",17467,80,1.02 [0.70-1.49],0.9236068552107584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIT2,Slit homolog 2 protein,20435,99,1.34 [1.03-1.74],0.0314165545830164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK1,SLIT and NTRK-like protein 1,17564,80,0.53 [0.27-1.02],0.0580313863040951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK2,SLIT and NTRK-like protein 2,21071,101,2.73 [1.82-4.10],1.2036857150878769e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK6,SLIT and NTRK-like protein 6,20501,98,1.47 [0.94-2.29],0.0891567696788097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLK,STE20-like serine/threonine-protein kinase,17790,82,1.16 [0.92-1.45],0.2060248814591995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,18042,82,1.58 [1.27-1.95],3.343086295900901e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,17974,79,1.51 [1.03-2.22],0.0353020849700535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD1,Mothers against decapentaplegic homolog 1,20402,95,1.13 [0.92-1.39],0.2343777757133743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD2,Mothers against decapentaplegic homolog 2,18044,80,1.05 [0.79-1.40],0.7335784151561473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD3,Mothers against decapentaplegic homolog 3,18044,80,1.04 [0.69-1.57],0.8493858264863053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD5,Mothers against decapentaplegic homolog 5,20792,98,0.47 [0.19-1.14],0.0953125397265292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMARCA2,Probable global transcription activator SNF2L2,20435,99,0.85 [0.65-1.09],0.196801549906131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMC3,Structural maintenance of chromosomes protein 3,17467,80,1.08 [0.74-1.57],0.7051400022858842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,18042,82,1.00 [0.70-1.42],0.9946427324027548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,21071,101,3.13 [2.29-4.28],8.491983461422983e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,20956,99,3.16 [2.19-4.55],7.009625423902298e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD1,Sphingomyelin phosphodiesterase,20973,100,2.26 [1.66-3.08],2.0257995441374322e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD3,Sphingomyelin phosphodiesterase 3,17564,80,1.18 [0.86-1.63],0.3046385108282644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,20917,99,1.03 [0.79-1.35],0.8011654115731552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,18044,80,0.83 [0.58-1.19],0.3088272232250473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMS,Spermine synthase,17515,78,1.07 [0.78-1.46],0.6779010604341238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMTN,Smoothelin,18022,81,1.48 [1.22-1.80],5.632300811188127e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP23,Synaptosomal-associated protein 23,20881,98,1.06 [0.86-1.31],0.5826727816390627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP25,Synaptosomal-associated protein 25,17515,78,0.93 [0.59-1.45],0.7331146155648999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP29,Synaptosomal-associated protein 29,20948,102,1.08 [0.90-1.31],0.4064570874329114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAPIN,SNARE-associated protein Snapin,18071,81,0.74 [0.51-1.08],0.1214275900692126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCA,Alpha-synuclein,17690,82,0.88 [0.73-1.05],0.1430646171191598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,20696,99,2.28 [1.77-2.94],1.8901709510964958e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",17604,78,2.17 [1.39-3.37],0.0006210734252696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',18060,81,1.24 [0.87-1.78],0.2369863169714563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNU13,NHP2-like protein 1,17476,78,0.65 [0.40-1.05],0.0757522158205304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX15,Sorting nexin-15,17690,82,0.64 [0.43-0.95],0.0250778344125922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX18,Sorting nexin-18,18042,82,1.01 [0.65-1.57],0.9757436356751898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX2,Sorting nexin-2,18044,80,1.26 [1.01-1.57],0.0380559823317221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX5,Sorting nexin-5,17604,78,0.72 [0.34-1.55],0.3992039668234141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX9,Sorting nexin-9,20881,98,1.07 [0.83-1.37],0.6140621908154069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD1,Superoxide dismutase [Cu-Zn],20483,95,0.74 [0.50-1.09],0.1270152927028923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",20889,101,1.25 [0.83-1.86],0.286833611919735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD3,Extracellular superoxide dismutase,18123,81,0.61 [0.33-1.11],0.105701643861411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,18071,81,1.66 [1.25-2.21],0.0004269345046432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,20402,95,4.60 [3.18-6.66],6.705563984606732e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORD,Sorbitol dehydrogenase,20978,100,0.95 [0.74-1.22],0.7039606000755496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORT1,Sortilin,20852,98,2.01 [1.30-3.11],0.0016498516869698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOST,Sclerostin,20852,98,1.46 [0.92-2.31],0.1087942221063028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,17606,79,0.86 [0.52-1.43],0.5541887151251605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX2,Transcription factor SOX-2,18033,81,0.83 [0.33-2.05],0.6786464385237995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX9,Transcription factor SOX-9,17606,79,3.10 [1.38-6.95],0.005945405734332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,18071,81,1.57 [0.92-2.68],0.094650179324572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPAG1,Sperm-associated antigen 1,18071,81,1.13 [0.81-1.57],0.4866109043901424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARC,SPARC,20948,102,1.02 [0.79-1.32],0.8685945543636024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARCL1,SPARC-like protein 1,20921,98,1.59 [0.98-2.60],0.062505390382416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPART,Spartin,17690,82,1.14 [0.87-1.49],0.3482812501480051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPESP1,Sperm equatorial segment protein 1,18107,82,1.17 [0.64-2.15],0.6043847063453378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,20889,101,4.92 [3.92-6.18],3.2020903039033755e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK2,Serine protease inhibitor Kazal-type 2,17690,82,1.70 [1.00-2.88],0.0503089970996894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,20854,99,2.82 [2.38-3.35],3.788400397692978e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK5,Serine protease inhibitor Kazal-type 5,20889,101,1.24 [0.76-2.03],0.3923489117518506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK6,Serine protease inhibitor Kazal-type 6,21071,101,1.11 [0.78-1.56],0.5641195798392769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK8,Serine protease inhibitor Kazal-type 8,17476,78,1.51 [0.95-2.42],0.0831298558443305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,20811,101,4.27 [3.02-6.03],1.6451914800630968e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,20956,99,3.78 [2.53-5.67],1.0346183305483704e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT3,Kunitz-type protease inhibitor 3,18042,82,1.09 [0.95-1.25],0.2045946031857547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPOCK1,Testican-1,20696,99,0.45 [0.28-0.73],0.0011666222458085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,20878,98,3.62 [2.93-4.48],3.397483790180333e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,20780,98,5.62 [3.71-8.49],2.838238794040944e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPP1,Osteopontin,21110,101,1.90 [1.34-2.68],0.0003008330055866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",17564,80,1.69 [1.13-2.54],0.0107460474282584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRING1,SREBP regulating gene protein,17467,80,1.22 [0.91-1.64],0.1738519142282289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR1B,Cornifin-B,17790,82,1.04 [0.82-1.33],0.7232052933040529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR3,Small proline-rich protein 3,18060,81,1.29 [0.93-1.80],0.1241463761974071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRY2,Protein sprouty homolog 2,20526,99,0.97 [0.79-1.17],0.7299657469463154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",17515,78,0.77 [0.35-1.66],0.4998928766925706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTLC1,Serine palmitoyltransferase 1,18060,81,1.38 [0.92-2.07],0.1202787243370623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRC,Proto-oncogene tyrosine-protein kinase Src,20915,102,1.01 [0.87-1.16],0.9347389844369464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRP14,Signal recognition particle 14 kDa protein,20792,98,1.07 [0.80-1.44],0.6393019286195556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPK2,SRSF protein kinase 2,20854,99,1.10 [0.90-1.34],0.33746645295676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,18107,82,2.51 [1.45-4.35],0.0010639205508671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSB,Lupus La protein,20435,99,0.64 [0.43-0.94],0.0218288287680494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",17564,80,1.53 [0.94-2.48],0.0875890483296147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,20852,98,0.87 [0.76-1.01],0.0599320893896514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,20989,98,1.86 [1.25-2.78],0.0024258394219515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSH3,Protein phosphatase Slingshot homolog 3,17467,80,0.74 [0.36-1.52],0.4133697271465379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,18042,82,1.08 [0.75-1.57],0.6842516543816817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST13,Hsc70-interacting protein,17690,82,0.69 [0.47-1.00],0.0496425061868117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",20792,98,1.98 [1.50-2.62],1.330865336121855e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",21140,101,2.54 [1.90-3.38],2.0625189908686868e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",17564,80,1.17 [0.78-1.75],0.4546365312592673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAB2,Stabilin-2,18104,80,3.90 [1.81-8.41],0.0005161095474151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAM,Signal transducing adapter molecule 1,18044,80,1.40 [0.83-2.36],0.2016284329001622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAMBP,STAM-binding protein,20668,98,0.86 [0.65-1.14],0.3024416091346218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT2,Signal transducer and activator of transcription 2,17564,80,1.25 [0.96-1.62],0.1005145570000835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT5B,Signal transducer and activator of transcription 5B,20792,98,0.99 [0.87-1.13],0.8595899666982029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,17467,80,1.27 [0.95-1.71],0.1031672195855837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,21081,102,2.32 [1.74-3.10],8.929964928621149e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC2,Stanniocalcin-2,20863,101,6.77 [3.36-13.64],8.563952480388883e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STEAP4,Metalloreductase STEAP4,17515,78,1.03 [0.77-1.39],0.8243415456447327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STIP1,Stress-induced-phosphoprotein 1,20850,101,0.82 [0.63-1.08],0.1583874295827909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK11,Serine/threonine-protein kinase STK11,20501,98,0.96 [0.75-1.23],0.7396425318253843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK24,Serine/threonine-protein kinase 24,20435,99,1.08 [0.81-1.44],0.6120443069187882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK4,Serine/threonine-protein kinase 4,20881,98,1.03 [0.84-1.25],0.7883681367345516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STOML2,"Stomatin-like protein 2, mitochondrial",17467,80,1.05 [0.84-1.33],0.6553399331192121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX16,Syntaxin-16,20402,95,1.53 [1.20-1.95],0.0007073813236521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX1B,Syntaxin-1B,17606,79,0.78 [0.42-1.44],0.4221777168570086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX3,Syntaxin-3,18060,81,1.03 [0.60-1.78],0.9079811703209384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX4,Syntaxin-4,20792,98,1.50 [1.21-1.85],0.0001974360344711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX5,Syntaxin-5,17564,80,1.34 [0.88-2.04],0.1659432308064098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX6,Syntaxin-6,20402,95,1.42 [1.12-1.80],0.003642836198928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX7,Syntaxin-7,17564,80,2.02 [1.31-3.11],0.0014280634674553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX8,Syntaxin-8,20854,99,1.56 [1.13-2.15],0.0069465755990178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP1,Syntaxin-binding protein 1,18071,81,1.05 [0.80-1.39],0.7095810343385723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP3,Syntaxin-binding protein 3,20402,95,1.07 [0.72-1.61],0.7346566888982389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGP1,SURP and G-patch domain-containing protein 1,18042,82,1.12 [0.69-1.82],0.654535698131111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGT1,Protein SGT1 homolog,20402,95,0.93 [0.74-1.16],0.5139002900605558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT1A1,Sulfotransferase 1A1,21081,102,0.99 [0.87-1.13],0.9186581178136102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT2A1,Bile salt sulfotransferase,20854,99,1.58 [1.28-1.95],2.278566074219958e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF1,Formylglycine-generating enzyme,17564,80,1.17 [0.89-1.54],0.2654505755753997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,21081,102,1.54 [1.08-2.18],0.016723021150147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUOX,"Sulfite oxidase, mitochondrial",18071,81,1.56 [1.16-2.09],0.0032701099585041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD1,Sushi domain-containing protein 1,20501,98,0.93 [0.64-1.35],0.7064446735550685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD2,Sushi domain-containing protein 2,20889,101,2.75 [1.76-4.31],9.300857093559012e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD4,Sushi domain-containing protein 4,18044,80,1.65 [1.05-2.59],0.0285603027676026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD5,Sushi domain-containing protein 5,17600,81,0.75 [0.40-1.41],0.3666809734839905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SV2A,Synaptic vesicle glycoprotein 2A,17606,79,1.26 [0.95-1.68],0.1113521714506398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SWAP70,Switch-associated protein 70,18042,82,1.13 [0.65-1.99],0.6641706310953515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYAP1,Synapse-associated protein 1,17690,82,0.88 [0.62-1.26],0.4958533838762978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,17515,78,1.34 [1.02-1.75],0.034063079102906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYT1,Synaptotagmin-1,18060,81,0.78 [0.42-1.45],0.4304789036286914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYTL4,Synaptotagmin-like protein 4,18107,82,1.27 [0.99-1.63],0.0629829974837904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,17790,82,1.08 [0.88-1.33],0.4402919937675461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACC3,Transforming acidic coiled-coil-containing protein 3,20792,98,0.98 [0.84-1.14],0.7554446942304589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,18516,93,5.74 [3.37-9.76],1.1864628347780628e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TADA3,Transcriptional adapter 3,18044,80,1.16 [0.72-1.88],0.5346909832987492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,20792,98,2.63 [1.86-3.73],4.625586193840867e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAGLN3,Transgelin-3,17467,80,1.15 [0.80-1.63],0.4522911480580673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TALDO1,Transaldolase,18041,80,1.15 [0.72-1.82],0.5636023153108668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TANK,TRAF family member-associated NF-kappa-B activator,20526,99,1.11 [0.86-1.43],0.4299589065887339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAP1,Antigen peptide transporter 1,17790,82,0.82 [0.55-1.23],0.3405265024402849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARBP2,RISC-loading complex subunit TARBP2,20435,99,1.13 [0.90-1.42],0.2775600665875317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",17606,79,1.18 [0.95-1.46],0.1308539851713776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",18044,80,1.24 [0.72-2.11],0.4371737609942645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAX1BP1,Tax1-binding protein 1,18060,81,1.52 [1.12-2.08],0.0075188925184582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D17,TBC1 domain family member 17,20435,99,0.67 [0.43-1.07],0.0913827576845678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D23,TBC1 domain family member 23,20792,98,1.12 [0.92-1.36],0.2452979675825313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D5,TBC1 domain family member 5,20854,99,1.16 [0.94-1.43],0.1753316167235003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCA,Tubulin-specific chaperone A,17690,82,0.88 [0.69-1.14],0.3364474372638277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCB,Tubulin-folding cofactor B,20696,99,0.99 [0.82-1.18],0.8746560424454655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCC,Tubulin-specific chaperone C,20696,99,1.05 [0.84-1.31],0.6860570913439825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,20402,95,1.04 [0.84-1.28],0.745528390975116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBR1,T-box brain protein 1,17606,79,0.82 [0.47-1.42],0.4762019996493427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,20667,99,0.67 [0.57-0.79],1.8564249568228697e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1B,T-cell leukemia/lymphoma protein 1B,20501,98,1.08 [0.88-1.32],0.4553886522050527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN1,Transcobalamin-1,17784,78,1.34 [0.87-2.08],0.1845649659207841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,21110,101,3.72 [2.67-5.19],1.1272131658457447e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCOF1,Treacle protein,18107,82,2.20 [1.51-3.21],4.401174310693871e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCP11,T-complex protein 11 homolog,17790,82,0.75 [0.49-1.17],0.2060180835452138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCTN3,Tectonic-3,18107,82,1.81 [0.91-3.59],0.0881940185615658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDGF1,Teratocarcinoma-derived growth factor 1,20435,99,1.09 [0.97-1.23],0.1568425858109292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDO2,"Tryptophan 2,3-dioxygenase",17606,79,0.82 [0.45-1.48],0.5042218841633653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,18044,80,1.08 [0.80-1.45],0.6115196013423937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDRKH,Tudor and KH domain-containing protein,20435,99,1.13 [0.92-1.38],0.2518801707857091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEF,Thyrotroph embryonic factor,17476,78,0.87 [0.51-1.49],0.6070061608203609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,20948,102,3.98 [1.87-8.47],0.0003367224270485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TERF1,Telomeric repeat-binding factor 1,17564,80,1.65 [0.89-3.08],0.1129081599849236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TET2,Methylcytosine dioxygenase TET2,17761,82,1.01 [0.81-1.25],0.9619649389626004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX101,Testis-expressed protein 101,17606,79,1.04 [0.74-1.47],0.8194180592253568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX33,Testis-expressed protein 33,17790,82,1.08 [0.65-1.81],0.7681820784613975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TF,Serotransferrin,18124,81,2.68 [1.02-7.00],0.0450610659895257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFAP2A,Transcription factor AP-2-alpha,17515,78,0.81 [0.53-1.23],0.3142694836250158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,20791,101,1.98 [1.68-2.32],1.5037998696969123e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,20922,99,3.52 [2.80-4.44],1.434971240916717e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,20891,98,2.29 [1.98-2.66],8.219615416940013e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI,Tissue factor pathway inhibitor,20851,98,0.79 [0.44-1.44],0.4406649459989586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,20887,102,1.51 [1.21-1.88],0.0002291777203899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFRC,Transferrin receptor protein 1,20981,98,2.40 [1.66-3.47],2.8496109038940624e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TG,Thyroglobulin,18044,80,1.03 [0.84-1.26],0.783348741514276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,20854,99,2.87 [2.19-3.75],1.9428863566878408e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,21094,101,2.61 [1.98-3.45],1.3581572968927994e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB2,Transforming growth factor beta-2 proprotein,18044,80,1.14 [0.81-1.62],0.4537523158873648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,20783,98,0.53 [0.27-1.05],0.0673898144253574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,17564,80,2.55 [1.62-4.01],5.287926334103315e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,20948,102,0.43 [0.22-0.82],0.010263477337263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR3,Transforming growth factor beta receptor type 3,21140,101,1.59 [0.89-2.85],0.1198838916342332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,20847,98,0.68 [0.54-0.86],0.0010504537947042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,18123,81,3.93 [1.99-7.78],8.216393583127814e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,17435,80,1.01 [0.77-1.31],0.9661294920412864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,20881,98,3.67 [2.46-5.48],1.8910014477379438e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,20889,101,4.46 [3.43-5.80],9.664036019322319e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS4,Thrombospondin-4,20923,98,1.84 [1.27-2.66],0.0012021690083833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THOP1,Thimet oligopeptidase,20780,98,0.61 [0.34-1.09],0.0924555531412205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THPO,Thrombopoietin,20501,98,0.89 [0.56-1.40],0.606963414275965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THRAP3,Thyroid hormone receptor-associated protein 3,17476,78,0.95 [0.76-1.20],0.6796316232173749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THSD1,Thrombospondin type-1 domain-containing protein 1,17436,78,1.07 [0.56-2.03],0.8463664161823714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THTPA,Thiamine-triphosphatase,18000,79,0.84 [0.65-1.07],0.1523483801092031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,21081,102,3.19 [1.92-5.31],7.860621746364001e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIA1,Nucleolysin TIA-1 isoform p40,20273,97,0.99 [0.85-1.14],0.8763292704524553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIE1,Tyrosine-protein kinase receptor Tie-1,21140,101,1.51 [0.90-2.52],0.1151314364029823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",20407,98,1.06 [0.73-1.55],0.7569631265698543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,17790,82,2.32 [1.60-3.37],8.91636207735851e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,20989,98,1.14 [0.76-1.72],0.5292108194377764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,18107,82,1.32 [0.83-2.11],0.2398386934201316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,18060,81,1.03 [0.81-1.31],0.8184695936922814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,20693,98,5.47 [4.05-7.38],1.0853172935864224e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP2,Metalloproteinase inhibitor 2,18107,82,1.61 [1.14-2.26],0.0063887718134875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP3,Metalloproteinase inhibitor 3,20956,99,1.13 [0.99-1.29],0.0714412972537657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP4,Metalloproteinase inhibitor 4,20889,101,1.65 [1.12-2.43],0.0112906677519093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,20822,98,6.12 [2.85-13.17],3.53267355510501e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJAP1,Tight junction-associated protein 1,20948,102,1.09 [0.89-1.34],0.415351390753985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJP3,Tight junction protein ZO-3,17515,78,1.14 [0.68-1.90],0.6268999975492097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TK1,"Thymidine kinase, cytosolic",17790,82,1.50 [1.05-2.12],0.0242842677139304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,17564,80,4.37 [2.53-7.55],1.2151337445998068e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR2,Toll-like receptor 2,17790,82,2.00 [0.85-4.68],0.1118680509985216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR3,Toll-like receptor 3,21127,101,1.61 [1.18-2.19],0.0027080709844651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR4,Toll-like receptor 4,17564,80,3.41 [1.92-6.06],2.980755610307215e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,17606,79,1.16 [0.78-1.72],0.4705903832226729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED1,Transmembrane emp24 domain-containing protein 1,17790,82,1.21 [0.85-1.72],0.2883620542527226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED10,Transmembrane emp24 domain-containing protein 10,17476,78,0.89 [0.53-1.50],0.6554707461091869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED4,Transmembrane emp24 domain-containing protein 4,17476,78,0.69 [0.44-1.10],0.1173138051920892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED8,Protein TMED8,18042,82,1.07 [0.88-1.32],0.493551511644656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM106A,Transmembrane protein 106A,18044,80,1.17 [0.89-1.55],0.2587076148456372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM132A,Transmembrane protein 132A,17604,78,0.92 [0.66-1.30],0.6484763804669319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM25,Transmembrane protein 25,18071,81,0.95 [0.61-1.46],0.8107068850786249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMOD4,Tropomodulin-4,17467,80,1.90 [1.22-2.96],0.0042207317984695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11B,Transmembrane protease serine 11B,17515,78,0.85 [0.60-1.21],0.3684088319782633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,18029,81,1.75 [1.07-2.85],0.0244421082683631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,20792,98,1.89 [1.55-2.31],2.6877987128015223e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS5,Transmembrane protease serine 5,20590,99,0.77 [0.50-1.21],0.258236501376718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMSB10,Thymosin beta-10,20889,101,1.34 [1.06-1.69],0.0141342198260465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNC,Tenascin,20989,98,1.61 [1.13-2.30],0.0079752707814956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,20471,97,1.79 [1.40-2.30],4.810475739333685e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,18042,82,1.42 [0.97-2.08],0.0727851172196249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,20526,99,1.11 [0.68-1.81],0.6702371096610276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,17690,82,0.96 [0.70-1.33],0.8192907686025157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,20696,99,3.81 [3.07-4.72],7.000183523249863e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,20696,99,1.59 [1.42-1.78],9.2207702863177e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,20945,100,1.34 [0.91-1.96],0.1346676619924949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21127,101,4.54 [3.46-5.95],7.565013432311079e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,20847,98,6.18 [4.35-8.78],2.776736191742384e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,20948,102,4.95 [3.80-6.44],1.26182151675069e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,20878,98,2.37 [1.91-2.94],3.335981861102785e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,20526,99,1.27 [0.85-1.89],0.2393699334773271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,20878,98,6.59 [4.69-9.28],2.500764478658021e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,17690,82,2.08 [1.27-3.39],0.0033684522586903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,21071,101,3.52 [2.60-4.78],4.866479549891852e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,20889,101,6.27 [4.68-8.40],1.0840293271007092e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,20889,101,2.21 [1.89-2.59],2.585456025915258e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,21081,102,4.39 [2.87-6.72],9.1283361199292e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,21094,101,3.99 [2.99-5.32],4.102793897944253e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,20696,99,2.05 [1.67-2.52],1.114064032885598e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,21081,102,2.32 [1.70-3.16],1.040242602619981e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,20696,99,2.42 [2.03-2.88],7.087330185089868e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,21127,101,0.52 [0.32-0.83],0.0068349189989302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,20854,99,0.65 [0.48-0.87],0.004438318883857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,21127,101,0.31 [0.17-0.56],0.0001025073159876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,20956,99,6.00 [3.64-9.89],2.1364371560636185e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,21104,101,2.73 [1.67-4.46],6.207295151759028e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,20696,99,1.12 [0.83-1.52],0.4432603939403713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,18104,80,3.06 [1.99-4.72],4.139014759775517e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNIP1,TNFAIP3-interacting protein 1,18060,81,1.18 [0.92-1.49],0.1868823454189341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNN,Tenascin-N,18104,80,2.79 [1.71-4.56],4.022987136959616e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNNI3,"Troponin I, cardiac muscle",20501,98,1.23 [0.98-1.55],0.070126087869162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNPO1,Transportin-1,17790,82,1.06 [0.58-1.94],0.8377964450381732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNR,Tenascin-R,20696,99,1.21 [0.80-1.81],0.3681076869766356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNXB,Tenascin-X,20889,101,0.41 [0.22-0.77],0.0052436220612178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,18107,82,1.35 [1.07-1.71],0.0126504224115554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1,DNA topoisomerase 1,18042,82,1.10 [0.92-1.31],0.3092298033517275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1MT,"DNA topoisomerase I, mitochondrial",17467,80,0.85 [0.52-1.42],0.5409247499390668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP2B,DNA topoisomerase 2-beta,17564,80,1.20 [0.93-1.56],0.1607302775692878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOR1AIP1,Torsin-1A-interacting protein 1,17604,78,0.96 [0.64-1.46],0.8643187584068164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53,Cellular tumor antigen p53,20402,95,1.07 [0.70-1.63],0.7550180582980126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53BP1,TP53-binding protein 1,17564,80,1.52 [1.19-1.93],0.0006593654328073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53I3,Quinone oxidoreductase PIG3,17313,80,1.11 [0.76-1.62],0.5781544480996271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,20501,98,1.26 [0.75-2.14],0.3848020379800099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP73,Tumor protein p73,17606,79,0.75 [0.40-1.44],0.3922009166219345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPBGL,Trophoblast glycoprotein-like,17606,79,0.63 [0.34-1.17],0.1438158658270946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPD52L2,Tumor protein D54,17690,82,1.00 [0.82-1.21],0.9976637515206552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPK1,Thiamin pyrophosphokinase 1,18107,82,0.43 [0.19-0.94],0.0334093266725437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPM3,Tropomyosin alpha-3 chain,17476,78,1.20 [0.78-1.86],0.4040082412667571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPMT,Thiopurine S-methyltransferase,20402,95,0.68 [0.52-0.89],0.0048136483455461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,20711,98,1.99 [1.51-2.61],8.731539058390574e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP2,Tubulin polymerization-promoting protein family member 2,17790,82,1.06 [0.81-1.38],0.6850958137041195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP3,Tubulin polymerization-promoting protein family member 3,20435,99,0.35 [0.20-0.62],0.000284899650771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPR,Nucleoprotein TPR,17476,78,1.35 [0.96-1.91],0.0875428082772657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPRKB,EKC/KEOPS complex subunit TPRKB,17467,80,0.94 [0.67-1.32],0.7154267258782462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSAB1,Tryptase alpha/beta-1,21093,101,1.48 [1.05-2.09],0.0246561017320645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSD1,Tryptase delta,18071,81,1.74 [1.22-2.48],0.0023197604674639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSG1,Tryptase gamma,17564,80,1.10 [0.52-2.37],0.7989730494535956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPT1,Translationally-controlled tumor protein,20526,99,1.14 [0.90-1.43],0.2758973854135608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF2,TNF receptor-associated factor 2,20854,99,0.98 [0.76-1.27],0.906208151521776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",17564,80,0.90 [0.48-1.66],0.7283893117599907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,17476,78,1.20 [0.83-1.74],0.3282966204148689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,17790,82,1.09 [0.86-1.37],0.4784878026481509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREH,Trehalase,18104,80,1.93 [1.40-2.65],5.142841584224815e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,20847,98,2.43 [1.85-3.19],1.964562849541936e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML1,Trem-like transcript 1 protein,18123,81,1.01 [0.69-1.46],0.9737386569122624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML2,Trem-like transcript 2 protein,20889,101,1.68 [1.08-2.61],0.0225098311462825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,21071,101,1.46 [1.12-1.89],0.0046730422660007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,20854,99,0.94 [0.75-1.17],0.5766580789421729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM24,Transcription intermediary factor 1-alpha,17757,82,0.97 [0.70-1.35],0.8772183103584139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,18042,82,1.13 [0.93-1.37],0.2295321943447708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM26,Tripartite motif-containing protein 26,17467,80,1.01 [0.68-1.51],0.9632679400525967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM40,E3 ubiquitin ligase TRIM40,17606,79,1.21 [0.91-1.61],0.1963368194670724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM5,Tripartite motif-containing protein 5,20854,99,1.06 [0.86-1.30],0.6121182166433898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,18044,80,1.17 [0.93-1.48],0.1816647898784591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,17476,78,0.72 [0.47-1.11],0.1332431643699807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC1,Hamartin,17564,80,1.17 [0.92-1.50],0.2022394802422017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC22D1,TSC22 domain family protein 1,18071,81,1.20 [0.89-1.61],0.2238089075784721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSHB,Thyrotropin subunit beta,20881,98,0.72 [0.56-0.93],0.012029857725855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSLP,Thymic stromal lymphopoietin,20501,98,1.10 [0.83-1.46],0.499211801845337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSNAX,Translin-associated protein X,17476,78,0.62 [0.36-1.08],0.0902182614384479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN1,Tetraspanin-1,20501,98,0.79 [0.61-1.02],0.0747765812445607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN15,Tetraspanin-15,17476,78,1.38 [1.01-1.87],0.0416973024372893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN7,Tetraspanin-7,17515,78,0.71 [0.50-0.99],0.044796546375151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN8,Tetraspanin-8,18042,82,1.14 [0.91-1.42],0.2656056125248616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPYL1,Testis-specific Y-encoded-like protein 1,17564,80,0.82 [0.47-1.43],0.4836628202998037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TST,Thiosulfate sulfurtransferase,20402,99,1.12 [0.89-1.41],0.3437610851148988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTF2,Transcription termination factor 2,17606,79,1.07 [0.72-1.60],0.7330695325292329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTN,Titin,17476,78,1.40 [1.08-1.82],0.0104363571028742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTR,Transthyretin,17933,81,0.31 [0.14-0.66],0.0024947061354801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TUBB3,Tubulin beta-3 chain,17515,78,0.81 [0.37-1.78],0.5981673191638255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TWF2,Twinfilin-2,18104,80,1.06 [0.83-1.35],0.6661121095673004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXK,Tyrosine-protein kinase TXK,17790,82,1.06 [0.80-1.42],0.6668719367141032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXLNA,Alpha-taxilin,20696,99,1.20 [0.98-1.48],0.0779081012286288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXN,Thioredoxin,17835,78,0.57 [0.32-0.99],0.0454160979635608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC15,Thioredoxin domain-containing protein 15,20948,102,2.20 [1.21-4.00],0.0097849803552793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,21081,102,1.47 [1.16-1.86],0.0014207587962388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC9,Thioredoxin domain-containing protein 9,18060,81,1.08 [0.75-1.56],0.6676323895735932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNL1,Thioredoxin-like protein 1,17484,78,1.01 [0.81-1.27],0.9028667296421904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",20889,101,1.17 [0.82-1.67],0.3844750550272913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYMP,Thymidine phosphorylase,20755,98,1.16 [0.89-1.52],0.2747798267943884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,20881,98,2.47 [1.34-4.57],0.0037861981817309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",17564,80,1.63 [1.15-2.33],0.006679848534141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBAC1,Ubiquitin-associated domain-containing protein 1,20792,98,0.37 [0.21-0.64],0.0003482543098029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,18044,80,0.77 [0.36-1.62],0.4894190724585043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,18107,82,1.26 [0.91-1.76],0.1657182985935809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,17564,80,1.13 [0.80-1.59],0.4804515461540589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBQLN3,Ubiquilin-3,17476,78,1.24 [0.94-1.64],0.1255172981919438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBXN1,UBX domain-containing protein 1,17690,82,0.86 [0.64-1.17],0.3523650838587961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,18042,82,1.02 [0.88-1.19],0.7490593133351438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UGDH,UDP-glucose 6-dehydrogenase,17476,78,1.22 [1.03-1.44],0.0243674811204819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,17476,78,0.78 [0.39-1.55],0.4819492499626762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,20696,99,4.01 [2.97-5.42],1.4275278345742546e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,21067,100,0.39 [0.31-0.50],5.2849176758273606e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC5D,Netrin receptor UNC5D,17564,80,2.77 [1.41-5.47],0.0032294894368538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC79,Protein unc-79 homolog,17467,80,1.21 [0.84-1.76],0.306110155428924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNG,Uracil-DNA glycosylase,18044,80,1.20 [0.68-2.11],0.5323070433254131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPB1,Beta-ureidopropionase,18107,82,1.38 [1.13-1.69],0.0017704291510693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3A,Uroplakin-3a,17515,78,0.77 [0.48-1.23],0.2681372709872027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3BL1,Uroplakin-3b-like protein 1,17752,82,1.18 [0.84-1.65],0.3319930717793682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROD,Uroporphyrinogen decarboxylase,17690,82,0.85 [0.63-1.15],0.2846527654140846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROS,Uroporphyrinogen-III synthase,17606,79,0.70 [0.48-1.00],0.0511008698686648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USO1,General vesicular transport factor p115,20792,98,1.03 [0.84-1.26],0.7937750450150186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,18044,80,1.13 [0.85-1.50],0.3979204120042295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,18060,81,1.81 [1.30-2.52],0.0003966516032924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,17476,78,0.99 [0.77-1.27],0.9426205008520808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,20501,98,1.02 [0.85-1.24],0.8072351346736507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UXS1,UDP-glucuronic acid decarboxylase 1,20402,95,1.17 [0.83-1.66],0.3669890340301857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP5,Vesicle-associated membrane protein 5,20501,98,1.49 [1.16-1.91],0.0018579902559904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP8,Vesicle-associated membrane protein 8,17564,80,1.16 [0.92-1.46],0.2218300851191735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,20854,99,0.99 [0.80-1.22],0.916203582845063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASN,Vasorin,20575,97,3.10 [1.67-5.76],0.0003544548156968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASP,Vasodilator-stimulated phosphoprotein,18123,81,1.06 [0.80-1.39],0.7016149966998975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,20792,98,0.52 [0.27-0.99],0.0450104375875163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAV3,Guanine nucleotide exchange factor VAV3,17515,78,0.99 [0.79-1.23],0.9031723307727428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,20956,98,7.73 [5.24-11.39],4.9164224256948235e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAN,Versican core protein,21081,102,2.32 [1.31-4.12],0.0038546591055563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCPKMT,Protein-lysine methyltransferase METTL21D,17467,80,1.02 [0.79-1.32],0.8638504511903893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,21065,101,1.79 [1.36-2.36],2.767512203061128e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,17564,80,3.90 [2.05-7.42],3.278611265101316e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFC,Vascular endothelial growth factor C,20948,102,1.11 [0.82-1.51],0.4982666474237788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,21101,101,5.16 [3.37-7.89],3.72154106342194e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VGF,Neurosecretory protein VGF,18071,81,1.65 [0.88-3.12],0.1215001355492026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIM,Vimentin,20501,98,1.03 [0.87-1.22],0.7538542992130816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,17604,78,0.69 [0.26-1.82],0.4523794963524639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIT,Vitrin,18107,82,1.52 [0.88-2.63],0.1348588295211946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,20792,98,1.93 [1.45-2.55],4.904429453802931e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN1,Pantetheinase,18123,81,1.05 [0.79-1.41],0.7291843396184237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN2,Vascular non-inflammatory molecule 2,20792,98,1.45 [0.96-2.18],0.0768100628192941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,17790,82,1.08 [0.80-1.47],0.600727459556208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS37A,Vacuolar protein sorting-associated protein 37A,20792,98,1.10 [0.88-1.36],0.405089640601343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS4B,Vacuolar protein sorting-associated protein 4B,18044,80,0.99 [0.80-1.24],0.9549513472982938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,20792,98,1.11 [0.89-1.38],0.3754320971875411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,18044,80,1.66 [1.02-2.69],0.0403593265316871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,17476,78,1.67 [1.00-2.79],0.0512249084550545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,18044,80,2.59 [2.08-3.22],8.861836124791416e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,20863,101,5.64 [4.27-7.45],4.2609489208598075e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,20849,98,1.34 [1.05-1.71],0.0203342450480464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSNL1,Visinin-like protein 1,18060,81,0.83 [0.47-1.48],0.5259443852497453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM1,V-set and transmembrane domain-containing protein 1,20435,99,1.42 [1.06-1.91],0.0195663826706375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,17790,82,0.78 [0.42-1.45],0.4399200313024798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,20501,98,1.41 [1.12-1.79],0.0037338143334903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,21081,102,0.85 [0.67-1.07],0.1681511857715175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,20402,95,2.42 [1.65-3.57],7.523027210042941e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,17690,82,1.45 [1.03-2.02],0.031959342866157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA1,von Willebrand factor A domain-containing protein 1,21046,101,1.47 [0.97-2.22],0.0705758859467232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA5A,von Willebrand factor A domain-containing protein 5A,17467,80,1.03 [0.77-1.37],0.8601346935322546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,20629,98,2.82 [1.88-4.21],4.699201333517965e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,18071,81,1.21 [0.81-1.82],0.3498339237660132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWF,von Willebrand factor,21140,101,1.54 [1.21-1.94],0.000338540489776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",20889,101,1.21 [0.76-1.93],0.430047744441366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WAS,Wiskott-Aldrich syndrome protein,20526,99,1.14 [0.88-1.49],0.3122525638497288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,20501,98,1.05 [0.87-1.27],0.6040215145033319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,20435,99,0.98 [0.79-1.21],0.8217709462227252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASHC3,WASH complex subunit 3,18060,81,1.33 [1.03-1.71],0.0261525859550335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASL,Neural Wiskott-Aldrich syndrome protein,17564,80,1.00 [0.68-1.45],0.982097522505404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WDR46,WD repeat-containing protein 46,18044,80,1.00 [0.56-1.78],0.9947115671126142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,17665,79,1.66 [1.32-2.07],1.1335323951892374e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC12,WAP four-disulfide core domain protein 12,21028,101,1.45 [1.12-1.88],0.0050101409244594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,19843,97,3.28 [2.63-4.09],6.941852230312419e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",20618,99,0.35 [0.23-0.53],1.4428112661002791e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",20878,98,1.97 [1.13-3.42],0.0168494877171323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WIF1,Wnt inhibitory factor 1,21071,101,0.42 [0.25-0.72],0.0014931695887319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,20526,99,3.78 [2.66-5.37],1.0343259180533653e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,20696,99,0.93 [0.66-1.32],0.690269386670948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,21071,101,1.73 [1.38-2.17],1.7343803719067144e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,21047,101,2.67 [1.82-3.94],6.430170818034026e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XIAP,E3 ubiquitin-protein ligase XIAP,17564,80,1.26 [0.88-1.79],0.1999334501878906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,20948,102,0.75 [0.65-0.87],0.0001564317518498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XRCC4,DNA repair protein XRCC4,20435,99,0.98 [0.61-1.58],0.9264799358919544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,18060,81,3.93 [2.86-5.41],4.0751140254988355e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",18042,82,1.03 [0.89-1.19],0.6657831179050783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YES1,Tyrosine-protein kinase Yes,20792,98,1.15 [0.98-1.34],0.0918479113639536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YJU2,Splicing factor YJU2,18044,80,1.05 [0.59-1.89],0.8634594709924368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YOD1,Ubiquitin thioesterase OTU1,17476,78,0.59 [0.41-0.85],0.0047963223887114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YTHDF3,YTH domain-containing family protein 3,20526,99,1.00 [0.81-1.23],0.9979986428811364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YWHAQ,14-3-3 protein theta,17690,82,0.97 [0.74-1.28],0.8277102346264408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YY1,Transcriptional repressor protein YY1,17564,80,2.22 [1.20-4.10],0.0106826486336563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBP1,Z-DNA-binding protein 1,17564,80,1.27 [0.78-2.06],0.3416711409143155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,20402,95,1.36 [1.10-1.70],0.0054991169164197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,20501,98,1.28 [0.92-1.77],0.1441779708080006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,17476,78,0.92 [0.62-1.38],0.6881339641683212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZFYVE19,Abscission/NoCut checkpoint regulator,18042,82,0.97 [0.77-1.23],0.8129291981816212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZHX2,Zinc fingers and homeoboxes protein 2,18060,81,1.33 [0.79-2.22],0.2796607709489488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF174,Zinc finger protein 174,17564,80,0.95 [0.50-1.79],0.8682953134554885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF75D,Zinc finger protein 75D,17790,82,0.88 [0.61-1.27],0.4846573100423652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF830,Zinc finger protein 830,18044,80,0.75 [0.54-1.05],0.0900051077611515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,18042,82,1.93 [1.52-2.47],1.1686352899394193e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,18044,80,1.12 [0.77-1.63],0.5560840090340837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP3,Zona pellucida sperm-binding protein 3,17604,78,1.05 [0.96-1.15],0.267024642348463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP4,Zona pellucida sperm-binding protein 4,17467,80,0.92 [0.45-1.88],0.8154263188920146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZPR1,Zinc finger protein ZPR1,17515,78,1.00 [0.82-1.21],0.9858042428034676
